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SUMMARY
The UL9 gene is one of seven genes which map within 
the long unique region of the HSV-1 genome and are both 
necessary and sufficient for viral origin-dependent DNA 
replication in transfected tissue culture cells. The UL9 
gene encodes a polypepetide of 851 amino acids which 
binds specifically to the HSV-1 replication origins orig 
and oriL. From DNase I footprinting and gel retardation 
analyses, two binding sites for the origin binding 
protein (OBP) have been identified within both of these 
origins. Previous work (Weir et al., 1989) demonstrated 
that the sequence-specific recognition and binding 
activities resided within the C-terminal 317 amino acids 
of the UL9 protein.
My work has involved a mutational analysis of the UL9 
DNA binding domain in an attempt to define the regions 
involved in interaction with its target sequence.
Using an E .coli expression system, a series of C- 
terminal deletion (with 1 6 - 6 2  amino acids deleted) and 
small in-frame insertion mutants of the DNA binding 
domain were constructed and expressed as fusions linked 
to the N-terminal one third of the Staphylococcus aureus 
protein A. This system enabled easy detection of mutant 
proteins in Western blot assays by virtue of interaction 
of the Fc portions of the antibody conjugates with the 
protein A moieties. Fusions proteins were tested for 
sequence-specific DNA binding activity using gel 
retardation assays. Protein extracts were incubated with 
radio-labelled oligonucleotides containing orig binding 
sites I or II or a 100 bp fragment containing a 
functional orig (i.e. both sites) at 22°C or 37°C. 
Retarded complexes were resolved by electrophoresis 
through non-denaturing polyacrylamide gels. Analysis of 
C-terminal truncations demonstrated that the C-terminal 
33 amino acids of UL9 are dispensable for binding and 
that essential residues lie between amino acids 801 and 
818. Analysis of a set of ten mutants containing 
insertions of four amino acids at various positions 
identified different regions of the UL9 DNA binding
domain in which insertions either had little effect upon 
(insertions at amino acids 691, 708, 719, and 838) or 
abolished (insertions at amino acids 581, 591, 652 and 
668) sequence-specific DNA binding. Two mutants with 
insertions at amino acids 630 and 7 99 which were 
intermediate in their binding activity were also shown to 
exhibit temperature- or sequence-specific effects.
These results suggest that the UL9 DNA binding domain 
contains at least two distinct regions which are 
important for sequence-specific DNA binding.
Selected mutations were introduced into the full 
length UL9 open reading frame to investigate whether the 
alterations had any effect on the replicative function of 
the intact protein. The resulting mutant UL9 proteins 
were individually expressed under the control of the 
strong polyhedrin promoter in recombinant baculoviruses. 
This expression system was chosen because it allows 
mutant HSV-1 DNA replication proteins to be both 
overexpressed (facilitating biochemical studies) and 
screened for ability to participate in origin-dependent 
DNA replication (Stow, 1992) .
I confirmed that multiple infection of Spodoptera 
frugiperda insect cells with seven recombinant 
baculoviruses expressing the seven essential HSV-1 
replication proteins can facilitate replication of a co­
transfected HSV-1 orig-containing plasmid. By 
substituting the wt UL9 recombinant baculovirus with each 
of the mutant UL9 viruses, the effect of the alterations 
on UL9 function in origin-dependent DNA replication was 
investigated.
Each of the mutations which had been previously shown 
to abolish DNA binding activity also prevented 
replication of the orig-containing plasmid suggesting 
that interaction of UL9 with the origin is essential for 
the process of DNA replication. Of the mutant proteins 
which retained their DNA binding activity, one failed to 
promote replication of the origin containing plasmid 
while the others showed wt or diminished levels of 
activity. These results suggest that the C-terminal 
domain of the UL9 protein may have essential functions in
DNA replication in addition to its origin-binding 
activity.
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CHAPTER Is INTRODUCTION
The work presented in this thesis is concerned with 
the interaction of the herpes simplex virus type 1 origin 
binding protein UL9, with the viral origins of DNA 
replication and includes a mutagenic analysis of the C- 
terminal DNA binding domain. The following introduction 
briefly describes the virus and its life cycle and 
reviews our understanding of herpes simplex virus DNA 
replication. A brief comparison with other origin binding 
protein/DNA interactions during initiation of DNA 
replication is also included.
1.1 THE HERPESVIRUSES
1.1.1 The Family herpesviridae
The members of the family herpesviridae form a large 
group of DNA containing viruses which have been isolated 
from a wide range of higher eukaryotic hosts (Roizman et 
al., 1992).
The family is characterised on the basis of distinct 
morphological properties of the virion; all members 
possess a large double-stranded DNA genome present within 
an enveloped particle, 150-200 nm in diameter. The virus 
particle is composed of four distinct elements, namely 
the core, the capsid, the tegument and the envelope. The 
core contains the genomic DNA (Booy et al., 1991). It is 
surrounded by an icosohedral shaped capsid assembled from 
162 capsomeres of which 150 are hexomeric and 12 are 
pentameric prisms (Wildy et al., 1960; Schrag et al.,
198 9). The tegument is described as a layer of amorphous, 
proteinaceous material between the core and the outer 
lipid envelope. The envelope is the outermost structure 
of the virus and consists of a lipid bilayer derived from 
host cell nuclear and plasma membranes from which 
protrude numerous viral-encoded glycoprotein spikes of 
approximately 8 nm in length (Wildy and Watson., 1962; 
Spear and Roizman., 1972).
In addition to having common morphological
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characteristics, the herpesviruses share the ability to 
establish and maintain a latent state in their infected 
hosts. The wide occurrence of herpesviruses in 
vertebrates and their high degree of species specificity 
suggest that they have evolved in close association with 
their hosts. Historically they have been classified into 
three sub-families, referred to as alphaherpesvirinae, 
betaherpesvirinae and gammaherpesvirinae on the basis of 
their biological properties such as host range, 
reproductive cycle, cytopathology and characteristics of 
latent infection, rather than their genetic properties 
(Roizman, 1982; Mathews, 1982).
Alphaherpesvirinae
Many Members of this subfamily are neurotropic and exhibit 
a wide in vitro host range. The reproductive
cycle is short, usually less then 24 hours in cell 
culture, and results in the destruction of the 
susceptible cell. Latent infections are frequently 
established in the ganglia. Examples within this group 
include herpes simplex virus type 1 and type 2 (HSV-1 and 
HSV-2, respectively), varicella-zoster virus (VZV) and 
pseudorabies virus (PRV).
Betaherpesvirinae
This group exhibits a restricted host range and a 
longer reproductive cycle. Infection frequently results 
in an enlargement of the cells, and the establishment of 
latency may occur in a variety of tissues including 
secretory glands, kidneys and lymphoreticular cells.
Human cytomegalovirus (HCMV) is a member of this sub­
family .
This sub-family also has a narrow host range which is 
usually restricted to B or T lymphocytes. The length of 
reproductive cycle and cytopathology are variable and 
latent infections are frequently established in lymphoid 
tissue. This family includes Epstein-Barr virus (EBV).
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Comparisons of the predicted amino acid sequences of 
many herpesvirus proteins have shown that genetic 
relationships between individual viruses exist which are 
in general agreement with the biological classification. 
However some exceptions do exist e.g. human herpesvirus 6 
(HHV6). Originally, HHV6 was assigned to the 
Gammaherpesvirinae on the basis of its tropism for 
lymphocytes. However, on the basis of sequence homology 
and gene organisation, HHV6 is related to HCMV and more 
properly belongs to the Betaherpesvirinae. The existence 
of certain "core" genes common to all the subfamilies 
suggests that viruses belonging to these subfamilies 
share a common evolutionary origin 
(Reviewed by McGeoch, 1992).
The recent determination of the complete DNA sequence 
of channel catfish virus, which had previously been 
classified as a alphaherpesvirus, and which is 
morphologically indistinguishable from other 
herpesviruses (Wolf and Darlington, 1971), revealed only 
very distant relationships to any other herpesvirus 
(Davison, 1992). This may indicate a wider evolutionary 
divergence amongst herpesviruses than previously 
suspected or possibly a separate evolutionary origin for 
this virus.
1.1.2 The Pathogenicity of HSV-1
To date, seven herpesviruses have been described which 
are known to infect humans, namely HSV-1, HSV-2, VZV, EBV, 
HCMV, HHV-6 and HHV-7.
Herpes simplex virus (HSV) is an unusual virus in 
that it can cause a variety of clinical diseases. These 
diseases can be divided into two forms; those due to a 
primary infection and those resulting from reactivation 
of the latent virus.
In humans, infection with HSV-1 typically occurs 
early in life and the virus is transmitted by close 
physical contact. The most common clinical form of 
infection is associated with cold-sore lesions of the
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infections of the eye (herpes keratoconjunctivitis). The 
genital region is also a common site for primary 
infection by HSV taking the form of vesicular eruptions. 
HSV-2 infection is largely associated with these genital 
lesions although in an increasing number of cases they 
have been shown to be as a result of an HSV-1 infection. 
HSV-2 infections are usually sexually transmitted but 
severe generalised infections can also occur at birth as 
a result of a genital infection of the mother (Whitley et 
al., 1985) .
Despite recovery from a primary infection, HSV can 
establish a long term latent infection in the neuronal 
cells of the sensory ganglia and brain (Stevens and 
Cook., 1971; Baringer and Swoveland., 1973; Cook et al., 
1974; Fraser et al., 1981). Several factors such as 
trauma, fatigue and exposure to UV light have been 
associated with reactivation of the virus and re­
occurrence of cutaneous lesions. Reactivation can occur 
sporadically throughout life.
1.1.3 HSV-1 Latency
A major characteristic feature of HSV-1 infection is 
the ability of the virus to establish its genetic 
information in a non-infectious, non-replicating latent 
state in the neuronal cells of the sensory ganglia and 
brain (Stevens and Cook, 1971; Baringer and Swoveland, 
1973; Cook et al., 1974; reviewed by Hill, 1985). It is 
this property which plays an important role in its 
pathogenesis.
Using hybridisation techniques, Puga et al, (1978) 
first detected HSV DNA in the sensory ganglia of mice 
which had been latently infected with HSV-1. The precise 
state of the viral DNA in latently infected cells is not 
clear. The genome does not appear to be present as a 
linear molecule as terminal fragments have never been 
detected (Rock and Fraser, 1983; Efstathiou et al.,
1986) , and integration of the viral DNA into the host 
genome does not occur (Rock and Fraser, 1983; Mellerick 
and Fraser, 1987). It is therefore thought that the viral
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genome exists extrachromosomally as a circle or less 
likely a concatemer.
Limited transcription of the latent HSV-1 genome 
results in the accumulation of latency-associated 
transcripts (LATS) in the nuclei of latently infected 
cells (Stevens et al., 1987; Rock et al., 1987; Spivak 
and Fraser., 1987; Steiner et al., 1988; Wagner et al., 
1988a). Three LATs of 2, 1.5 and 1.45 kb in length which 
are transcribed from within the inverted repeat sequences 
flanking the Ul region have been identified (Spivak and 
Fraser, 1987; Wagner et al., 1988a). These transcripts 
partially overlap the immediate early gene 1 (IE-1) mRNA, 
but are transcribed from the opposite strand (Spivak and 
Fraser., 1987; Stevens et al., 1987). Open reading 
frames within the LATs have been proposed (Perry and 
McGeoch, 1988; Weschler et al., 1988). However, neither 
unique polyadenylated cytoplasmic LAT messages nor 
encoded polypeptides have been detected (Wagner et al.,
19 8 8 a; b) .
The isolation of an HSV-l/HSV-2 recombinant which was 
deficient in LAT expression but was still able
to establish a latent infection in mice suggested that 
LATs do not play an essential role in the establishment 
of latency (Javier et al., 1988). Using a rabbit eye 
model, the same mutant was shown to possess an impaired 
ability to re-activate in vivo (Hill et al., 1990). A 
similar situation was observed with the deletion mutant 
1704 (Maclean and Brown, 1987). Although the mutant was 
able to establish a latent infection in mice, re­
activation of the virus from explanted ganglia was found 
to be slower than that of the wt virus (Steiner et al., 
1989). Taken together, these studies suggest that the 
LATs, although not necessary for latency establishment, 
may have a role in mediating the frequency of viral 
reactivation.
Both in vivo and in vitro models have been used to 
study the viral requirements for the establishment, 
maintenance and reactivation of a latent HSV-1 infection 
(Wigdah) e t a l ., 1982; Shiraki and Rapp., 1986; Russell
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and Preston., 1986). As yet, no gene products have been 
shown to be specifically required for establishment and 
maintenance (Polvino-Bodnar et al., 1987; Meigneir et 
al., 1988; Russell et al., 1987). However, the immediate 
early protein VmwllO (Russell et al., 1987; Harris et 
al., 1989; Clements and Stow, 1989), the viral thymidine 
kinase (Coen et al., 1989; Efstathiou et al., 1989;
Tenser et al., 1989) and the HSV ribonucleotide reductase 
(RR) (Jacobsen et al., 1989) appear to be important for 
reactivation in various assays.
1.1.4 The HSV-1 Genome
(a) Structure of the HSV-1 Genome
The HSV-1 genome is a large, linear ds molecule 
containing approximately 152 kb of DNA with a molecular 
weight of approximately 10x10^ kDa (Becker et al.,
1968; Kieff et al., 1971). Electron microscopic studies 
and restriction endonuclease mapping have shown that the 
genome consists of two covalently linked components, 
referred to as the Long (L) and Short (S) segments, 
(Figure 1.). Both segments contain unique sequences, Ul 
(unique, long) and Ug (unique, short) which are flanked 
by large terminal and internal inverted repeats; TRl ,
IRl (terminal and internal repeat, long) and TRg, IRg 
(terminal and internal repeat, short). The sequences of 
the L and S inverted repeats are distinct from one 
another (Sheldrick and Berthelot, 1974; 1975; Hayward et 
al., 1975). A direct repeat of about 400 bp, termed the 
"a" sequence is present at each end of the genome 
(Davison and Wilkie, 1981). A single copy of this 
sequence is found at the S terminus, one or more at the L 
terminus and a variable number are located, in an 
inverted orientation, at the junction between the L and S 
segments (Roizman et al., 1979). A single residue 3' 
overhang occurs at both genome termini (Davison and 
Wilkie, 1981; Mocarski and Roizman, 1982a;b).
The two unique regions can invert relative to one 
another and preparations of HSV-1 DNA from plaque
6
Figure 1. Organisation of the HSV-1 Genome
The viral genome which comprises of two covalently 
linked segments L and S is shown. Each segment contains 
unique sequences Ul and Ug (solid lines) flanked by 
terminal and internal inverted repeat elements TRl and 
IRl / TRg and IRg respectively (open and shaded boxes). A 
direct repeat, termed the "a" sequence is present at 
each end of the genome and also in inverted orientation 
at the L - S junction. Inversion of the L and S 
components occurs and preparations of viral DNA contain 
an equimolar mixture of four isomeric molecules 
(orientation of segments indicated by arrows). These 
have been designated P (prototype), Ig (inversion of S), 
IL (inversion of L) and Il s (inversion of both L and S).
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purified virus have been found to contain an equimolar 
mixture of four isomeric forms, differing from one 
another in the relative orientation of Ul with respect 
to Us (Figure 1.). These isomers heve been designated 
P (prototype), Is (inversion of S), II (inversion of L) 
and Ils (inversion of both L and S), (Hayward et el., 
1975; Delius and Clements, 1976; Wilkie and Cortini,
1976; Roizman., 1979).
The prototype arrangement of the genome was chosen 
for mapping purposes (Roizman, 1979; McGeoch et al.,
1988). The internal recombination events which create all 
four isomers appear to be mediated by the "a" sequence 
(Mocarski and Roizman, 1982a;b). There is also evidence 
to suggest that all four isomers are able to take part in 
the production of infectious progeny (Davison and Wilkie, 
1983a) and participate in latent infections (Efstathiou 
et al., 1986). The isolation of viable HSV-1 mutants 
with genomes frozen in each of the four isomeric forms 
suggests that inversion is not essential for viral 
replication (Jenkins and Roizman, 1986).
The complete genome of HSV-1 strain 17 syn+ has been 
sequenced (McGeoch et al., 1985; 1986; 1988a; Rixon and 
McGeoch, 1985; Perry and McGeoch, 1988) and contains 
152,260 bp, (small variations in length occur due to 
differences in copy number of the "a" sequence and other 
tandemly repeated sequences), with a mean G+C% base 
composition of 68.3%. Three other human herpesviruses 
have also been completely sequenced; VZV, EBV and HCMV. 
DNA hybridisation studies have shown that as well as 
having similar gross structures, HSV-1 and HSV-2 genome 
sequences are related and closely co-linear. The parts of 
Ug and Ul of the HSV-2 strain HG52 which have been 
sequenced exhibit a 70 - 80% nucleotide identity within 
coding sequences with corresponding HSV-1 genes (Davison 
and Wilkie, 1981; 1983; Swain and Galloway, 1983; Swain 
et al., 1985; Lockshon and Galloway, 1986; Draper et al., 
1986; McGeoch et al., 1987; Worrad and Caradonna, 1988).
(b) Genetic Content of HSV-1
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DNA sequence analysis identified a high percentage of 
the HSV-1 genome as having protein coding potential. A 
total of 72 open reading frames, with the potential to 
encode 70 distinct polypeptides were initially identified 
within the L and S regions of the genome (Figure 2).
Fifty six genes, UL1 - UL56, were located within the Ul 
region and twelve, US1 - US12, within Ug. HSV-1 contains 
one spliced gene, UL15 whose intron contains the UL16 
and UL17 ORFs. Immediate-early genes 1 and 3 (IE-1 and 
IE-3) were mapped to the Rl and Rg repeat sequences, 
and are therefore represented twice (McGeoch et al.,
1985; 1988a). A second ORF, encoding the protein ICP34.5, 
within Rl was first described in HSV-1 strain F (Chou 
and Roizman, 1986; 1990) and has since been confirmed in 
HSV-1 strain 17 (Dolan et al., 1992).
Recent data has also revealed a distinct 
transcriptional unit mapping within the UL2 6 gene. The 
product of its ORF, UL2 6.5 corresponds to the C-terminal 
329 amino acids of the UL26 protein (Liu and Roizman, 
1991). Barker and Roizman, (1992) and Barnett et al., 
(1992) have also reported the existence of an additional 
gene, designated UL4 9.5 between the UL4 9 and UL50 ORFs.
Of the genes identified, the functions of 
approximately one third remain unknown. Functions of the 
remaining gene products include roles in transcriptional 
regulation, DNA replication and virion structure and 
assembly. Eleven out of twelve genes present in the Ug 
region and at least nine of the Ul genes have been shown 
to be non-essential for viral growth in tissue culture 
(Umene, 1986; Weber et al., 1987; Longdecker and Roizman, 
1986; 1987; Baines and Roizman, 1991; MacLean et al.,
1991).
1.1.5 HSV-1 Structural Proteins
Around thirty different virion structural 
polypeptides have been detected, the majority of which 
are encoded by HSV-1 late genes (Spear and Roizman, 1972; 
Heine et al♦, 1974; Marsden et al., 1976; reviewed by 
Dargan., 1986). These proteins comprise of glycoproteins,
Figure 2. Genetic Content: of the HSV-1 Genome
C,
The viral genome is represented as four succesive 
lines of 40 kb with unique sequences shown as solid 
lines and major repeat elemets as open boxes. The 
location and orientation of proposed functional open 
reading frames are shown by solid arrows and LAT 
transcripts as arrowed, dotted lines. Genes are numbered 
UL1 - UL56 and US1 - US12 plus RL1 (encoding ICP 34.5), 
RL2 (IE-1) and RSI (IE-3). The origins of DNA 
replication (orig and ori^ are also indicated.
This diagram was kindly provided by Dr. D.J. McGeoch.

tegument proteins and capsid proteins.
Glycoproteins
The HSV-1 genome encodes at least nine antigenically 
distinct glycoproteins: gB (encoded by UL27), gC (UL44), 
gD (US6 ), gE (US8 ) , gG (US4) , gH (UL22), gl (US7) , gK 
(UL53) and gL (UL1) (Spear, 1976; Marsden et al., 1978; 
1984; Bauke and Spear, 1979; Buckmaster et al., 1984; 
Roizman et al., 1984; Gompels and Minson, 198 6 ; Frame et 
al., 1986; Longnecker et al., 1987; Johnson and Feenstra, 
1987; McGeoch et al., 1985; 1987; 1988a; Hutchinson et 
al., 1992). These glycoproteins comprise the major virus- 
specific components of the virus envelope and virus- 
infected cell membranes (Spear, 1976; Roizman et al.,
1984) .
The roles of gB, gD, gC and gH in the initial stages
of infection are described later in the text. gC, gE and
gl are also believed to have functions which may modulate 
the immune response to infection (Eisenberg et al., 1987; 
Johnson and Feenstra, 1987; Dublin et al., 1990); gC 
functioning as a complement receptor and the gE/gl 
complex as an Fc receptor.
Tegument: Proteins
The tegument is the least well defined component of
the HSV-1 virion and appears as an amorphous region
present between the capsid and envelope (Spear and 
Roizman, 1972).
Tegument proteins are defined as those not found 
associated with viral capsids or envelopes which are 
released from the virion by non-ionic detergents (Roizman 
and Furlong, 1974; Spear, 1980; Lemaster and Roizman,
1980). It is uncertain how many virus encoded proteins 
constitute this region and how they are structurally 
oriented. However, major components of the tegument 
include the protein involved in transactivation of IE 
gene expression, Vmw65 (UL48), (Post et al., 1981; 
Batterson and Roizman, 1983; Campbell et al., 1984), and 
the 81/82 kDa products of the UL47 gene (McLean et al.,
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1990) which have been implicated in the modulation of 
Vmw65 activity (McKnight et al., 1987).
Capsid Proteins
Among the approximately thirty structural proteins 
which constitute the HSV-1 virion, only seven are 
components of the nucleocapsid.
Capsids isolated from HSV infected cells are either 
"full", (containing viral DNA) or "empty", (lacking viral 
DNA). Initial experiments identified four proteins, VP5, 
VP19c, VP23 and VP24 as components of empty viral capsids 
from the nuclei of infected cells (Gibson and Roizman, 
1972). A fifth protein pl2, with a molecular weight of 12 
kDa, was subsequently identified (Heilman et al., 1979; 
Cohen et al., 1980). Two other proteins, unique to full 
capsids, VP21 and VP22a, have also been identified.
VP5 (ICP5) is referred to as the major capsid protein 
and is the product of the UL19 gene (Davison and Scott, 
1986b; McGeoch et al., 1988a). It forms the hexameric and 
possibly the pentameric capsomeres of the capsid (Schrag 
et al., 1989). VP19c is a DNA binding protein identified 
by direct amino acid sequencing of purified capsid 
proteins as the product of the UL38 gene (Rixon et al.,
1990). A similar approach demonstrated that VP23 is 
encoded by the UL18 gene.
VP22a and VP21 are components of the core region of 
full capsids.'Preston et al, (1983) proposed that the 
VP22a protein was encoded by the UL2 6 gene since a mutant 
with a tj> lesion within the gene was defective in VP22a 
processing. This mutant also failed to package its DNA 
into capsids at the NPT therefore implicating the protein 
in viral DNA encapsidation. McNabb and Courtney, (1992) 
have recently reported that the pl2 protein may be 
encoded by UL35. The two proteins, VP24 and VP21, have 
recently been suggested to be the products of the UL2 6 
gene (Davison et al., 1992).
1.2 HSV-1 LYTIC INFECTION
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1.2.1 Initial Stages of Infection
At present, the pathway by which HSV-1 gains entry 
into its host is not completely clear. A model for entry 
of HSV-1 has been proposed which involves a series of 
interactions between the viral envelope and the cell 
plasma membrane which trigger membrane fusion, 
nucleocapsid penetration and virion disassembly 
(Sarmiento et al., 1979; Little et al., 1981; Weller et 
al., 1983; Gompels and Minson, 1986; McGeoch and Davison, 
1986b; Ligas and Johnson, 1988; Highlander et al., 1987; 
1988; Johnson and Ligas, 1988; Desai et al., 1988; Fuller 
et al., 1989; Buckmaster et al., 1984; Fuller and Spear, 
1987; Cai et al., 1988; Herold et al., 1991).
The initial attachment of HSV-1 to cells has been 
shown to involve the binding of viral envelope 
glycoproteins to heparan sulphate proteoglycans on the 
cell surface (WuDunn and Spear, 1989; Lycke et al.,
1991). Evidence supporting this proposal came from 
observations that digestion of cell surface heparan 
sulphate can reduce HSV binding to cells (WuDunn and 
Spear, 1989) and that certain aminoglycosides can block 
the binding of the virus to its cell receptor (Langeland 
et al., 1987; 1988).
The cellular receptor for basic fibroblast growth 
factor (bFGF) was recently proposed to act as a viral 
entry point (Kaner et al., 1990). This seems unlikely, 
however, as a report by Muggeridge et al, (1992) 
demonstrated that bFGF receptor was not required for 
viral infection in most cell types.
Adsorption of HSV-1 to the cell surface is thought to 
be mediated by virally encoded glycoproteins which 
protrude from the viral envelope. It is possible that a 
non-glycoprotein component may also be involved in viral 
attachment as adsorption can take place in the absence of 
normal glycosylation (Campadelli-Fiumi et al., 1982; 
Spivak et al., 1982; Svennerholm et al., 1982; Kuhn et 
al., 1988). Initial non-specific adsorption may be 
followed by specific irreversible binding to the cell 
surface (Hochberg and Becker, 1968; Rosenthal et al.,
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1984).
Three HSV-1 envelope glycoproteins have been shown to 
be essential for viral infectivity: gB (Sarmiento et al., 
1979/ Little et al., 1981), gD (Ligas and Johnson, 1988) 
and gH (Weller et al., 1983; McGeoch and Davison, 1986; 
Gompels and Minson, 1986; Desia et al., 1988). Studies 
utilising monoclonal antibodies, liposomes containing 
virion proteins and t^s mutants, implicate these proteins 
in the processes of viral attachment, fusion of the viral 
envelope with the cell and virion entry (Deluca et al., 
1982; Bzik et al., 1984; Gompels and Minson, 1986; 
Highlander et al., 1987; Fuller and Spear, 1987; Cai et 
al., 1988; Desai et al., 1988; Fuller et al., 1989;
Fuller and Lee, 1992; Herold et al., 1991; Kuhn et al., 
1990) .
Following penetration of the host cell membrane, the 
nucleocapsid is transported through the cytoplasm to the 
nucleus where it is uncoated and the DNA is released into 
the nucleus via nuclear pores (Batterson and Roizman, 
1983). The nuclear entry process is thought to require 
the participation of a viral protein as studies with a 
HSV-1 ts mutant whose mutation was later mapped to the 
UL36 gene (McGeoch et al., 1988), identified a block in 
the release of viral DNA and an accumulation of capsids 
at the nuclear pores (Batterson et al., 1983). It is 
possible however that the mutant UL36 protein may prevent 
normal activity of cellular uncoating proteins.
1.2.2 Effect of HSV-1 Infection on Host: Cell 
Macromolecular Synthesis
Infection of cells with HSV-1 results in a rapid 
decrease in host cell macromolecular synthesis, 
degradation of cellular mRNAs and induction of viral gene 
expression (reviewed by Fenwick., 1984; Roizman and 
Roane, 1964; Nishioka and Silverstein, 1977; 1978; Schek 
and Bachenheimer, 1985; Kwong and Frenkel, 1987). The 
host cell "shut-off" activity can be divided in two 
distinct phases.
The "early shut-off" phase is mediated by one or more
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virion components and does not require viral gene 
expression (Fenwick et al., 1979; Hill et al., 1985). It 
involves a reduction in synthesis of the majority of host 
cell polypeptides (Sydiskis and Roizman, 1967; 1968) 
arising from the disaggregation of polyribosomes and the 
degradation of host mRNA (Nishioka and Silverstein, 1977; 
1978; Shek and Bachenheimer, 1985).
Studies using viable HSV-1 mutants defective in 
inducing the virion host cell shut-off (vhs), (Read and 
Frenkel, 1983) showed that the virion-mediated shut-off 
function involved the HSV-1 UL41 gene (Kwong et al.,
1988). This involvement was confirmed when insertion of 
the UL41 gene from HSV-2 strain G, which exhibits a 
strong shut-off function, into the HSV-1 strain 17, which 
is less efficient in early shut-off, was found to restore 
vhs function (Fenwick and Everett, 1990). In addition, 
HSV-2 strain HG52, which exhibits poor shut-off has been 
shown to encode a truncated UL41 product (Everett and 
Fenwick, 1990) .
UL41 gene mutants defective in vhs also produce more 
stable viral mRNAs and host mRNAs have significantly 
longer half-lives than in wt infections (Read and 
Frenkel, 1983; Kwong and Frenkel, 1987; Oroskar and Read, 
1987; 1989; Strom and Frenkel, 1987). The vhs polypeptide 
appears to provide a non-specific mRNA degradation 
function which may play a role in regulating the 
abundance and patterns of accumulation of both viral and 
cellular mRNAs (Kwong and Frenkel, 1987; Oroskar and 
Read, 1987). It has been proposed that the vhs product 
may be a RNase or may interact with a cellular factor to 
de-stabilise both host and viral mRNA (Kwong and Frenkel,
1989) .
The "delayed shut-off" phase requires the expression 
of viral genes (Fenwick and Clark, 1982; Read and 
Frenkel, 1983) and involves further reduction in the 
levels of host protein synthesis and enhanced degradation 
of host mRNA.
In contrast to the shut-off described above, the 
synthesis of some cellular polypeptides including
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cellular stress and heat-shock proteins is in fact 
stimulated during HSV-1 infection. (LaThangue et al./ 
1984; Patel et al./ 1986; Kemp et al., 1986).
1.2.3 Control of HSV-1 Gene Expression
During lytic infection of tissue culture cells by 
HSV-1 viral genes are transcribed by the host RNA 
polymerase II enzyme (Alwire et al., 1974; Preston and 
Newton, 1976; Costanzo et al., 1977) in a temporally 
regulated fashion. Three distinct phases based on the 
kinetics and characteristics of their expression can be 
identified (Honess and Roizman, 1974; Clements et al., 
1977; Jones and Roizman, 1979).
The first set of genes to be transcribed are the 
immediate early (IE) or alpha genes. The IE transcripts 
are produced in the absence of de novo protein synthesis 
(Honess and Roizman, 1975; Preston et al., 1978) and 
functional IE gene products are essential for the 
subsequent induction of early viral gene expression which 
takes place prior to the onset of viral DNA replication 
(Honess and Roizman, 1974; Clements et al., 1977; Wagner, 
1985). The IE and E gene products are in turn required 
for the expression of true late proteins (some late 
proteins are expressed before DNA replication) and viral 
DNA synthesis (Honess and Roizman, 1974; Jones and 
Roizman, 1979; Clements et al., 1977).
(a) Immediate Early Genes
The HSV-1 genome posseses five IE genes: IE-1, IE-2 
(UL54), IE-3, IE-4 (US1) and IE-5 (US12), which encode 
the polypeptides Vmw 110, Vmw63, Vmwl75, Vmw68 and Vmwl2 
respectively. All the IE genes, with the exception of IE- 
2 , have promoters located within the repeat regions of 
the genome. IE-1 and IE-3 are located wholely within the 
Rl and Rg repeats respectively and are therefore 
represented twice (Watson et al., 1979; Anderson et al., 
1980; Mackem and Roizman, 1980 Marsden et al., 1982;
Rixon et al., 1982). The IE-4 and IE-5 genes have 
identical promoters and 5' untranslated leader sequences
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present in the Rg region, but their coding sequences 
differ and are located at opposite ends of the Ug region 
(Watson et al., 1981). The IE-2 gene maps entirely within 
the Ul sequence (Whitton et al., 1983).
Studies of the IE promoter regions have revealed the 
presence of multiple cis-acting elements upstream of 
the transcriptional initiation start site, which are 
recognised by both viral and cellular trans-acting 
proteins (Mackem and Roizman, 1980; 1981; Murchie and 
McGeoch, 1982; Whitten et al., 1983; Whitton and 
Clements, 1984a). Two distinct components are contained 
within these promoters. A "TATA" box sequence, located 
about 20-30 nucleotides upstream of the mRNA start site 
is necessary for basal and induced levels of 
transcription (Mackem and Roizman, 1982a;b;c; Cordingly 
et al., 1983; Preston et al., 1984; Kristie and Roizman, 
1984; Bzik and Preston, 1986) . Further upstream, a 
separate domain containing multiple cis-acting elements 
confers enhancer functions and responsivity to the 
regulation of IE expression by Vmw65.
The upstream regulatory regions contain "GC-rich" 
elements (GC-boxes), which function as binding sites for 
the transcriptional activator Spl (Jones and Tjian.,
1985; Briggs et al., 1986), in addition to a consensus 
sequence, TAATGARAT (where R is a purine), which is 
present in one to three copies, in either orientation 
(Mackem and Roizman, 1982c; Whitton et al., 1983;
Whitton and Clements, 1984; Preston et al., 1984; Gaffney 
et al., 1985).
The specific induction of IE gene transcription is 
mediated via the TAATGARAT element by the tegument 
protein Vmw65 (VP16), encoded by the UL4 8 gene (Mackem 
and Roizman, 1982b; Kristie and Roizman, 1984; Campbell 
et al., 1984; Dalrymple et al., 1985; Gaffney et al., 
1985; Bzik and Preston, 1986; O'Hare and Hayward, 1987a). 
Vmw65 alone is unable to bind directly to DNA (Marsden et 
al., 1987), but its transactivation activity has been 
proposed to arise from a physical interaction with the 
cellular transcription protein Oct- 1 and one or more
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other cellular factors. These together form an immediate 
early complex (IEC) which binds specifically to the 
TAATGARAT element (McKnight et al., 1987; Preston et al., 
1988; O'Hare and Goding, 1988; Gerster and Roeder, 1988; 
Kristie et al., 1989; Ace et al./ 1988). Chemical 
modification interference analysis has demonstrated that 
Oct-1 binds to the octamer consensus sequence ATGCAAAT, 
overlapping the TAATGARAT element (ATGCAATGARAT), (Pruijn 
et al./ 1986; Fletcher et al., 1987; O'Hare and Goding,
1988) .
Mutational analyses of Vmw65 have identified a highly 
acidic domain at the C-terminus which functions as a 
potent transcriptional activating region (Triezenberg et 
al., 1988a; Sadowski et al., 1988; Cousens et al., 1989), 
and it has been proposed that Vmw65 interacts with Oct-1 
via the residual N-terminal portion (Triezenberg et al., 
1988a; Werstuck and Capone, 1989a;b).
In addition to Vmw65, the IE proteins VmwllO and 
Vmwl75 also appear to be involved in the regulation of IE 
gene expression (O'Hare and Hayward, 1985a;b; 1987;
Gelman and Silverstein, 1987a;b).
(b) Immediate Early Gene Products
Four of the IE gene products, Vmwl75, VmwllO, Vmw68 
and Vmw63 are phosphorylated nucleoproteins. Vmwl2, in 
constrast, is cytoplasmic and unphosphorylated (Pereira 
et al., 1977; Marsden et al., 1978; 1982; Fenwick and 
Walker, 1979; Hay and Hay, 1980; Wilcox et al., 1980; 
Ackerman et al., 1984) . Studies with ts_ and deletion 
mutant viruses in the five IE genes have indicated that 
only Vmwl75 and Vmw63 are absolutely essential for viral 
growth in tissue culture cells (McCarthy et al., 1989; 
Post and Roizman, 1981; Sacks et al., 1985; Sears et al., 
1985; Longnecker and Roizman, 1986; Stow and Stow, 1986;
1989) .
Vmwl75
Initial studies with HSV-1 ts_ mutants demonstrated 
that a lesion in the IE-3 gene of the tsK mutant resulted
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in the over-expression of IE gene products at the NPT. In 
addition, neither early nor late genes were expressed, 
with the exception of the large subunit of the 
ribonucleotide reductase protein. These results 
demonstrated that Vmwl75 plays a role in the stimulation 
of early and late gene promoters in addition to the 
repression of IE gene expression (Marsden et al., 1976/ 
Preston et al., 1979a; Dixon and Schaffer, 1980; Watson 
and Clements, 1980).
The stimulation of an HSV-1 E gene promoter by Vmwl75 
was subsequently demonstrated using transfection assays 
in which the presence of a plasmid expressing Vmwl75 
resulted in a marked increase in the activity of an E 
gene promoter linker to a reporter gene (Everett, 1984b; 
Quinlan and Knipe, 1985; O'Hare and Hayward, 1985a) . 
Repression of an IE promoter/CAT construct by Vmwl75 has 
also been shown in similar experiments (O'Hare and 
Hayward, 1985b; Deluca and Schaffer, 1985; Gelman and 
Silverstein, 1986).
Vmwl75 is the only IE protein known to bind 
specifically to a conserved DNA sequence, 5'-ATGCTG-3'. 
The identification of such a site within the IE-3 
(Vmwl75) promoter (Muller, 1987) led to the proposal that 
the binding of the protein to this site, which 
corresponds to the mRNA cap site, represses expression. 
Whether Vmwl75 represses the other IE promoters in a 
similar fashion is unclear as IE-1 is the only other IE 
gene to contain the binding site consensus within its 
promoter (Beard et al., 1986; Faber and Wilcox, 1986; 
Kristie and Roizman, 1986; Muller, 1987; Patterson and 
Everett, 1988). Even so, a subsequent study reported that 
although mutation of the Vmwl75 binding site within the 
IE-1 promoter reduced repression of the IE-1 promoter in 
vitro, it failed to have the same effect on VmwllO 
expression during normal HSV-1 infection (Everett and 
Orr, 1991).
In addition to recognising the ATCGTC motif, Vmwl75 
is also able to bind to other sequences (Kristie and 
Roizman, 1986; Michael et al., 1988), but as yet, no
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specific sequence responsive to Vmwl75 or indeed any 
other viral IE protein has been identified in either 
early or late promoters (Everett, 1984a; Coen et al.,
1986; Michael et al., 1988; Kattar-Cooley and Wilcox,
1989)
VmwllO
The effect of VmwllO on gene promoter activity has 
been investigated using transient expression assays 
similar to those used for the study of Vmwl75. The 
results show that VmwllO is a potent activator of gene 
expression from all three classes of virus promoters in 
addition to a number of cellular gene promoters (Everett, 
1984; O'Hare and Hayward, 1985a;b; Quilan and Knipe,
1985; Gelman and Silverstein, 1985; Mavromara-Nazos et 
al., 1986). This potent transactivation effect has been 
shown to take place with VmwllO acting independently or 
in association with Vmwl75 (Everett, 1984b; 1986; Quinlan 
and Knipe, 1985; O'Hare and Hayward, 1985a; Deluca and 
Schaffer, 1985; Gelman and Silverstein, 1986). However, 
in the context of the viral genome, VmwllO is not 
sufficient to transactivate early gene transcription 
since a functional Vmwl75 is also required (Deluca et 
al., 1985).
VmwllO has also been shown to be the only HSV-1 gene 
product required to reactivate HSV-2 from latently 
infected cells in vitro (Russell et al., 1987b; Harris 
et al., 1989).
Vmw63
Mutant viruses containing t_s lesions within the IE-2 
gene have been isolated which over-produce an abberant form 
of Vmw63 and the Vmwl75 protein at the NPT (Sacks et al.,
1985). Although the ts mutants exhibited normal levels of 
viral DNA synthesis and E gene expression, the production of 
many late gene products was restricted (Rice and Knipe,
1988) , suggesting that Vmw63 has a role in the regulation of 
late gene expression.
Activation of E gene promoters by Vmw63, in concert
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with VmwllO and Vmwl75 has been reported and there is 
also evidence that the protein can act as a trans­
repressor of transcription in combination with Vmwl75 and 
VmwllO (Sekulovich et al./ 1988; Everett, 1986; Rice and 
Knipe, 1988). Vmw63 is known to act at a post- 
transcriptional level (McLauchlan et al., 1992).
Vmw68
Characterisation of an HSV-1 deletion mutant 
revealed that Vmw68 is only essential for viral growth in 
certain cell types, suggesting that an analogous function 
may be present in other cell types (Post and Roizman,
1981). As the impaired growth correlated with a 
deficiency in late gene expression, a possible role for 
Vmw68 in late gene regulation has been suggested (Sears 
et al., 1985).
Vmwl2
Vmwl2 is the least characterised of the IE proteins. 
The function of this protein has not been defined but it 
is non-essential for viral growth in tissue culture 
(Longnecker and Roizman, 1986; Umene, 1986; Brown and 
Harland, 1987).
(c) Early Genes
Early gene expression is dependent upon promoter 
trans-activation by IE proteins (Honess and Roizman,
1974; Clements et al., 1977; Wagner, 1985; Zhang and 
Wagner, 1987; Weinheimer and McKnight, 1987). In 
comparison to IE genes, E genes appear to show a greater 
variation in the kinetics of their expression and as a 
result, have been divided into two subgroups, early 
(betai) and delayed-early (beta2 ).
The HSV-1 UL39 gene, which encodes the large subunit 
of the ribonuclotide reductase enzyme has been 
traditionally classified as an early gene product but its 
expression under IE conditions and the presence of a 
TAATGARAT element in its promoter suggest that it should 
more correctly be considered as an IE gene. (Roizman and
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Batterson, 1985; Wymer et al., 1989).
The glycoprotein, gD, is expressed as an early 
protein but is not maximally synthesised until after the 
onset of viral DNA replication (Gibson and Spear, 1983) , 
a property typical of delayed early genes (Roizman and 
Batterson, 1985; Wagner, 1985). This increased expression 
may simply reflect an increased template copy number 
(Everett and Johnson, 1986b).
Mutational analysis of the promoter regulatory 
regions of many HSV-1 early genes has failed to detect 
any specific sequences involved in their transactivation 
by VmwllO and Vmwl75. Linker scanning mutagenesis of the 
HSV-1 TK gene has identified important elements such as a 
"TATA" box upstream of the transcriptional start site,
GA- and GC-rich regions and a "CCAATT" box (McKnight et 
al., 1985; Everett, 1983; Eisenberg et al., 1985; El 
kareh et al., 1985). Binding of various cellular 
transcriptional factors such as the "CCAATT" box binding 
factor and Spl to such elements has been demonstrated 
(Jones et al., 1985; Graves et al., 1986). It has 
therefore been suggested that the transactivation of 
early gene expression by the IE gene products may be 
mediated indirectly through their interactions with 
certain cellular transcription factors (Everett, 1984b; 
Eisenberg et al., 1985; Coen et al., 1986).
Although many HSV-1 promoters contain homologies to 
"TATA", "CCAATT" and GC-rich elements, a great deal of 
diversity between promoters of genes in the same temporal 
class has been observed (Mackem and Roizman, 1982c; 
Wagner, 1985). This may explain why differential levels 
of expression are exhibited by genes belonging to the 
same class (Honess and Roizman, 1974; O'Hare and Hayward, 
1985a; Harris-Hamilton and Bachenheimer, 1985).
(d) Late Genes
In addition to requiring functional IE and E gene 
products (Watson and Clements, 1980), experiments with 
DNA synthesis inhibitors and DNA-negative tjs mutants 
demonstrated that late gene expression also shows a
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dependency on viral DNA synthesis (Honess and Roizman, 
1974; Holland et al 1980; Conley et al., 1981; Pederson 
et al., 1981).
Late genes exhibit variations in their kinetics of 
expression and are sub-divided into two groups; leaky- 
late (gammai) and true-late (gamma2 ). Leaky-late genes 
(eg. UL19 encoding the major capsid protein), are 
expressed at low levels before the initiation of DNA 
synthesis, while true-late gene products (eg UL47 which 
encodes a tegument protein, McLean et al., 1990) are 
undetectable in the absence of viral DNA synthesis 
(Roizman and Batterson, 1985; Wagner, 1985; Johnson et 
al., 1986).
Like the promoters of early genes, no sequence 
specific elements for transactivation by viral gene 
products have been identified in late promoters (Everett, 
1984b).
Late gene promoters lack the upstream regulatory 
regions which are present in IE and E promoters. Detailed 
mutational analysis of the promoter regions of two HSV-1 
late genes, US11 and UL44, demonstrated that the presence 
of a "TATA" box and a mRNA transcriptional start site, in 
combination with a cis-acting HSV-1 origin of replication 
was sufficient for full expression (Johnson and Everett, 
1986a; Homa, 1986). Indeed, deletion of the regulatory 
regions of the gD gene leaving the "TATA" box and mRNA 
cap site intact resulted in conversion of the gene from 
early to late regulation (Johnson and Everett, 1986b).
It is unclear what role viral DNA replication plays 
in late gene expression. An increased template copy 
number must contribute towards an increase in late gene 
expression but this is unlikely to be the only 
explanation as mRNA accumulation during transfection 
experiments is far greater (Johnson and Everett, 1986a). 
An alternative explanation may be that late gene 
expression is activated as a result of structural changes 
arising during the replication process (Johnson and 
Everett, 1986a; Mavromara-Nazos and Roizman, 1987).
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1.2.4 HSV-1 DNA Replication: Properties of Replicating
DMA
Analysis of parental viral DNA by restriction enzyme 
digestion suggested that following entry of the genome 
into the nucleus, it is rapidly circularised (Jacob and 
Roizman, 1977/ Poffenberg and Roizman, 1985) probably by 
direct ligation of the terminal "a" sequences (Davison 
and Wilkie, 1983; Poffenberg et al., 1983). This process 
may be facilitated by the presence of complementary 3' 
single base extensions at the L and S termini (Mocarski 
and Roizman, 1982a;b., Davison and Rixon, 1985). Either a 
host cell enzyme or a component of the virion is thought 
to carry out the ligation as de novo protein synthesis is 
not required (Poffenberg and Roizman, 1985).
Analysis of newly synthesised, radio-labelled, viral 
DNA, demonstrated that it sedimented more rapidly than 
unit length genomes (Jacob and Roizman, 1977). In 
addition, enzyme digestion patterns of the replicative 
intermediates indicated that they lacked terminal 
fragments leading to the proposal that the DNA is present 
in an "endless" state, either as circular monomers or 
large concatemers (Jacob et al., 197 9; Jongeneel and 
Bachenheimer, 1981).
The rate of sedimentation in neutral velocity 
gradients varies amongst the replicative intermediates. 
Those appearing early in infection, around 2-3 hpi, 
sediment up to twice as fast as unit length viral genomes 
while those appearing later in infection, around 4-6 hpi, 
sediment at least lOOx faster (Jacob and Roizman, 1977; 
Ben-Porat and Tokazewski, 1977). The earlier 
intermediates are thought to arise during an initial 
template amplification stage which produces circular 
monomers (Ben-Porat and Tokazewski, 1977).
Electron microscopic studies of the latter 
intermediates have described their appearance as "large 
tangled masses" (Ben-Porat and Rixon, 1979) . This 
observation, along with their high sedimentation rate and 
lack of genomic termini suggest that during later stages 
of infection viral DNA replication occurs by a rolling-
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circle mechanism generating concatemers consisting of 
tandem head-to-tail repeats of the viral genome (Jacob et 
al., 1979) . Further evidence for this mechanism has been 
provided by an in vitro HSV-1 DNA replication system in 
which the seven replication proteins purified from HSV- 
infected cells were used to reconstitute viral DNA 
synthesis on a circular template with a pre-formed 
replication fork. Electron microscopy and alkaline 
agarose gel electrophoresis demonstrated that DNA 
replication in this system occurs via a rolling circle- 
type mechanism (Rabkin and Hanlon, 1990).
It is, however, possible that the rapidly sedimenting 
DNA synthesised late in infection may arise by other 
mechanisms. For example newly synthesised circular 
daughter molecules may remain linked after each round of 
replication (Jongeneel and Bachenheimer, 1981), or 
homologous recombination may occur between replicating 
genomes. It is known that HSV-1 exhibits a high frequency 
of recombination during infection (Schaffer et al., 1974; 
Honess et al., 1980; Weber et al., 1988).
During DNA replication, the L and S segments of the 
viral genome invert relative to one another producing 
four different isomers which are functionally equivalent 
and are present in equimolar amounts. Although the 
presence of the viral "a" sequence is thought to be 
essential for segment inversion, inversion has also been 
observed between inverted copies of other sequences in 
different regions of the genome (Pogue-Geile et al.,
1985; Jenkins et al., 1985; Varmuza and Smiley, 1985; 
Weber et al., 1987; 1988). The only viral proteins 
required for homologous recombination between replicating 
DNA molecules are the seven proteins directly required 
for viral DNA synthesis (see Section 1.3; Weber et al., 
1988). It is possible that replicating viral DNA is a 
highly recombinogenic substrate for host enzymes.
1.2.5 HSV-1 DMA Processing and Assembly of Virions
Following replication of the HSV genome, the large 
concatemeric DNA molecules must be processed into unit
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length genomic molecules, probably by site-specific 
cleavage, before they can be packaged into viral capsids.
The HSV "a" sequence, present at both termini of the 
viral genome has been shown to contain the cis-acting 
elements required for site specific cleavage and 
packaging (Vlazny and Frenkel, 1981; Mocarski and 
Roizman, 1982; Stow et al., 1983; Spaete and Mocarski,
1985). Insertion of an additional "a" sequence within the 
viral genome resulted in the production of a novel 
terminus at that position (Smiley et al., 1981; Mocarski 
and Roizman, 1982a;b; Varmuza and Smiley, 1985), and 
plasmid DNA containing an "a" sequence along with an HSV- 
1 origin of replication could be packaged and propagated 
as a defective genome in the presence of a helper virus 
(Stow et al., 1983; 1986; Deiss and Frenkel, 1986).
The structure of the HSV-1 "a” sequence is 
illustrated in Figure 3.
A direct repeat of 17-21 bp (DR^ ) is present at each 
end of the "a" sequence with a further two direct repeats 
DR2 and DR4 , varying in copy number, located internally.
Two unique regions, and Uc, proximal to the repeat 
sequences b (Rl ) and c (Rg), lie between the DR1 and 
internal repeat regions (Davison and Wilkie, 1981;
Mocarski and Roizman, 1981) .
Although the nucleotide sequence of the "a" element 
varies between different virus strains, two highly conserved 
regions termed pac-1 and pac-2 are present in the Ub and Uc 
regions respectively and both appear to be essential for the 
cleavage/packaging process (Varmuza and Smiley, 1985; Deiss 
et al., 1986).
The DNA cleavage and packaging events are closely 
coupled and although the exact nature of events is not 
known, several models have been proposed (Ladin et al.,
1980; Vlazny et al., 1982; Deiss and Frenkel, 1986;
Addison, 1986).
The DRi elements at the L and S termini of the viral 
genome, unlike their internal counterparts, are 
incomplete in sequence. Circularisation of the linear 
genome however results in the generation of a novel joint
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Figure 3- Organisation of the HSV-1 "a" Sequence
The organisation of the "a" sequence from the L - S 
junction (a') is shown. A direct repeat of 17 - 21 bp 
DR]_, (represented by open boxes) is present at each end 
of the sequence. Two separate repeat elements, DR2 and 
DR4 , are located internally. DR2 (stripped box) consists 
of 1 - 22 copies of a 12 bp direct repeat and DR4 
(shaded box) represents a directly repeated 37 bp 
element present in 0 - 3 copies. Two unique regions Uj-, 
and Uc (solid lines), proximal to the IRl and IRg repeat 
sequences (b' and c'), lie between DR^ and DR2 /DR4 .
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fragment, in which tandem "a" sequences share a DR1 
element. Nasseri and Mocarski (1988) have shown that a 
17 9 bp fragment from across this a-a junction contains 
the cleavage signal. It has been proposed that during 
replication a putative cleavage/packaging protein complex 
recognises and cleaves an a-a junction within the 
concatemeric molecules of viral DNA only when it occurs 
in a particular orientation. Cleavage at the next 
similarly orientated junction will therefore generate a 
unit length genome with an "a" sequence at both termini. 
Cleavage of the viral DNA at an "a" sequence is thought 
to initiate the packaging of unit genome lengths by 
enabling insertion of a free terminus into a pre-formed 
capsid. The DNA may then be continuously packaged into 
this structure until the next identically orientated "a" 
sequence is recognised and cleaved.
Once a full length genome has been packaged, the 
capsid aquires an envelope by budding through the nuclear 
membrane which is a rich source of virally encoded 
glycoproteins (Roizman and Furlong, 1974). From the 
nucleus the virus particles are then transported to the 
cytoplasmic membrane via the golgi apparatus and are 
released from the cell as mature virions.
Studies on DNA encapsidation have been aided by the 
isolation and characterisation of t_s mutants which 
replicate their DNA but are defective in its processing 
and packaging. t£ lesions in such mutants have been 
mapped to within the UL6 , UL12, UL26, UL28 and UL32 genes 
suggesting that encapsidation is dependent upon several 
viral gene products (Weller et al., 1983; 1987; 1990; 
Preston et al., 1983; Matz et al., 1983; Sacks and 
Schaffer, 1987; Rixon et al., 1988; Anderson et al.,
1990). It is however unclear what particular role these 
proteins play in viral DNA processing and packaging.
1-3 ELEMENTS REQUIRED FOR HSV-1 DNA REPLICATION
1.3.1 Elements Required in cis
The presence of specific viral DNA replication
25
origins was first inferred from early electron microscopy 
studies of replicating HSV-1 DNA which revealed the 
presence of replication bubbles at particular regions 
within the genome (Friedman et al., 1977). Indirect 
evidence for the existence of two viral replication 
origins was obtained from studies with defective genomes 
generated during the serial passage of viral stocks at a 
high moi (Frenkel et al./ 1975).
Defective viral genomes, consisting of tandemly 
repeated copies of small segments of viral DNA were 
classified into two groups, class I and class II, 
according to the origin of these sequences (Frenkel et 
al., 1976; 1980; Schroder et al., 1975; 1976; Graham et 
al., 1978; Locker and Frenkel, 1979).
Class I defective genomes were found to contain 
segments from the S region (Frenkel et al., 1975; 1976; 
Locker and Frenkel, 1979; Kaerner et al., 1979; 1981) 
while class II contained segments from near the centre of 
Ul (Schroder et al., 1975; Kaerner et al., 1979; Frenkel 
et al., 1980; Locker et al., 1982; Spaete and Frenkel,
1982). These observations thus indicated the existence of 
separate replication origins within the L and S segments 
(Vlazny and Frenkel, 1981). The two origins were 
subsequently referred to as orig and oriL*
(a) Analysis of Orig
Fragments of DNA from the S region of the wt HSV-1 
genome were cloned into plasmids and analysed in 
transfection assays either in the absence or presence of 
superinfecting wt helper virus (Stow, 1982). Fragments 
containing functional viral replication origins were 
identified by their ability to enable amplification of 
the linked plasmid vector sequence when helper functions 
were provided by the superinfecting virus. An origin was 
identified within a 995 bp fragment which mapped entirely 
within the repeat unit Rg. Deletion analysis of this 
orig-containing fragment defined a 90 bp region 
containing all the necessary cis-acting signals required 
for the initiation of HSV-1 DNA synthesis (Stow, 1982;
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Stow and McMonagle, 1983). Because of its location within 
the viral Rg region, the HSV-1 genome contains two 
identical copies of orig.
Orig lies between the 5' ends of two divergently 
transcribed IE genes (IE-3 in Rg and US1 or US12 at 
either side of Ug). Although this region has been 
proposed to contain a transcribed ORF, the status and 
possible role in DNA replication of this transcript 
remains unclear (Hubenthal-Voss et al., 1987/ Hubenthal- 
Voss and Roizman, 1988).
The 90 bp core orig sequence contains an almost 
perfect 45 bp palindrome with an 18 bp tract containing 
only A and T residues at its centre (Stow and McMonagle,
1983), (Figure 4.). Deletion mapping of the highly 
homologous HSV-2 orig (Lockshon and Galloway, 1986) 
defined a 75 bp minimal origin also containing a 
palindrome. The importance of this palindromic sequence 
in both HSV-1 and HSV-2 was demonstrated when disruption 
of the region with insertions and deletions resulted in a 
loss of origin activity (Stow, 1985; Lockshon and 
Galloway, 1988). Although a conflicting report by Deb and 
Doelberg, (1988), suggested that the entire right arm of 
the palindrome was dispensable for origin function, 
subsequent studies investigating the role of protein 
binding sites within the origin provided no support for 
this assertion (Weir and Stow, 1990).
Plasmid amplification studies with orig-containing 
fragments have shown that regions flanking the palindrome 
enhance DNA replication (Stow, 1982/ Stow and McMonagle, 
1983/ Lockshon and Galloway, 1988; Wong and Schaffer,
1991). Indeed in one study deletion of the flanking 
sequences containing IE gene transcriptional regulatory 
elements resulted in an 80 fold reduction in DNA 
replication (Wong and Schaffer, 1991). As a result, it 
has been proposed that the HSV-1 orig region, like other 
eukaryotic origins, may consist of two functional 
components; a core region and an auxiliary component 
containing enhancer or promoter sequences (DePamphilis, 
1988). Binding of transcription factors to the auxiliary
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Figure 4. Comparison of Oriy. and Orig Sequences
The positions of the HSV-1 origins of replication 
(oriL and orig) within the viral genome are shown 
schematically in the upper part of the figure. Below, 
the sequences of oriL and orig have been aligned and 
the solid bars represent conserved bases. Above the ori^ 
sequence the limits of the 144 bp palindrome are 
indicated by the dashed arrows. The dotted lines below 
the orig sequence show the limits of the minimal orig as 
defined by Stow and McMonagle, (1983) and the closed 
circles indicate the limits of the orig palindrome.
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sequences may directly enhance DNA synthesis (Wong and 
Schaffer, 1991) or, as observed at the E.coli origin, 
transcription initiated near orig may facilitate 
duplex melting (Kornberg, 1988).
The orig of VZV shares some homology with HSV-1 orig. 
It too contains a palindrome of similar length although 
the central AT-rich tract is longer. To the left of the 
VZV palindrome lies an 11 bp sequence which is identical 
to a segment on the left arm of the HSV-1 palindrome. The 
observation that HSV-1 trans-acting functions can amplify 
plasmids containing the VZV origin suggested that the 11 
bp conserved region may be part of a sequence involved in 
origin recognition (Stow and Davison, 1986), (See also 
Section 1.3.2d.
(b) Analysis of Oriy.
Analysis of sequences comprising the HSV-1 oril 
region has proved to be difficult mainly because of the 
tendency of this region to suffer deletions when cloned 
into bacterial hosts (Spaete and Frenkel, 1982; Gray and 
Kaerner, 1984; Weller et al., 1985). The region was first 
sequenced from virion DNA (Gray and Kaerner, 1984; Quinn 
and McGeoch, 1985). Weller et al, (1985), subsequently 
cloned a 425 bp fragment containing the deletion prone 
sequences into a yeast vector and showed that it 
exhibited origin function in a plasmid amplification 
assay when HSV-1 helper functions were supplied in trans. 
DNA sequence analysis of the oriL region revealed the 
presence of a 144 bp perfect palindrome with striking 
homology (85%) to the region covering the orig palindrome 
and extending approximately 40 bp to one side (Quinn and 
McGeoch, 1985; Weller et al., 1985), (Figure 4.). The 
presence of a long perfect palindromic sequence probably 
accounts for the instability of oriL in bacterial 
plasmids (Collins, 1980). The essential role of the 
palindromic sequence in origin function was again 
demonstrated when deletions from the centre resulted in 
loss of activity (Weller et al., 1985). In the sequence 
of Gray and Kaerner, (1984), two tandem copies of the
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It should be noted that in EHV-1, the oriL is not located in a 
equivalent position to its HSV-1 counterpart and also that VZV 
lacks an oriL altogether.
long palindrome were present within the oril region.
The oriL sequence lies within an untranscribed region 
of the HSV-1 genome between two divergently transcribed 
genes, UL29 and UL30. Interestingly, these genes encode 
the major DNA binding protein and the DNA polymerase 
respectively, both of which are essential for HSV-1 DNA 
replication.
OriL of HSV-2 has also been cloned and sequenced. A 
136 bp almost perfect palindrome is present in this 
region which exhibits 8 8 % identity to HSV-1 oriL 
(Lockshon and Galloway, 1986).
The significance of three origins of replication 
within the HSV-1 genome is unclear. Deletion mutants 
containing only a single copy of orig have been isolated 
and are unimpaired in their growth in tissue culture 
(Longnecker and Roizman, 1986). The isolation of a viable 
deletion mutant lacking 150 bp of oriL demonstrates that 
this origin is dispensable for viral replication 
(Polvino-Bodnar et al., 1987). Indeed VZV does not posses 
an equivalent of oriL/ only two copies of orig (Davison 
and Scott, 1986/ Stow and Davison, 1986). Finally, 
viruses lacking oriL but containing two partially 
defective copies of orig have been constructed which 
exhibit a significant growth defect (Challberg, 1991). An 
analogous mutant virus containing the wt oriL however 
showed no defect. Orig and oriL therefore appear to be 
functionally equivalent, and wt growth seems to require 
only two (or perhaps even one) functional origin.
1-3.2 Trans-acting Functions Essential for HSV-1 DNA
Synthesis
An important initial approach to the identification 
of genes encoding trans-acting functions required for 
HSV-1 DNA synthesis was the isolation and 
characterisation of mutants exhibiting defects in DNA 
synthesis (Schaffer et al., 1987). Analysis of ts and 
null mutants defective in DNA synthesis lead to the 
identification of seven distinct genes which encode 
products essential for HSV-1 DNA replication.
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A separate approach, using a transient 
complementation assay involved testing the ability of 
cloned HSV-1 genomic fragments to amplify a co­
transfected HSV-1 origin-containing plasmid (Challberg, 
1986; Wu et al., 1988). Initially a set of five plasmids 
covering most of the HSV-1 genome was shown to support 
replication of an origin-containing plasmid. Subsequently 
a combination of sub-cloning, deletion analysis and 
restriction enzyme digestion of these fragments, in 
conjunction with HSV-1 sequence data (McGeoch et al.,
1988) led to the identification of seven HSV-1 genes,
UL5, UL8, UL9, UL29, UL30, UL42 and UL52, which were both 
necessary and sufficient for origin dependent plasmid 
amplification (Wu et al., 1988). The locations of the 
seven genes within the HSV-1 genome are shown in Figure 
5. The IE genes IE-1, IE-2 and IE-3 were also identified 
as being important for DNA replication in this assay. 
Although none of the IE genes was absolutely essential, 
various combinations were necessary for plasmid 
amplification. This presumably reflects their role in 
turning on the other seven genes which belong to the E 
class. (Wu et al., 1988; Heilbronn and Zur Hausen, 1989).
Detailed mapping of the lesions within the DNA 
negative ts mutants described above demonstrated that the 
mutations lay within the same seven genes identified in 
the transient transfection assay (Dixon and Schaffer, 
1980; Purifoy and Powell, 1981, Littler et al., 1983;
Coen et al., 1984; Weller et al., 1987; Zhu and Weller, 
1988; Marchetti et al., 1988).
The identical results obtained from the two 
approaches suggest that all the HSV-1 genes essential for 
viral DNA synthesis have been identified. Indeed the 
extent of plasmid amplification demonstrated in 
transfection assays using individual genes was only 
slightly lower than that observed when fragments 
representing most of the viral genome were used 
(Challberg, 1986). It remains possible that other 
functions which are not considered to play a significant 
role in DNA replication in tissue culture may actually
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Figure 5. Location of DNA Replication Functions on the
Herpes Simplex Virus Genome
The HSV-1 genome is shown schematically with the 
unique regions drawn as thin lines and the inverted 
repeats flanking the long and short unique regions as 
closed and open boxes respectively. The positions and 
orientation of the ORFs encoding the seven proteins 
essential for viral DNA replication are shown by arrows 
and the predicted molecular size (in kilodaltons) of 
each protein indicated below. The origins of replication 
orig and ori]^  are also indicated, (adapted from Olivo 
and Challberg, 1989, Functional analysis of the herpes 
simplex virus gene products involved in DNA replication. 
In: Herpesvirus transcription and its regulation, Ed.
E .K.Wagner.).
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play an essential role in vivo (Field and Wildy, 1978; 
Cameron et al., 1988; Goldstein and Weller, 1988a;b).
(a) DNA Polymerase Holoenzyme (encoded by genes UL30 and
UL42)
A novel DNA polymerase activity biochemically 
distinct from the host DNA polymerase was first 
identified in HSV-1 infected cell extracts by Keir and 
Gold, (1963) . Genetic analysis of ts and drug resistant 
mutants demonstrated that this polymerase activity was 
virally encoded and essential for viral DNA synthesis 
(Hay and Subak-Sharpe, 1976; Purifoy et al., 1977; Honess 
and Watson, 1977; Knipe et al., 1979; Dixon and Schaffer, 
1980; Purifoy and Powell, 1981; Coen et al., 1982; 1984).
The DNA polymerase activity was mapped to the UL30 
gene using marker rescue analysis (Chartrand et al.,
1980; Coen et al.,1984) and the ORF predicted to encode a 
polypeptide of approximately 136 kDa (Gibbs et al., 1985; 
Quinn and McGeoch et al., 1985). purification
of the polymerase demonstrated the presence of a 
polypeptide of 140 kDa (Powell and Purifoy, 1977; Knopf, 
1979; O'Donnell et al., 1987a).
The production of viral DNA polymerase activity from 
the UL30 gene using in vitro transcription and 
translation, (Dorsky and Crumpacker, 1988), yeast 
expression systems (Haffey et al., 1988) and recombinant 
baculovirus expression (Marcy et al., 1990) indicated 
that the UL30 protein is sufficient for catalysis.
Biochemical studies of the viral polymerase 
demonstrated that the UL30 protein is associated with 
several distinct functions. In addition to the DNA 
polymerase activity, the protein also exhibits an 
intrinsic proof-reading 3'-5' exonuclease activity 
(Knopf, 1979; Ostrander and Cheng, 1980, Marcy et al.,
1990), and a 5'-3' exonuclease/RNaseH activity which 
specifically degrades RNA/DNA hybrids or duplex DNA in 
the 5'-3' direction (Crute and Lehman, 1989; Marcy et 
al., 1990). This is likely to be analogous to the 5'-3' 
exonuclease function of E .coli DNA pol I required during
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DNA repair and removal of RNA primers (Kornberg, 1980).
Several mutants have been isolated which exhibit 
resistance to a variety of anti-viral drugs and have 
alterations mapping within the UL30 gene (Hay and Subak- 
Sharpe, 1976; Crumpacker et al./ 1980; Coen et al./ 1982; 
Honess et al./ 1984). These drugs, e.g. acyclovir, 
aphidicolin, phosphonoacetic acid and phosphonoformic 
acid, exert their effects by mimicking and/or competing 
with natural dNTPs or pyrophosphate. Mapping of the 
mutations localis'd them to four highly conserved regions 
within the C-terminal half of the DNA polymerase protein 
proposed to constitute a nucleotide binding site (Gibbs 
et al., 1985; 1987; Larder et al., 1987; Tsurumi et al., 
1987; Wong et al., 1988).
Many DNA dependent DNA polymerases exist as a complex 
with one or more non-covalently linked proteins, the 
presence of which is required to increase the efficiency 
or modify the activity of the enzyme. The HSV-2 DNA 
polymerase co-purifies with a 50-60 kDa polypeptide 
(Powell and Purifoy, 1977; Vaughan et al., 1985). An 
equivalent protein has also been identified which co- 
purifies with the HSV-1 DNA polymerase and has been shown 
to be the product of gene UL42.
The UL42 gene encodes a 65 kDa phospho-protein which 
was originally observed as a double-stranded DNA binding 
activity in HSV-1 infected cells (Bayliss et al., 1975; 
Marsden et al., Parris et al., 1988; Gallo et al., 1988).
Antisera generated against the UL42 gene product were 
shown to precipitate not only the UL42 protein but also 
the UL30 polypeptide from HSV-1 infected cells indicating 
the presence of a complex between the two (Gallo et al., 
1988; Parris et al., 1988). The proposal that the DNA 
polymerase holoenzyme exists as a heterodimer consisting 
of subunits encoded by UL30 and UL42 has been 
substantiated by results obtained from sedimentation and 
filtration analysis of highly purified preparations of 
the enzyme (Gottlieb et al., 1990).
Although the UL42 protein is not required for the 
catalytic activity of the DNA polymerase, it does appear
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to have a 4 - 10 fold specific stimulatory effect on 
polymerase activity. This effect can be blocked by the 
addition of a 65 kDa DNA binding protein (DBP) monoclonal 
antibody suggesting a specific role for the protein as an 
accessory subunit of the DNA polymerase (Gallo et al.,
1989). The UL42 gene product has been proposed to 
accomplish the stimulatory effect by enhancing the DNA 
polymerase's affinity for primer termini thereby 
increasing its processivity (Gottlieb et al., 1990; 
Hernandez and Lehman, 1990). Indeed a comparison of the 
catalytic properties of baculovirus-expressed UL30/UL42 
protein complex with that of the individual subunits 
demonstrated that the inclusion of the UL42 protein 
results in processive polymerisation and the generation 
of full length products on a singly primed M13 ss-DNA 
template. In constrast, UL30 alone synthesises only short 
products using this template.
The region of the UL30 gene product which interacts 
with the UL42 protein has been mapped using in vitro 
transcription/translation and immuno-precipitation 
experiments to the C-terminal 208 amino acids. This 
region is distinct from those involved in substrate 
binding (Digard and Coen, 1990).
It is not known whether the uncomplexed UL42 protein 
has a specific role in viral DNA synthesis, and the 
significance of its ds-DNA binding activity during 
replication is still unclear. Like other DNA polymerase 
accessory proteins the UL42 gene product may function as 
a tight "clamp" to hold the UL30 enzyme and its DNA 
template together thereby reducing the possibility of 
dissociation (Mace and Alberts, 1984; Huber et al., 
1987a;b).
(b) Major ss DNA-Binding Protein (encoded by gene UL29)
The major single-stranded DNA-binding protein (mDBP) 
was first recognised as an abundant major viral-induced 
protein of 130 kDa in HSV-1 infected cells (Honess and 
Roizman, 1973; Powell and Courtney, 1975) . Analysis of t_s 
mutants later determined that this protein was the
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product of the UL29 gene and that it was essential for 
viral DNA replication (Conley et al., 1981; Weller et 
al., 1983; Dixon et al., 1983; Godowski and Knipe, 1983; 
1985; 1986; Leinbach et al./ 1984, Holland et al., 1984).
mDBP binds preferentially and cooperatively to ss-DNA 
templates with no detectable sequence specificity 
(Bayliss et al., Powell and Purifoy, 1976; Knipe et al., 
1982; Ruyechan, 1983; Ruyechan and Weir, 1984). This 
observation suggested that the function of mDBP could be 
analogous to that of the E .coli ss-DNA binding protein 
(SSB) which binds to and stabilises regions of ss-DNA at 
the replication fork (Powell et al., 1981; Ruyechan,
1983; Ruyechan and Weir, 1984; Lee and Knipe, 1983). 
Powell et al, (1981) also reported that mDBP can reduce 
the melting temperature of parental duplex DNA in vitro 
thus suggesting a role in facilitating strand separation.
Analysis of UL29 ts mutants was carried out in an 
attempt to map the functional domains of the mDBP.
Several mutants were found to specify products which were 
either defective in ss-DNA binding activity or defective 
in their localisation to the cell nucleus (Lee and Knipe, 
1983; Leinbach, 1984; Quinlan et al., 1984; Gao et al., 
1988; Gao and Knipe, 1989). Two regions of UL29 have been 
implicated in binding to ss DNA (Knipe, 1989; Leinbach 
and Heath, 1988; Gao et al., 1988; Wang and Hall, 1990). 
Both regions are conserved in the VZV and EBV mDBP 
homologues (Wang and Heath, 1990). The smaller region 
contains a predicted zinc-binding motif which is common 
to many DNA binding proteins (Berg, 1986). It has been 
suggested that this motif may participate in intra or 
intermolecular interactions which contribute to 
cooperative DNA-binding and/or to the stabilisation of 
the larger "core" DNA- binding region which is located 
near the C-terminus (Gao et al., 1988; Leinbach and 
Heath, 1988; Gao and Knipe, 1989; Wang and Hall, 1990). 
The presence of zinc however does not appear to be 
necessary for the mDBP's binding activity (Leinbach and 
Heath, 1988).
Attempts to map the nuclear localisation signals have
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suggested that several regions of the protein may 
contribute (Gao and Knipe, 1989/ Knipe, 1989). These 
signals appear to be distinct from those required for DNA 
binding as several ts mutants were isolated which either 
entered the nucleus but failed to bind ss-DNA, or 
retained their binding activity but failed to localise to 
the nucleus (Gao et al., 1988; Gao and Knipe, 1989;
Knipe, 1989).
The identification of mutants which expressed mDBP 
which could bind DNA in vitro and localise to the nucleus 
in vivo yet failed to replicate DNA suggested that mDBP 
exhibits additional functions required for DNA synthesis 
(Gao et al., 1988; Gao and Knipe, 1989). These may 
include essential interactions with other viral or 
cellular factors involved in DNA replication or be 
connected with DNA duplex melting.
Other mDBP ts_ mutants tested had altered 
sensitivities to DNA polymerase inhibitors (Chiou et al., 
1985) suggesting that mDBP may interact with the viral 
DNA polymerase and modulate its catalytic activity 
(Godowski and Knipe, 1985; 1986). Using activated DNA 
templates, Ruyechan and Weir, (1984), demonstrated that 
mDBP exhibited a small stimulatory effect on the activity 
of the viral UL30/UL42 DNA polymerse complex. A 
conflicting report from O'Donnell et al, (1987), however 
suggested that mDBP had the opposite effect and inhibited 
polymerase activity. More recent studies, in which the 
mDBP was shown to have a modest stimulatory effect on the 
action of the HSV-1 UL30 catalytic subunit (Gottlieb et 
al., 1990) and additionally on the polymerase holoenzyme 
(Hernandez and Lehman, 1990) appear to substantiate the 
former claim.
The use of monoclonal antibodies against mDBP has 
shown that the intranuclear distribution of mDBP 
throughout the viral replicative cycle is regulated in 
part, by the infected cell physiology and the state of 
viral DNA replication (Showalter et al., 1981; Knipe and 
Spang, 1982; Quinlan and Knipe, 1983; Quinlan et al.,
1984; de Bruyn-Kops and Knipe, 1988) .
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In cells, in which viral DNA replication is blocked 
by the use of chemicals or ts_ mutants with lesions in the 
UL30 gene, mDBP localises to nuclear framework-associated 
structures called pre-replicative sites (Quinlan and 
Knipe, 1983; Quinlan et al,. 1984; deBruyn-Kops and 
Knipe, 1988). During viral DNA replication, however, mDBP 
is associated with replicating viral DNA and accumulates 
in structures referred to as replication compartments 
(Lee and Knipe, 1983; deBruyn-Kops and Knipe, 1988).
Mutant viruses expressing altered mDBP failed to assemble 
the pre-replicative sites, suggesting that mDBP is 
involved in the organisation of these sites. Several 
cellular proteins are also re-localised to pre- 
replicative sites and replicative compartments in HSV-1 
infected cells (deBruyn-Kops and Knipe, 1988; Bush et 
al., 1991; Wilcock and Lane, 1991).
Analysis of a mDBP mutant which significantly 
inhibited the replication of wt HSV-1 suggested that the 
protein may also play a role in the stimulation of late 
gene expression (Gao and Knipe, 1991).
(c) Helicase-Primase Complex (encoded by genes UL5, UL8 and
UL52)
Crute et al., (1988), first described the induction 
of a novel DNA-dependent ATPase and helicase activity in 
HSV-1 infected cells. DNA-dependent ATPase activity is a 
known property of DNA helicases which function by 
coupling the unwinding of duplex DNA with the hydrolysis 
of ATP. The DNA helicase activity, which was purified to 
near homogeneity, contained three major polypeptides with 
molecular weights of 120 kDa, 97 kDa and 70 kDa. In 
addition to an ATPase and helicase activity, DNA- 
dependent GTPase and DNA primase activities were also 
found to co-purify with the three proteins (Crute et al.,
1989) .
The components of the HSV-1 helicase-primase complex 
were identified using specific antisera in Western blot 
assays as the products of the HSV-1 UL5, UL8 and UL52 
genes (Crute et al♦, 1989). These proteins had already
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been shown by Wu et al., (1988) to be essential for 
origin dependent DNA replication.
Attempts to reconstitute the enzyme activity in vitro 
from the individual components have not yet proved 
successful. However by triply infecting insect cells with 
three viruses expressing the UL5, UL8 and UL52 proteins, 
a functional HSV-1 helicase-primase
complex was produced in vivo (Dodson et al., 1989/ Calder 
and Stow., 1990). This complex exhibited identical enzymatic 
activities to the complex found in HSV-1 infected cells 
(Dodson et al., 1989).
Very little information is available regarding the 
functions of the individual subunits of the helicase- 
primase complex. Biochemical experiments have failed to 
detect any enzymatic activities in the individual UL5,
UL8 or UL52 proteins (Calder and Stow., 1990; Dodson and 
Lehman., 1991).
The existence of a consensus ATP binding site within 
the UL5 gene suggests that this gene product may be 
involved in the ATPase and DNA helicase activities 
(McGeoch et al., 1988; Zhu and Weller, 1988). The ATP 
binding site represents two of the six sequence motifs 
present in the UL5 protein which are common to the 
members of a large superfamily of proteins which includes 
many DNA and RNA helicases (Gorbalenya et al., 1989).
Results from mutational analysis of the most highly 
conserved regions of these helicase motifs demonstrated 
that all six are essential for UL5 function in a 
transient DNA replication assay (Zhu and Weller, 1992a).
The ability of several UL5 mutants to form complexes with 
the other components of the helicase-primase complex 
suggested that the domains responsible for these 
protein/protein interactions are distinct from those 
required for helicase activity (Zhu and Weller, 1992a).
Although UL5 alone does not exhibit any enzyme 
activities, co-expression of the UL5 and UL52 gene 
products resulted in the formation of a complex which 
exhibited enzymatic properties virtually indistinguisable 
from the three subunit complex (Calder and Stow, 1990;
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Dodson and Lehman, 1991). Since the UL8 protein appeared 
to be dispensable for the four known enzyme activities, 
its function was somewhat unclear. However recent 
intracellular localisation studies suggested that the UL8 
protein may play a role in facilitating efficient nuclear 
uptake of the helicase-primase complex (Calder et al., 
1992). In addition Sherman et al, (1992) recently 
demonstrated that although the UL5/UL52 complex can 
synthesise primers of the same size and at the same rate 
as the three subunit complex, the UL8 subunit is required 
for their efficient utilisation by DNA polymerase. Using 
a coupled polymerase/primase assay, M13 ss-DNA was 
converted to nicked or gapped ds-circles by either HSV-1 
DNA polymerase holoenzyme or by E.coli polymerse I when 
the reaction was primed by the UL5/UL8/UL52 complex. 
Little or no elongation of primers was observed with 
either polymerase in the absence of the UL8 protein. DNA 
synthesis was restored by the addition of partially 
purified UL8 protein. On the basis of these observations, 
the UL8 protein has been proposed to function by 
increasing the efficiency of primer utilisation by 
stabilising the association between the primers and the 
template DNA (Sherman et al., 1992). This role for the 
UL8 protein may previously have been overlooked because 
poly dT was used as a template, and any primers 
dissociating from the template would have been able to 
re-anneal rapidly.
(d) Origin Binding Protein (encoded by gene UL9)
Using filter binding assays, Elias et al (1986), 
first detected a protein, in extracts from HSV-1 infected 
cells, which bound specifically to the HSV-1 origins of 
replication. This protein, found only in infected 
extracts, accumulated during viral infection at the same 
time as the viral-induced DNA polymerase and UL42 gene 
product suggesting that it may play an important part in 
the initiation of origin dependent DNA synthesis (Elias 
et al., 1986).
Identification of the gene encoding the origin
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binding activity was achieved by expressing the genes 
required for viral DNA synthesis in insect cells using a 
baculovirus expression vector (Olivo et al., 1988) and 
also in BHK cells using a tsK vector (Weir et al., 1989) 
and testing the products for origin binding activity.
Both approaches identified the UL9 gene as encoding the 
origin binding protein (OBP).
Experiments using rabbit antisera raised against 
synthetic decapeptides corresponding to the C-terminal 
seqences of four replication proteins (UL5/ UL8, UL9 and 
UL52), confirmed this identification. Protein/DNA 
complexes formed between a labelled probe fragment 
containing the HSV-1 orig sequence and extracts from HSV- 
1 infected cells were immunoprecipitated only with the 
anti-UL9 antiserum (Olivo et al., 1988). Similarly the 
mobility of these complexes in a gel retardation assay 
was specifically reduced in the presence of UL9-specific 
antibody (Weir et al./ 1989).
The size of the UL9 protein, predicted from DNA 
sequence analysis, is 94,246 (McGeoch et al., 1988b) and 
its apparent Mr based on SDS-PAGE gel mobility is 82 - 89 
kDa (Elias and Lehman, 1988; Olivo et al., 1988; Calder, 
Ph.D thesis 1991). No modifications of the UL9 protein 
have been reported and experiments using C-terminal 
specific antisera suggest that the protein has an intact 
C-terminus (Olivo et al., 1989).
DNase 1 footprinting analysis, using purified UL9 
protein, demonstrated that the protein specifically 
protects two sites within the HSV-1 orig region. Site I 
contains a 18 bp sequence which overlaps with the left 
end of the orig palindrome (Figure 6). Site II is 
identical in 15 out of the corresponding 18 bases to site 
I and is located on the right arm of the palindrome.
Within the 18 bp region of site I, lies an 11 bp 
sequence (5'-CGTTCGCACTT-3') which is conserved within 
oris of HSV-2 and VZV, and oriL of HSV-1 and HSV-2 
(Weller et al., 1985; Stow and Davison., 1986; Lockshon 
and Galloway., 1986; 1988). Two further, almost 
identical, copies of this sequence are present in HSV-1
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Figure 6. Origin Binding Sites Within Orig
The 75 bp sequence of the HSV-1 minimal origin, as 
defined by Lockshon and Galloway, (1988), is shown 
opposite and the 45 bp near perfect palindrome indicated 
by the narrow arrows. The bracketed regions, labelled 
site I and site II, refer to sequences protected from 
DNase I digestion as reported by Elias and Lehman,
(1988). The 11 bp conserved sequence present within site 
I, site II and motif III has been underlined and the 
orientation of each indicated by the arrows below.

orig/ in inverted orientation to site I. One copy lies 
within binding site II and the other in a region outside 
the palindrome adjacent to site I (motif III).
Methylation interference analysis, site directed 
mutagenesis and comparisons with other binding sites have 
indicated that an 8 bp sequence (5'-GTTCGCAC-3') within 
the 11 bp conserved region may represent the actual UL9 
recognition sequence (Koff and Tegtmeyer., 1988; Deb and 
Deb., 1989). It has been proposed that the 8bp sequence 
corresponds to two, pentameric inverted repeats sharing a 
two base overlap (5'-GT(T/G)CG-3'), and that each 
pentamer may function as a UL9 protein recognition site. 
No direct evidence supporting this proposal exists, 
however it appears to be consistent with the observation 
that UL9 forms a stable dimer in solution (reviewed by 
Challberg and Kelly., 1989; Fierer and Challberg., 1992).
Binding studies using synthetic ds- 
oligonucleotides have demonstrated that UL9's affinity 
for an isolated site I is approximately lOx greater than 
for site II (Elias and Lehman., 1988). No binding to an 
isolated motif III (which differs from site I only at a 
single residue contacted by the UL9 protein) was 
observed.
The affinity of UL9 for site I within the origin was 
observed to decrease when binding site II was deleted 
suggesting that there may be cooperative interaction 
between proteins bound to the two sites. Further evidence 
for this came from studies which showed that the 
introduction of two point mutations within an isolated 
site I resulted in a 100 fold decrease in UL9 affinity 
whereas the same mutations introduced into a fragment 
containing the complete orig sequence produced only a two 
fold reduction in affinity for site I (Elias et al.,
1990) .
Mutational analyses of orig have also demonstrated a 
direct relationship between the ability of the UL9 
protein to bind to site I and orig function (Deb and 
Deb., 1989; Weir and Stow., 1990). Binding of UL9 was 
abolished when the sequence within site I was changed
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from GTTCGCAC to GTTCTCAC (Weir and Stow,. 1990). Koff 
and Tegtmeyer (1988) had previously reported that 
positions 4 and 5 within this recognition sequence form 
important contacts with OBP.
Deletion of site II resulted in a decrease in origin 
activity to about 5 - 10% of the wt level suggesting that 
two functional binding sites are required for efficient 
initiation of viral DNA replication (Lockshon and 
Galloway., 1988; Weir and Stow., 1990). A conflicting 
report by Deb and Doelberg (1988) which suggested that 
site II is not required for efficient origin activity is 
now considered to be erroneous. Deletion of motif III 
resulted in a 2 fold decrease in oris activity (Weir and 
Stow, 1990) .
A series of mutant origins with varying numbers of AT 
dinucleotides inserted into the central AT-rich region of 
the orig/ resulted in a cyclic change in origin 
efficiency (Lockshon and Galloway, 1988). Maximum oris 
activity was observed when integral numbers of helical 
turns of DNA were inserted, suggesting that UL9 molecules 
bound to sites I and II may have to be present on the 
same side of the DNA helix for efficient origin function. 
Thus, in addition to sequence specificity, the relative 
orientation of the binding sites may be important for 
efficient origin function.
Binding of UL9 to supercoiled origin-containing 
plasmids alters the structure of the origin without the 
requirement for ATP. Nuclease and chemical footprinting 
analyses have demonstrated that UL9 loops and distorts the 
AT-rich region between binding sites I and II when free 
energy is provided by positive supercoiling (Koff et al.,
1991).
Nucleoprotein complexes consisting of purified UL9 
and origin-containing DNA have been visualised by 
electron microscopy providing evidence for inter- and 
intramolecular interactions. The results suggest that 
following initial sequence-specific recognition multimers 
of UL9 protein may assemble at the replication origin 
(Rabkin and Hanlon, 1991).
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Expression of various regions of the UL9 protein as 
fusion proteins in E.coli mapped the UL9 sequence- 
specific DNA binding domain to the C-terminal 317 amino 
acids of the protein (Weir et al., 1989). Subsequent 
studies have further narrowed the DNA binding domain to a 
269 amino acid stretch amino acids 564 to 832). This 
region has been proposed to contain a pseudo-leucine 
zipper and a helix-turn-helix motif both of which are 
suggested to be involved in DNA binding (Deb and Deb,
1991) .
Other functions are associated with the N-terminal 
two thirds of the UL9 protein. A consensus leucine zipper 
motif common to many DNA binding proteins and which is 
believed to be the site of protein/protein interactions 
involved in dimerisation is present at amino acids 150 - 
173 (Landschulz et al., 1988). Studies of mutations which 
alter the leucines within the motif suggest that it too 
is essential for UL9 function (Martinez et al., 1992). 
Whether the zipper has a role in protein dimerisation or 
in the interaction with other components of the 
replicative machinery is not yet known.
The N-terminal portion of the UL9 protein also 
contains six sequence motifs found in all members of a 
superfamily of DNA and RNA helicases (Gorbalenya et al., 
1988; 1989) distinct from the superfamily to which UL5 
belongs (Zhu and Weller, 1992b). The importance of the 
helicase motifs in UL9 function was investigated using an 
in vivo complementation assay in which mutant UL9 
proteins were tested for their ability to complement a 
replication deficient null mutant in the UL9 gene and 
allow amplification of a HSV-1 oris~containing plasmid. 
The introduction of site-specific mutations into the 
highly conserved regions of five of these motifs resulted 
in the loss of UL9 replicative function (Martinez et al.,
1992) suggesting that UL9 helicase activity is likely to 
be essential for viral DNA replication.
Using partially ds substrates, an intrinsic 3'-5' 
helicase activity was identified in the UL9 protein 
(Bruckner et al., 1991; Fierer and Challberg, 1992). This
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suggests that UL9 may function analogously to SV40 T- 
antigen by specifically binding to the origin of. 
replication and then using its intrinsic helicase 
activity to achieve local unwinding of the DNA duplex. 
This activity, however remains to be demonstrated (Fierer 
and Challberg, 1992).
The role of the UL9 protein in the initiation of 
viral DNA replication is thus still unclear. Nevertheless 
by analogy with other eukaryotic and prokaryotic systems, 
it seems likely that UL9 will be involved in the 
separation of the parental strands at the origin and the 
assembly of a multi-protein preinitiation complex leading 
to subsequent initiation of DNA synthesis (Elias et al., 
1990) .
Other Enzyme Activities Likely to be Required for HSV DNA
Replication
In addition to the activation specified by the known 
virus-coded replication proteins it is likely that HSV 
DNA replication will require a topoisomerase activity to 
relieve torsional strain ahead of the replication fork 
and a DNA ligase activity to join Okazaki fragments 
following the removal of RNA primers. Whether these 
activities are provided by viral or host enzymes remains 
unknown.
1.3.3 Trans-acting Functions Indirectly Involved in 
HSV-1 DNA Synthesis
(a) Viral Enzymes Involved in Nucleotide Metabolism
Thymidine Kinase (encoded by gene UL23)
The HSV-1 encoded thymidine kinase (TK) was first 
described by Kit and Dubbs, (1963) and functions by 
phosphorylating thymidine, other pyrimidine 
deoxyribonucleosides and a variety of nucleoside 
analogues (Dubbs and Kit, 1964; Jamieson and Subak- 
Sharpe, 1974; Chen and Prusoff, 1978).
Studies using tk~ mutants indicated that TK is non-
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essential for viral growth in dividing tissue culture cells 
as TTP is provided by host pathways (Dubbs and Kit,
1964). An impairment in growth was however observed in 
serum-starved cells indicating that the viral enzyme 
activity is essential in non-dividing cells (Jamieson et 
al., 1974; Field and Wildy, 1978).
Using a mouse model, several tk- mutants were shown 
to be unable to reactivate from a latent infection (Coen 
et al., 1989; Efstathiou et al., 1989). The identifiction 
of latency-associated transcripts in the ganglia from the 
infected mice, suggested that the virus encoded TK is not 
essential for the establishment of a latent infection in 
mice, but appears to be involved in the reactivation 
process (Coen et al., 1989; Tenser et al., 1989).
Ribonucleotide Reductase (encoded by genes UL39 and UL40)
Cohen, (1972) provided the first evidence 
demonstrating that HSV induced a novel RR activity. RR 
plays an important role in the formation of DNA 
precursors as it catalyses the reduction of 
ribonucleoside diphosphates to the corresponding 
deoxyribonucleoside diphosphates (Cohen, 1972; Thelander 
and Reicard, 1979).
Biochemical analysis indicated that the viral-encoded 
RR consists of two non-identical subunits; a large 149 
kDa subunit (RR^), and a smaller 38 kDa subunit (RR2 ) 
which are encoded by co-terminal transcripts from the 
UL39 and UL40 genes (McLauchlan and Clements, 1983; 
Bacchetti et al., 1984; Preston et al., 1984; Frame et 
al., 1985).
A lesion within the UL39 gene in mutant tsl207 was 
shown to impair viral growth at the NPT, which suggested 
that RR was essential for virus replication (Preston et 
al., 1984) . Studies using two other UL39 mutants hrR3 and 
ICP6 however, indicated that the HSV-1 RR activity is 
dispensable for virus growth and DNA replication in 
dividing cells in culture at 34°C. RR does however appear 
to be essential for viral growth in non-dividing, serum- 
starved cells and also in cells at higher temperatures
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(Goldstein and Weller, 1988a;b). These results suggest 
that host pathways involved in the synthesis of dNTPs may 
be inactivated in non-dividing cells and at elevated 
temperatures generating a requirement for the viral RR 
under such conditions. Indeed, it has been shown that 
cellular RR is not present in non-dividing and terminally 
differentiated cells (Thelander and Reichard, 1979).
Deoxyuridine 5' triphosphatase (encoded by gene UL50) 
Deoxyuridine 5' triphosphatase (dUTPase) catalyses 
the hydrolysis of dUTP to dUMP and pyrophosphate (PPi), 
(Wohlrab and Francke, 1980; Caradonna and Cheng, 1981).
Studies on an HSV-1 mutant in which the dUTPase gene 
had been inactivated demonstrated that the viral enzyme 
is dispensable for viral growth in exponentially growing 
and serum-starved cells (Fisher and Preston, 1986).
dUTPase may play a role in providing a supply of dUMP 
for conversion into dTMP. However, because the enzyme is 
able to reduce the intracellular concentration of dUTP it 
has been suggested that its principal role is to prevent 
incorporation of uridine into nascent DNA.
(b) Other Enzyme Activities Induced in HSV-1 Infected 
Cells
Uracil-DNA Glycosylase (encoded by gene UL2)
Uracil-DNA glycosylase functions in a DNA repair 
mechanism by removing uracil residues from DNA which 
arise either from mis-incorporation of dUTP or from the 
deamination of cytosine residues in the DNA.
An HSV-1 encoded uracil-DNA glycosylase activity was 
first reported by Caradonna and Cheng, (1981). Analysis 
of an HSV-1 UL2 insertion mutant demonstrated that the 
viral enzyme is dispensable for viral growth in tissue 
culture (Mullaney et al., 1989).
Protein kinase
Blue and Stobbs, (1981) first reported a novel 
protein kinase activity in HSV-1 infected cells. Based on
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It has been reported that autophosphorylation occurs in 
the N-terminal region of the HSV RR1 subunit.
amino acid sequence similarity with known eukaryotic 
kinases, the US3 protein was proposed to be a protein 
kinase (McGeoch and Davison, 198 6). Biochemical and 
genetic studies have since confirmed this and 
demonstrated that the protein is dispensable for viral 
growth in tissue culture (Frame et al., 1987; Purves et 
al., 1987) .
Subsequent studies have shown that the US3 encoded 
protein kinase phosphorylates a membrane protein encoded 
by the UL34 gene (Purves et al., 1991; 1992). Whether 
other substrates for the protein kinase exist remains to 
be determined, but it is possible that proteins 
indirectly or directly involved in DNA replication may be 
regulated by phosphorylation.
A second HSV induced protein kinase activity has been 
reported in infected cell nuclei. Recent work has shown 
that this activity, identified as the product of the UL13 
gene is capable of autophosphorylation (Cunningham et 
al., 1992).
Alkaline Exonuclease (encoded by gene UL12)
Keir and Gold, (1963) first described an HSV-1 
alkaline exonuclease activity in infected cells. This 
enzyme was later identified as the product of the UL12 
gene (McGeoch et al., 1986; Draper et al., 1986) and 
consists of a single polypeptide which exhibits both 5'- 
3' exonuclease and endonuclease activities (Morrison and 
Keir, 1968; Hoffman and Cheng, 1979; Strobel-Fidler and 
Francke, 1980).
Early studies using UL12 ts_ mutants reported 
conflicting data concerning whether this enzyme is 
essential for viral growth (Moss et al., 1979; Francke 
and Garret, 1982; Moss, 1986). However, more recently, 
Weller et al, (1990), using an exonuclease null mutant, h 
ave provided definitive evidence that the exonuclease is 
essential for viral growth but not for viral DNA 
replication.
Interestingly, the enzyme appears to localise in 
replication compartments within the nucleus (Randall and
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Dinwoodie, 198 6) and has been shown to co-precipitate 
with the viral DNA polymerase (Vaughan et_al., 1985).
Possible roles for the HSV-1 exonuclease have been 
proposed which include the cleavage of DNA concatemers, 
the provision of dNTPs for DNA synthesis and an 
involvement in recombination events (Weller et al.,
1990).
1.4 INITIATION OF DNA REPLICATION
Detailed studies of DNA replication in relatively 
simple prokaryotic and eukaryotic organisms have proved 
invaluable in the understanding of the underlying 
mechanisms in other organisms. The development of origin- 
dependent in vitro DNA replication systems for E .coli 
(Fuller et al./ 1981), bacteriophage lambda (Wold et al., 
1982) and SV40 (Li and Kelly., 1984) provided evidence 
for a common series of events involved in the initiation 
of DNA replication: (i) the interaction of an origin
binding protein with a specific sequence within the 
origin of replication results in the formation of an 
initial complex; (ii) the melting of a small stretch of 
DNA within the origin leads to an open complex 
(replication bubble); (iii) daughter strand synthesis is 
initiated and a helicase activity extends the replication 
bubble.
As described in Section 1.3.2(d), the events 
following the binding of UL9 to the HSV-1 origins that 
lead to the initiation of viral DNA replication are not 
fully understood. However, the discovery that UL9 
exhibits functions similar to better-characterised DNA 
initiator proteins such as the E .coli DnaA protein, the 
lambda 0 protein and the SV40 T antigen, suggests that it 
may have a similar role to play in the initiation of 
viral DNA synthesis.
1.4.1 Initiation of E.coli DNA replication
E .coli DNA replication is initiated at a unique 
site within the chromosome called oriC. The minimal
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region essential for replication, comprising all the 
necessary cis-acting sequences, encompasses 245 bp (Oka 
et al., 1980) and contains several sequence blocks which 
are highly conserved among the oriC regions of 
Enterobacteriaceae (Zyskind et al., 1983). Mutational 
analyses of this region revealed the presence of two 
types of sequence element which are essential for the 
initiation of DNA synthesis (Figure 7). Four 9-mer tandem 
repeats (dnaA boxes) are located towards one end of oriC 
(Oka et al., 1984) and function as specific recognition 
sites for the E . coli dnaA initiator protein (Fuller et_ 
al., 1984; Kaguni and Kornberg., 1984). Three tandem 
repeats of an AT-rich 13-mer (Left, Middle, Right) are 
found at the opposite edge of oriC (Oka et al., 1980) and 
have been proposed to contain the duplex opening sites 
for initiation of DNA synthesis.
The dnaA protein is a monomer of 52 kDa which binds 
ATP tightly and hydrolyses it very slowly (Sekimizu et al.,
1987). Both the ATP- and ADP-bound forms of dnaA bind 
specifically to the consensus sequence 5'-TTAT (C/A) CA(C/A) A- 
3' found within the four dnaA boxes of oriC and also in the 
control regions of several E .coli genes, including the dnaA 
gene itself (Zyskind and Smith., 1986; Fuller et al., 1984). 
DNase I footprinting studies identified a region 
protected by dnaA encompassing about 200 bp of the
origin, including all but the three AT-rich 13mers 
(Fuller et al., 1984).
The formation of an initial dnaA-oriC complex (Fuller 
and Kornberg, 1983; Fuller et al., 1984), consisting of a 
core of about 20-40 dnaA monomers wrapped in supercoiled 
DNA (Fuller and Kornberg., 1983; Funnell et al., 1987;
Baker and Kornberg., 1988), causes partial unwinding of 
the duplex to form an open complex (See Figure 8). This 
process requires ATP hydrolysis, carried out by the dnaA 
protein itself (Bramhill and Kornberg., 1988a,b), a 
negatively supercoiled template (Baker and Kornberg.,
1988) and the presence of a histone-like DNA binding 
protein, HU (Dixon and Kornberg, 1983; Ogawa et al.,
1985) which may stabilise a desirable bend in the DNA
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Figure 7. Replication Origins of E.coli, Bacteriophage
Lambda and Simian virus 40
A schematic representation depicting the minimal 
E .coli origin, OriC, is shown in the top figure. It 
contains three 13mer tandem repeats (L [Left], M 
[Middle], R [Right]) indicated as solid arrows, within 
an AT-rich segment. The shaded boxes adjacent to this 
region represent four 9mer tandem repeat dnaA binding 
sites (dnaA boxes).
The Bacteriophage Lambda origin (centre figure) is 
schematically drawn and contains four nearly perfect 
19mer repeats (shaded boxes) which bind the 
bacteriophage lambda 0 protein. Adjacent to this region 
lies a 49 bp AT-rich domain.
The SV40 origin (bottom figure) is schematically 
drawn opposite. The core origin contains three 
functionally distinct domains, the early palindrome, 
central domain and AT-rich domain, as indicated. The T 
antigen binding sites (GAGGC motifs) are represented by 
the small solid arrows and are located within the 
central domain and also within a region outside the core 
origin adjacent to the early palindrome.
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Figure 8- Initiation of E.coli DMA. Replication
A schematic illustration of the E.coli origin of 
replication, OriC is shown in Figure a. DnaA binding 
sites (A) and the three AT-rich 13mer repeats (arrows) 
are indicated. Gene transcription from a promoter 
located close to the origin facilitates binding of dnaA 
which initiates duplex melting at the AT-rich repeats. 
In the presence of ATP and HU, dnaB molecules can bind 
to the ss DNA loop (Figure b.). Primase generates 
primers for the holopolymerase III thereby initiating 
bidirectional replication (Figures c. and d.), 
(reproduced from Adams, 1991, DNA replication, Ed.
D.Rickwood.).
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(Skarstad et al., 1990). Regions of single-stranded DNA 
which are sensitive to single-strand specific 
endonuclease digestion have been detected at the three 
AT-rich 13-mers (Kowalski and Eddy, 1989), but the 
mechanism by which the dnaA protein/oriC complex forms 
the open complex is still unclear. One proposal involves 
a specific interaction between the dnaA protein and one 
or more of the 13-mers. This interaction has not, 
however, been detected by DNase I footprinting. The 
reduced stability of dnaA-oriC complexes on templates 
from which the 13-mers had been deleted (Yung and 
Kornberg, 1989), the ability of a synthetic 13-mer 
oligonucleotide to compete with dnaA binding to oriC, and 
the presence of 13-mer sequences near dnaA boxes in other 
origins (Bramhill and Kornberg, 1988) all suggest some 
specificity in the reaction between the 13-mers and dnaA. 
It has been suggested that only the right hand AT-rich 
region is recognised by the dnaA protein. Melting is 
initiated and unwinding of the DNA in the region of the 
non-contacted 13-mers ensues as a result of their high AT 
content conferring a reduced helical stability. This 
hypothesis is consistent with mutational studies which 
revealed that the right 13-mer is the only AT-rich 
element required for dnaA/HU opening of oriC (Bramhill 
and Kornberg., 1988), although all three were required 
for the formation of the pre-priming complex. Further 
evidence supporting this proposal is that the sequence of 
the right 13-mer and the spacing between it and the 
leftmost dnaA box is completely conserved in the origins 
of the enteric bacteria whereas the left and middle 13- 
mers tolerate base substitutions (Asada et al., 1982; 
Kowalski and Eddy., 1989).
The binding of dnaA to oriC allows the assembly of a 
multi-protein pre-priming complex in preparation for 
initiation of DNA synthesis (Baker et al., 1986; 1987; 
Funnell et al., 1987). Once an open complex is formed, 
the dnaB helicase, with the help of dnaC binds to both 
DNA strands in the single-stranded region. Although 
absolutely essential for complex assembly, the dnaC
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protein inhibits the helicase activity of dnaB and must 
therefore be removed before replication can proceed 
(Kornberg and Baker, 1992). Electron microscopy has shown 
that the pre-priming intermediate is larger and less 
symmetrical than the initial complex and also encompasses 
the region containing the three 13-mer repeats (Funnell 
et al., 1987).
In addition to its role in opening the duplex 
evidence exists which suggests that dnaA also plays a 
direct role in the loading of dnaB onto the DNA. DnaB 
binds very poorly to ss-DNA and is normally unable to do 
so if single stranded DNA binding protein (SSB) is bound 
(Wahle et al., (1989). DnaB with the aid of dnaC can only
utilise this DNA as a template when dnaA associates with 
the DNA prior to SSB addition. DnaC is always required 
for this process suggesting that protein-protein 
interactions between dnaA and either dnaB or dnaC (or a 
complex of both) may be essential for dnaB loading.
The helicase action of dnaB melts the DNA bi- 
directionally forming a replication bubble and providing 
the templates for initiation of DNA synthesis (Baker et 
al., 1987; Bramhill and Kornberg, 1988a;b). An 
interaction between dnaG primase and dnaB is thought to 
produce a mobile primosome which generates primers for 
both leading and lagging strand synthesis. The primosome 
moves with 5'-3' polarity in the direction of the 
replication fork allowing multiple primings to take place 
during discontinuous synthesis (Kornberg and Baker,
1992). Primers are extended by DNA polymerase III on both 
the leading and lagging strands and replication proceeds 
bi-directionally from the origin (Baker et al., 1986; 
1987).
DNA gyrase and SSB are also required during fork 
movement. Following initial strand separation and 
extention of the replication bubble, the displaced DNA 
strands are maintained in an extended conformation by SSB 
providing a suitable template for DNA primase and DNA 
polymerase activity (Kornberg, 1980; 1982; 1988).
Topoisomerase II (DNA gyrase) cuts and reseals the
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duplex to release the torsional strain of positive 
supercoiling ahead of the advancing fork (Funnel et al., 
1987/ Baker, 1986/ 1987).
The identification of dnaA boxes within the promoter 
of the dnaA gene as well as in other genes led to the 
suggestion that in addition to its role in initiation of 
DNA synthesis, dnaA may also play a part in regulating 
the transcription of its own and other genes. Indeed 
Schaefer and Messer, (1989) demonstrated that insertion 
of a dnaA box site into the middle of the dnaA ORF 
resulted in a transcriptional block of dnaA and 
downstream gene expression (Schaefer and Messer, 1989).
1.4.2 Initiation of Bacteriophage Lambda DNA. replication
Following entry into E .coli, linear phage lambda DNA 
circularises and bidirectional replication is initiated 
from a single origin within the phage genome, oriA 
(Schnos and Inman, 1970). Initiation of phage DNA 
replication resembles initiation at E .coli. oriC, except 
that the host proteins dnaA and dnaC are not required. 
Instead two virally-coded proteins, 0 and P, interact 
with ori A and with other host replicative proteins to 
initiate DNA synthesis (Eisen et al., 1966/ Ogawa and 
Tomizawa, 1968/ Friedman et al., 1984).
Mutational analysis defined a region within the viral 
0 gene which contained the essential sequences required 
for origin function. Two major characteristic domains 
were identified consisting of four nearly perfect 
repeats of 1CJ bp, and an adjacent 4 9 bp AT-rich segment 
(Schnos and Inman, 1970/ Scherer, 1978). (See Figure 7).
The 0 protein may be regarded as the functional 
analogue of E.coli dnaA as it too recognises and binds to 
the origin. Nuclease and methylation protection analyses 
demonstrated that the 0 protein binds to the four 19 bp 
repeat elements (Tsurimoto and Matsubara, 1981/ Zahn and 
Blattner, 1985). The internal symmetry of each element 
also suggests that the 0 protein may bind as a dimer 
(Zylicz et al., 1984).
Electron microscopy experiments indicated that the
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formation of specialised nucleoprotein complexes at ori 
is responsible for localising the initiation of DNA 
synthesis (Dodson et al., 1985). Binding of 0 protein to 
the origin results in the formation of an initial 
nucleoprotein structure called the "O-some" whose 
condensed appearance under the electron microscope 
suggested that the DNA was bent or wrapped around the 
protein (Dodson et al., 1985; 1986; Zahn and Blattner, 
1985).
Once bound, the 0 protein initiates melting of the 
flanking AT-rich region, (demonstrated by an increased 
sensitivity to ss-specific nuclease digestion), forming 
an open complex into which the rest of the replicative 
machinery can enter (Schnos et al., 1988), (Figure 9). 
Unlike the E .coli dnaA/oriC complex, the lambda ori /0 
protein complex does not require the binding of ATP for 
helix de-stabilisation at the AT-rich region (Schnos et 
al., 1988). The mechanism by which the localised strand 
separation occurs has been suggested to be dependent on 
the tension arising from duplex supercoiling. How this 
energy or that arising from bending the origin is 
transferred into strand separation is still unclear 
(Schnos et al., 1988; Dodson et al., 1989).
Studies using hybrid phage indicated that the 0 
protein origin binding domain lay within the N-terminus 
of the protein while the C-terminus was responsible for 
its interaction with the viral P protein (Furth et al., 
1978). The P protein, an analogue of the E .coli dnaC 
protein, binds host dnaB and interacts with the "O-some", 
thus recruiting a helicase actvity to the origin for 
duplex unwinding (Dodson et al., 1986). The binding of 
the 0 protein to the origin acts as the catalyst for the 
unwinding reaction as the dnaB helicase activity can only 
function on pre-formed open complexes (LeBowitz and 
McMacken, 1986).
Initiation of DNA synthesis depends on these 
reactions and on the host dnaJ and dnaK proteins causing 
transition of the open complex into a form competent for 
localised activity of the dnaG primase and DNA polymerase
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Figure 9. Initiation of Bacteriophage Lambda DNA
Replication
A schematic drawing of the bacteriphage lambda origin 
of replication is illustrated in Figure a. The binding 
of O-protein (large circles) to the four 19mer repeat 
motifs (black boxes) initiates unwinding of the duplex 
at the AT-rich region within the origin. Duplex opening 
allows binding of P-protein (dashed line)/dnaB (squares) 
complexes which link the ss DNA region to the O-protein 
(Figure b.). Disassembly of the complex by dnaJ and dnaK 
allows the dnaB helicase function to extend the ss 
region (Figure c.). DnaG generates primers (zig-zag 
lines) for the holopolymerase III thereby initiating 
leading strand synthesis for bidirectional replication 
(Figure d.), (reproduced from Adams, 1991).
Binding of O protein to ori K 
causes melting of 
AT-rich region
P-protein and Dna B «
bind to single-stranded DNA
Dna J binds to P and both
are released by action of Dna K.
Primase makes primers which
are extended by
V
holopolymerase III
c
Bidirectional replication
d
Ill holoenzyme (Wold et a l ., 1982; Tsurimoto and 
Matsubara, 1982; LeBowitz and McMacken, 1984; LeBowitz et 
al. , 1985). Subsequent replication requires the same 
proteins as E .coli oriC dependent DNA synthesis 
suggesting that identical replication forks are assembled 
(Mensa-Wilmot et a l ., 1989).
1.4.3 Initiation of SV40 DNA replication
The SV40 genome consists of a circular DNA duplex of 
approximately 5000 bp which complexes with histones 
forming nucleosomes which are indistinguishable from 
those of host cellular chromatin. DNA replication is 
initiated bi-directionally from a single origin, and, 
since SV40 encodes only a single replication protein, (T 
antigen), the virus relies almost entirely on the host 
cell replication machinery (Tegtmeyer, 1972; Stillman, 
1989) .
Deletion and substitution analysis of SV40 origin 
sequences revealed a 64 bp core origin containing all the 
elements required for initiation of DNA replication in 
vitro (Stillman et al., 1985; Deb et al., 1986a; Smale 
and Tjian, 1986; Dean et al., 1987a). Further mutational 
studies indicated that the core origin contained at least 
three functionally distinct domains (Deb et al.,
1986a;b;c).
The central domain contains four pentanucleotide 
motifs (5'-G(A/G)GGC-3') arranged on the two arms of a 27 
bp palindrome. These sequence elements are recognised by 
the viral initiation protein T antigen, and each one is 
bound by a single monomer (Tjian, 1978; DeLucia et al., 
1983; Mastrangelo et al., 1985). Flanking the central 
domain lies an imperfect palindrome (early palindrome) of 
unknown function and a 17 bp AT-rich tract. Additional T 
antigen binding site sequences are also present to the 
left of the early palindrome.
The SV40 origin therefore exhibits some striking 
similarities to the origins of E .coli and bacteriophage 
lambda. All three genomes contain multiple binding sites, 
recognised by the relevant initiator proteins, with
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adjacent AT-rich tracts.
Binding of the 95 kDa T antigen to the four 
pentameric repeats in the origin, in the presence of ATP, 
leads to the assembly of an organised nucleoprotein 
structure which is competent for replication initiation 
(Mastrangelo et al., 1985). This multimeric structure 
consists of a double T-antigen hexamer complex covering 
the entire core origin plus 12 bp on either side (Deb and 
Tegtmeyer, 1987; Borowiec and Hurwitz, 1988; Mastrangelo 
et al., 1989).
The presence of ATP induces specific conformational 
changes in the DNA at the early palindrome and AT-rich 
segments (Borowiec and Hurwitz, 1988) and the result is 
localised duplex melting within the former region (Figure 
10.). This reaction does not require the hydrolysis of 
ATP (Dean et al., 1987; Borowiec and Hurwitz, 1988; 
Roberts, 1989).
In addition to catalysing localised melting of duplex 
DNA, T-antigen, which exhibits an intrinsic helicase 
activity, has been shown to continue bi-directional DNA 
unwinding during the progression of the SV40 replication 
fork (Hurwitz, 1990; Wessel et al., 1992). This process 
requires the hydrolysis of ATP, and the presence of a 
cellular SSB (RF-A) and topoisomerase I (Dodson et al., 
1987; Parsons et al., 1990). It has been suggested that 
the dodecamer complex acts at the centre of the 
replication fork and that the duplex DNA is threaded 
through the intact complex which then extrudes single­
stranded DNA loops (Wessel et al., 1992).
The SV40 T-antigen does not bind tightly to ss DNA 
and the whole initiating complex would fall apart if it 
were not stabilised by the binding of other T-antigen 
molecules to auxiliary sites out with the core origin 
(Gutierrez et al., 1990). Changes in the phosphorylation 
status of T-antigen have been suggested to play a role in 
the binding and release of the protein (McVey et al.,
1989) .
Following the opening of the origin region, priming 
of both leading and lagging strand DNA synthesis is
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Figure 10. Initiation of SV40 DNA Replication
The SV40 origin of replication and flanking regions 
are schematically outlined in Figure a. where the black 
boxes indicate the positions of T antigen (Tag) binding 
sites within the core origin (site II) and also within 
auxilary regions (sites I and III) . The AT-rich segment 
within site II is also indicated by the arrow above. Tag 
(circles) binds firmly to site II (less firmly to other 
sites) and opens up the duplex at a region between sites 
I and II (Figure b.). Functioning as a helicase Tag, 
along with an SSB complex (ovals) opens up the whole 
origin and allows polymerase alpha/primase to bind 
(Figure c.) and initiate replication of the early 
template strand (Figure d.). Polymerase delta/PCNA 
complex takes over leading strand synthesis while 
polymerase alpha/primase initiates lagging strand 
synthesis (Figure e.) and bidirectional replication 
ensues (Figure f.), (reproduced from Adams, 1991).
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believed to be carried out by the DNA polymerase 
alpha/primase complex. Leading and lagging strand DNA 
synthesis is then catalysed by two mammalian DNA 
polymerases Pol delta and Pol alpha respectively (Prelich 
et al., 1987; Decker et al., Wold et al., 1988; Lee et 
al., 1989). PCNA is required as an auxiliary factor for 
Pol delta which allows highly processive synthesis of the 
leading strand. It is not clear whether T-antigen has a 
role in directing the Pol enzymes and other replication 
proteins to the origin region, although an association 
between T antigen and DNA pol alpha has been reported 
(Smale and Tjian, 1986; Donreiter et al., 1990).
1.5 Alms of the Work Presented in this Thesis
The previous sections describe several features that 
UL9 shares with the more intensely studied initiator 
proteins required for initiation of E .coli., phage lambda 
and SV40 DNA synthesis.
Understanding the precise role of UL9 in the 
initiation of HSV DNA synthesis will contribute to our 
overall knowledge of the mechanisms of viral DNA 
replication and hopefully also assist the development of 
an in vitro system for the study of HSV DNA replication.
The work presented in this thesis is concerned with 
the mechanism by which UL9 recognises and binds to the 
HSV origins. Weir et al. (1989) demonstrated that a
protein A-UL9 fusion containing the C-terminal one-third 
of the UL9 protein contained all the information 
necessary for sequence-specific DNA binding activity. The 
aim of this study was to construct deletion and insertion 
mutants within this region and to study their 
interactions with the origin in an attempt to define the 
important regions of UL9 involved in the DNA/protein 
interaction. In addition, selected mutations were 
introduced into full length copies of the UL9 gene which 
were expressed using recombinant baculoviruses. These 
viruses were analysed in a transient viral origin- 
dependent replication assay in insect cells in which
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amplification of an orig-containing plasmid is driven by 
superinfection with a mixture of seven recombinatvh 
baculoviruses which express the full complement of 
essential HSV-1 DNA replication proteins. By this means 
it was possible to assess the ability of the mutant UL9 
proteins to participate in viral DNA replication.
56
CHAPTER 2: MATERIALS AND METHODS
2 .1 MATERIALS
2.1.1 Chemicals and Reagents
The majority of chemicals were obtained from either 
BDH CHEMICALS Ltd., or SIGMA CHEMICALS Ltd and were of 
analytical grade or better. Exceptions to this were : 
Tissue culture reagents were obtained from GIBCO LIFE 
TECHNOLOGIES Ltd.; Ammonium persulphate, TEMED (N,N,N'N 
tetramethylethylenediamine), gelatin, Bio-Rad protein 
assay dye reagent from BIO-RAD LABS Ltd; Ampicillin 
(penbritin) from BEECHAM RESEARCH LABS Ltd.; HPLC grade 
dimethyl-sulphoxide and formamide from FLORA CHEMICALS 
Ltd.; Absolute alcohol and methanol from HAYMEN Ltd.; 
Glacial acetic acid, hydrochloric acid, chloroform and 
glycerol from MAY and BAKER Ltd. DEAE-sephacel and 
sequencing solutions from PHARMACIA Ltd.; Prestained 
Protein molecular weight markers from STRATAGENE; Horse 
radish peroxidase-protein A and alkaline phosphatase- 
protein A antibody detection kits from PROMEGA Ltd.; 
Nitrocellulose membrane from SCHLEICHER and SCHUELL.; 
Kodak X-OMAT XS-1 and duplicating films from KODAK Ltd.; 
wacker silane GF 38 from WACKER CHEMICALS and dialysis 
membrane from MEDICELL INTERNATIONAL Ltd.
2.1.2 Solutions 
Blocking buffer:
lx TBST plus 3% gelatin heated to 37°C.
Blotting (Towbin) buffer (Towbin et al., 1979):
25 mM Tris.HCl (pH 8.3), 192 mM glycine, 20% (v/v) 
methanol.
Cell lysis buffer (CLB):
0.5% SDS, 20 mM Tris.HCl (pH 7.5), 2 mM EDTA. 
Denhardt's reagent (50x):
1% polyvinylpyrrolidone, 1% BSA, 1% Ficoll 400. 
Electrophoresis buffer (SDS-PAGE):
52 mM Tris, 53 mM glycine, 0.1% SDS.
Gel soak I:
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200 mM NaOH, 600 mM NaCl.
Gel soak II:
1 M Tris.HCl (pH 8.0), 600 mM NaCl.
GTE buffer:
50 mM glucose, 10 mM EDTA, 25 mM Tris.HCl (pH 8.0). 
HBS (lipofection):
150 mM NaCl, 20 mM hepes.NaOH (pH 7.4).
HeBS buffer:
137 mM NaCl, 5 mM KC1, 0.7 mM Na2HP0 4 , 5.5 mM D- 
Glucose, 21 mM hepes.NaOH (pH 7.05).
Hybridisation buffer:
6x SSC, 5x Denhardt's solution, 0.05% SDS, 50 ug/ml 
denatured calf thymus DNA, 20 mM Tris.HCl (pH 7.5),
1 mM EDTA.
Loening's buffer:
36 mM Tris, 36 mM NaH2P04, 1 mM EDTA.
Optimem pH 6.0:
2 65 ul cone HC1 was added to 100 ml optimem and 
vigo rously stirred for 1 hour.
Phenol/Chloroform solution:
50% TE saturated phenol (v/v), 50% chloroform (v/v). 
Pre-hybridisation buffer:
6x SSC, 5x Denhardt's solution, 0.1% SDS, 20 ug/ml 
denatured calf thymus DNA.
4x Resolving gel buffer (RGB):
1.5 M Tris.HCl (pH 8.9), 0.4% SDS.
SSC (20x):
3 M NaCl, 0.3 M trisodium citrate.
4x Stacking gel buffer (SGB):
0.488 M Tris.HCl (pH 6.7), 0.4% SDS.
STET buffer:
8% (w/v) sucrose, 0.5% (v/v) TritonX-100, 50 mM 
Tris.HCl (pH 8.0), 50 mM EDTA.
TBE buffer:
90 mM Tris base, 89 mM boric acid, 1 mM EDTA.
TBS (Tris buffered saline):
20 mM Tris.HCl (pH 7.5), 500 mM NaCl.
TBST:
lx TBS plus 0.05% TWEEN.
58
TE buffer:
10 mM Tris.HCl (pH 8.0), 1 mM EDTA.
TM buffer:
10 mM Tris.HCl (pH 7.5), 10 mM MgCl2 .
TSB (Transformation and storage buffer):
L-broth (pH 6.1), (Section 2.1.8), 10% (w/v) PEG (mw 
3350), 5% (v/v) DMSO, 10 mM MgCl2/ 10 mM MgS04.
2.1.3 Plasmids
The following plasmids were provided by Dr. N. D. 
Stow.
Plasmid pAcYMl is a AcNPV transfer vector (Matsuura 
et al., 1987) containing all the upstream sequences of 
the polyhedrin gene promoter, the untranslated leader and 
the A of the initiating ATG codon but lacking the rest of 
the polyhedrin coding sequences. This plasmid contains a 
unique BamHI site for cloning genes which are to be 
translated from their own ATG translational start site.
Plasmid pBL91 consists of a HSV-1 DNA fragment 
containing the UL9 gene (nucleotides 20670 to 23542; 
McGeoch et al., 1988a), ligated to Xhol linker 
oligonucleotides and cloned into the filled-in unique 
BamHI site of pAcYMl.
Plasmid pTZ19U (Mead et al., 1986) is a standard 
cloning vector conferring ampicillin resistance and 
containing a multiple cloning site.
Plasmid pEC8 (also referred to as pST19; Weir and 
Stow, 1990) consists of a 100 bp fragment specifying a 
functional HSV-1 orig replication origin inserted into 
the vector pTZ19U.
2.1.4 Enzymes
Restriction enzymes were manufactured by BOEHRINGER 
MANNHEIM and NEW ENGLAND BIOLABS, T7 DNA polymerase by 
PHARMACIA and nuclease Bal-31 by BETHESDA RESEARCH LABS.
2.1.5 Synthetic Oligonucleotides
Oligonucleotides were synthesised by Dr. J.
McLauchlan using a model 8600 Biosearch DNA synthesiser.
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Oligonucleotides used during the course of this study 
to sequence UL9 mutants are listed below :
Oligonucleotide 1 
Oligonucleotide 2 
Oligonucleotide 3 
Oligonucleotide 4 
Oligonucleotide 5 
Oligonucleotide 6 
Oligonucleotide 7
5'- AACAACGTAACGGCTTC -3' 
5'- AAATTGTCGCGCTCATG -3' 
5'- TCAACGTCACCGGAGAG -3' 
5'- TGACGTGCTGGACCTAC -3' 
5'- CCGTTAGCGAGACGGAC -3' 
5'- TGTTGGACGCCCACCAC -3' 
5'- TGTTTGCGCACGCACTC -3'
Oligonucleotides used in gel retardation assays are: 
Oligonucleotide I :
5'- GATCCGCGAAGCGTTCGCACTTCGTCCCA
GCGCTTCGCAAGCGTGAAGCAGGGTCTAG -5' 
Oligonucleotide II :
5'- GATCTGGGGCGAAGTGCGAGCACTTCGCG
ACCCCGCTTCACGCTCGTGAAGCGCCTAG -5'
2.1.6 Radiocheraicals
All radio-labelled compounds were supplied by 
AMERSHAM INTERNATIONAL PLC.
Specific Activity
(i) 5' [cX-^p]- deoxyribonucleoside >3000 Ci/mmol
triphosphates
(ii) l-[35-s]-Methionine >1000 Ci/mmol
(iii) [35-s]- dATP >1000 Ci/mmol
2.1.7 Viruses, Cells and Tissue Culture Media
Spodoptera frugiperda (Sf) insect cells (strain IPLB- 
SF-21 : Kitts et al./ 1990) were routinely used for the 
growth of baculoviruses, preparation of DNA and protein 
extracts and plasmid amplification assays. Sf cells were 
maintained in TC100 medium, containing 5% (v/v) foetal 
calf serum, penicillin (100 units/ml) and streptomycin 
(100 ug/ml).
Recombinant baculoviruses AcUL5, AcUL8, AcUL9,
AcUL2 9, AcUL30, AcUL42 and AcUL52 containing the HSV-1 
UL5, UL8, UL9, UL29, UL30, UL42 and UL52 genes
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respectively have been previously described by Stow,
(1992). The parental virus used in constructing 
recombinants expressing mutant UL9 genes was AcRP231acZ 
(Possee and Howard, 1987).
Recombinant baculoviruses containing mutant HSV-1 UL9 
genes were constructed during this study as described 
later in the text.
2.1.8 Bacterial Strains and Culture Media
The E . coli strains used were DH5 and K12AHlAtrp.
The following culture solutions were used:
L-Broth - 10 g/1 NaCl, 10 g/1 bactopeptone, 5 g/1
yeast extract.
L-Broth agar - L-Broth plus 1.5% w/v agar.
Ampicillin, when appropriate, was added to the above 
solutions at a concentration of 50 ug/ml.
2.1.9 Antisera
Rabbit antiserum raised against a decapeptide 
corresponding to the C-terminus of the UL9 gene product 
was provided by Dr. M.D Challberg (Olivo et al., 1988).
2.2 METHODS
2.2.1 Isolation and Propagation of Recombinant
Baculoviruses 
(a) Growth of Cells
Spodoptera frugiperda (Sf) insect cells were grown in 
supplemented TC100 medium at a temperature of 28°C. Cells 
were detached and passaged routinely every three to four 
days.
(b) Preparation of Virus Stocks
Stocks of recombinant baculoviruses were propagated 
in Sf cells. Cell monolayers in 500 ml flasks were 
infected with virus at a moi of 1 - 5 pfu per cell in 50 
ml of supplemented TC100 medium. Infected cultures were
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harvested after 3 - 4  days when an extensive cytopathic 
effect was observed. Cells were pelleted at 2000 rpm 
(Beckman JA-14 rotor) and the resulting supernatant 
centrifuged at 14000 rpm for 5 hours at 4°C. The pellet 
of cell released virus was resuspended in approximately 
one tenth the original volume of supplemented TCI00 
medium, sonicated in a Cole Palmer ultrasonic bath and 
aliquots stored at -70°C. Sterility checks were carried 
out using blood agar plates.
(c) Titration of Virus
The titration of baculovirus stocks was carried out 
as described by Brown and Faulkner, (1977).
All virus stocks were titrated on Sf cell monolayers 
in 35 mm petri dishes. Serial 10-fold virus dilutions 
were prepared using supplemented TCI00 medium and 0.1 ml 
of each dilution inoculated after the removal of the 
growth medium. After one hour at RT, the inoculum was 
carefully removed and replaced with 1.5 ml of overlay 
medium (made by mixing equal volumes of TCI00 medium and 
melted 3% (w/v) low gelling temperature agarose prewarmed 
to 37°C) which was allowed to solidify. 1.5 ml of 
supplemented TCI00 medium was then added as a liquid 
overlay and the plates incubated at 28°C for 4 days. 0.5 
ml of a 1 in 25 dilution of stock neutral red stain (0.5% 
w/v) was then added to the plates which were returned to 
28°C and plaques counted the following day.
(d) Transfection of Cells with DMA
Recombinant viruses were generated by co-transfecting 
Sf cell monolayers with viral and plasmid DNAs using the 
calcium phosphate precipitation method, (Graham and van 
der Eb, 1973).
Sf cell monolayers were set up in 35 mm petri dishes 
one day prior to transfection. 1 ug plasmid DNA and 1 ug 
Bsu36l-cleaved AcRP231acZ DNA were gently mixed in 1 ml 
of HeBS (pH 7.05) in a 15 ml Falcon tube. 70 ul of 2 M 
CaCl2 was then added and the mixture left at RT for 3 min 
during which time a fine precipitate appeared. Monolayers
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from which the growth medium had been removed were 
inoculated with the calcium phosphate precipitate, 
incubated for 1 hour at RT then overlaid with 2 ml of
growth medium and moved to a 2 8°C environment for a
further 3 hours. The CaPC>4 precipitate was then removed, 
the cells washed once with growth medium then returned to
28°C with 2 ml of fresh medium as an overlay. The virus
progeny were harvested 3 days later by scraping cells 
into the medium and stored at -70°C until required.
(e) Plaque Purification of Recombinant Baculoviruses
Recombinant viruses were purified by titration of the 
progeny from transfected monolayers as described above. 
X-gal (0.5 mg/ml) was added to the neutral red stain to 
identify recombinant viruses in which the B-galactosidase 
gene of the parental virus had been disrupted. Well 
isolated white plaques (putative recombinants) were 
picked using sterile Pasteur pipettes and placed into 0.5 
ml of supplemented TC100 medium and sonicated. Stocks of 
virus were derived from the progeny of individual plaques 
and the presence of recombinants was confirmed by Western 
blot assays and radiolabelling of infected cell proteins.
2.2.2 Manipulation of DNA
(a) Restriction Enzyme Digestion of DNA
DNA samples ( 1 - 5  ug) were usually digested in a 20 
ul volume containing the appropriate enzyme buffer and a 
suitable amount of restriction enzyme (usually 3 units/ug 
D N A ). Most digestions were carried out at a temperature 
of 37°C for 1 . 5 - 2  hours.
For the analysis of small scale plasmid DNA 
preparations (see section 2.2.4b), 2 ul samples were 
digested in a total volume of 20 ul as above but with the 
addition of 10 ug/ml RNase A.
(b) Ligation of Linker Oligonuleotides to Plasmid DMA
Linear plasmid DNA molecules were treated with 1 unit 
of calf intestinal alkaline phosphatase at 37°C for 1
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hour to prevent recircularisation during ligation. After 
phenol/chloroform extraction and ethanol precipitation,
2.5 ug DNA was ligated overnight at RT to 0.25 ug 
phosphorylated synthetic linker oligonucleotides in a 
total volume of 20 ul containing ligase buffer and 1 unit 
of T4 DNA ligase.
The T4 DNA ligase was inactivated by heating the 
reaction to 70°C for 10 min. A restriction enzyme 
digestion was then carried out at 37°C for 3 hours to 
cleave ligated linker oligonucleotides and produce 
"sticky" ends. The reaction was extracted with 
phenol/chloroform, and the ligated DNA precipitated with 
0.5 vol of isopropanol for 4 hours at RT and then 
recircularised in a 30 ul vol using 1 unit of T4 
DNA ligase at 37°C for 4 hours. 1 ul samples of ligated 
DNA were used to transform competent E .coli bacteria.
(c) Digestion of Plasmid DNA. with Nuclease Bal-31
35 ug of plasmid pBl DNA was linearised with the 
restriction enzyme Sail in a total volume of 100 ul for 3 
hours at 37°C then serially extracted with phenol and 
chloroform and precipitated with 2.5 vols of ethanol. 
Pelleted DNA was lyophilised and resuspended in 180 ul 
H2O. 45 ul 5x Bal-31 buffer (100 mM Tris.HCl [pH8.0],60 
mM MgCl2 , 60 mM CaCl2 / 5 mM EDTA [pH 8.0],1 M NaCl) and 1 
unit of the enzyme Bal-31 were added. A 35 ul sample 
(zero time point) was immediately removed into 350 ul 
0.02 M EGTA (pH 8.0), 0.15 M NaCl, extracted with phenol/ 
chloroform and ethanol precipitated. The remainder of the 
reaction was incubated at 31°C and 35 ul samples were 
withdrawn at various times (from 1 to 10 min) and treated 
as above. Pelleted DNA was lyophilised and resuspended in 
22 ul H2 O. 5 ul of each sample was digested with BamHI 
and electrophoresed in a mini agarose gel to determine 
the extent of deletion.
Plasmid DNA digested to an appropriate extent with 
Bal-31 was treated with calf intestinal alkaline 
phosphatase and ligated to 14 bp Xbal linker 
oligonucleotides containing termination codons in all
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three frames. Following ligation, the reaction products 
were digested with Xbal and recircularised as described 
in section b, prior to transformation of E .coli.
(d) Linker Insertion Mutagenesis
Plasmid pBl DNA was partially digested with Haelll or 
MvnI (which leave blunt ends) using either short 
incubation periods or digestion in the presence of 
ethidium bromide.
In the first case, 10 ug of pBl were cleaved with 10 
units of enzyme in a total vol of 50 ul at 37°C for 
various times. Partial cleavage in the presence 
of ethidium bromide was carried out using 10 ug of pBl 
and 50 or 10 units of enzyme in the presence of 20 or 50 
ug/ml of ethium bromide in a volume of 100 ul. These 
reactions were incubated at 37°C for 22 min.
4 ul samples from each reaction were then run on 1% 
agarose gels alongside plasmid pBl cleaved with a single­
cut enzyme to check the extent of linearisation. DNA 
samples with the highest concentration of linear 
molecules were dephosphorylated with calf intestinal 
alkaline phosphatase and the linears purified by agarose 
gel electrophoresis and DEAE-sephacel column 
chromatography (see section 2.2.5a). Purified linear 
molecules were then ligated to 12 bp EcoRI linker 
oligonucleotides overnight at RT (see section 2.2.2 b), 
cleaved with EcoRI and the resulting molecules 
recircularised in preparation for transformation into 
competent E.coli cells.
2.2.3 Preparation and Tramsformation of Competent E.coli
DH5 Cells
The method was essentially as described by Chung and 
Miller (1988).
50 ml of L-broth was inoculated with 300 ul of an
overnight culture of E.coli DH5 cells and grown to an O.D
of 0.3 at 630 nm. Bacteria were pelleted at 2,300 rpm for
10 min at 4°C, resuspended in 2 ml TSB and incubated on
ice for 10 min. 200 ul aliquots were placed in
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polypropylene tubes and stored on ice.
DNA was added in a small volume (usually < 7ul) to 
the competent cells which were incubated on ice for about 
25 min. 800 ul of TSB containing 20 mM glucose was then 
added and the bacteria incubated at 37°C in an orbital 
shaker for 1.5 hours. 200 ul of undiluted and diluted 
transformed cells were spread onto agar plates containing 
50 ug/ml of ampicillin and incubated overnight at 37°C.
2.2.4 Preparation of Plasmid DNA
(a) Large Scale Preparation of Plasmid DNA
4 ml of L-broth containing 50 ug/ml ampicillin was 
inoculated with either a picked bacterial colony from an 
ampicillin agar plate or 10 ul of bacterial stock (stored 
in 7% DMSO at -70°C) and incubated overnight at 37^C. 
These cultures were added to 300 ml of L-broth containing 
50 ug/ml ampicillin and shaken at 37°C in a 2 L conical 
flask until an optical density measured at 630 nm of 0.6 
was reached. 1 ml of chloramphenicol solution (34 mg/ml 
dissolved in absolute alcohol) was then added to the 
culture and shaking was continued overnight.
Bacterial cells were harvested by centrifugation at 
8000 rpm for 10 min at 4°C in a Sorvall GS3 rotor. Cell 
pellets were resuspended in 9 ml GTE buffer (50 mM 
glucose, 25 mM Tris-HCl (pH 8.0), 10 mM EDTA) , 1 ml of 
lysozyme solution (20 mg/ml prepared in 0.2 M Tris-HCl pH 
8.0) added and the cells incubated with gentle mixing for 
5 min at RT. 20 ml of freshly prepared 1% SDS/0.2 M NaOH 
was then added and incubation continued for a further 5 
min at 4°C. Finally, 10 ml of ice cold 5 M potassium 
acetate (pH 4.8) was added and the cellular DNA and 
bacterial debris pelleted by spinning at 18,000 rpm 
(Sorvall SS34 rotor) for 15 min at 4°C. 16.5 ml 
isopropanol was then added to the supernatant for 5 min 
at RT. The DNA was recovered by centrifugation at 10,000 
rpm (Sorvall SS34 rotor) for 30min at 4°C. The resulting 
DNA pellet was washed in 70% ethanol, air dried and 
redissolved in 2 ml TE.
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The plasmid DNA was further purified by 
centrifugation to equilibrium on a caesium chloride- 
ethidium bromide density gradient.
2.3 g of CsCl was dissolved in the DNA solution (2 
ml) and 50 ul of ethidium bromide solution (10 mg/ml) 
added. The mixture was allowed to stand for a few min at 
RT before spinning for 3 min at high speed in a 
microfuge. The resulting supernatents were removed and 
placed in "quick seal" Beckman TL100 tubes. After heat 
sealing, the tubes were spun at 80,000 rpm overnight at 
20°C in a Beckman TL100 vertical rotor. Two DNA bands 
were observed and the lower one, consisting of closed 
circular plasmid DNA, was removed with a syringe.
Ethidium bromide was extracted by mixing four times with 
an equal volume of isoamyl alcohol. The aqueous phase was 
dialysed against TE for 2 hours and the DNA precipitated 
in ethanol overnight. The DNA pellet was redissolved and 
subsequently treated with RNase A (50 ug/ml) for 30 min 
at 37°C. After phenol/chloroform extraction and ethanol 
precipitation, the final air dried pellet of plasmid DNA 
was dissolved in 200 ul of TE.
Plasmid DNA was quantified by UV absorption at 2 60 nm 
taking an absorbance of 1.0 to correspond to a 
concentration of 50 ug/ml DNA.
(b) Small Scale Preparation of Plasmid DNA (Maniatis,
1982)
1.5 ml of a 2.0 ml overnight shaken E .coli culture 
was spun for 12 sec in a microcentrifuge. After removal 
of the supernatant the cell pellet was resuspended in 100 
ul of STET buffer by vortexing and 16 ul of a 20 mg/ml 
solution of lysozyme was added for 30 sec. The tube was 
placed in a boiling water bath for 50 sec and spun at 
high speed in a microcentrifuge for 10 min. The glutinous 
cell pellet was removed and 100 ul isopropanol added to 
the supernatant. After 15 mins at -20°C, precipitated 
nucleic acids were recovered by spinning again at high 
speed for 10 min, washed in 70% ethanol, lyophilised then 
redissolved in 35 ul TE buffer.
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2.2.5 Gel Electrophoresis of DNA
(a) Non-denaturing Agarose Gel Electrophoresis
For analysis of DNA restriction fragments horizontal 
1% agarose gels were prepared in TBE buffer or Loening's 
buffer containing 0.5 ug/ml of ethidium bromide. Before 
loading, DNA samples were mixed with one quarter volume 
5x tracker dyes (5x appropriate electrophoresis buffer, 
50% sucrose and 0.2% bromophenol blue (BPB)). Loaded gels 
were then electrophoresed at 100 V for 3 - 4  hours (TBE 
gels) or 35 V overnight (Loening's buffer gels). Rapid 
analysis of small amounts of DNA was carried out on 1% 
agarose mini-gels (20 ml) run in TBE buffer at 50 V for 
approximately 45 min. DNA bands in both cases were 
visualised under short wave UV light and photographed 
using Polaroid film (type 667).
DNA fragments were purified by excising the required 
gel slice from an agarose gel (observed under long wave 
UV light) and placing it in boiled dialysis tubing along 
with 1 ml of 0.5x TBE buffer. The closed bag was immersed 
in an electrophoresis tank containing 0.5x TBE 
perpendicular to the direction of the current flow. DNA 
was electroeluted from the gel slice for 2 hours at 200 
V. The buffer containing DNA was removed and passed 
through a 0.5 ml bed volume DEAE-sephacel column 
equilibriated with 0.1 M NaCl in TE. The column was 
washed with 5 ml of 0.1 M NaCl/TE solution. The DNA was 
then eluted from the column with 2x 0.4 ml aliquots of 1 
M NaCl/TE solution, precipitated with 2 ml of ethanol.
The DNA was pelleted, lyophilised and dissolved in TE.
(b) Non-denaturing Polyacrylamide Gel Electrophoresis
Purification of radio-labelled DNA fragments or 
analysis of small DNA restriction fragments was carried 
out on vertical 6% polyacrylamide gel slabs in TBE 
buffer. Stock solutions of 30% acrylamide were prepared 
in water with an acrylamide to bisacrylamide ratio of 
28.5:1.5 and deionised by stirring with amberlite resin. 
Final gel solutions (50 ml) were polymerised by addition
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of 500 ul of 10% (w/v) ammonium persulphate solution and 
50 ul TEMED. Gels were electrophoresed at 150 V for 2.5 - 
3 hours.
Resolved radio-labelled DNA fragments were located by 
autoradiography of the wet polyacrylamide gel and 
purified as described in section 2.2.4a. The radio­
labelled DNA was stored at -20°C.
Separated unlabelled DNA restriction fragments were 
visualised on acrylamide gels under UV light after soaking 
the gel in lx TBE containing ethidium bromide (0.5 ug/ml).
(c) Denaturing Polyacrylamide Gel Electrophoresis
DNA sequencing reactions were resolved on 6% 
polyacrylamide, 7.7 M urea, 0.5 - 2.5x TBE gradient gels 
(Hong, 1987).
Prior to pouring the gel, both sequencing plates were 
washed with 100% ethanol. The front notched plate was 
then covered with approximately 5 ml replecote™ while 5 
ml "Wacker" solution (25 ul Wacker silane GF38, 150 ul 
10% acetic acid, 5 ml ethanol) was applied to the back 
plate followed by 5 washes with 100% ethanol.
DNA samples were boiled for 2 - 3  min in 95% 
deionised formamide, 0.05% BPB and 0.05% xylene cyanolFF, 
20 mM EDTA (pH 7.5) before loading 3 ul into the 
previously rinsed wells. Gels were electrophoresed at 60 
W for approximately 2 hours in lx TBE tank buffer until 
the BPB dye front reached the bottom of the gel. After 
removal of the siliconised front gel plate, the gel was 
soaked in 10% acetic acid for 30 min then dried onto the 
"wackered" back plate in a 140°C oven for 1 - 1 . 5  hours. 
The dried gel was then exposed to autoradiography film 
overnight at RT.
2.2.6 Plasmid DNA sequencing
Plasmid DNA was sequenced by the dideoxy chain 
termination sequencing protocol (Sanger et al., 1977) 
using denatured plasmid DNA templates (Hattori and 
Sakaki, 1986).
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(a) Preparation of Denatured Plasmid DNA
This method was derived from that described by 
Hattori and Sakaki (1986) .
Bacterial cells from a 15 ml overnight culture were 
pelleted by spinning for 15 min at 9000 rpm (SS34 rotor) 
and resuspended in 1 ml of lysozyme solution (2 mg/ml 
lysozyme, 50 mM glucose, 25 mM Tris.HCl (pH 8.0), 10 mM
EDTA) for 5 min at RT. 2 ml of 1% SDS/0.2 M NaOH was then
added for 5 min at 4°C followed by 1.5 ml of ice-cold 5 M
potassium acetate (pH 4.8), for a further 5 min. After a
centrifugation for 15 min at 4°C and 9000 rpm, the 
supernatant was removed and phenol/chloroform extracted. 
The DNA was precipitated with 2 vols of ethanol for 30 
min at RT and pelleted for 15 min. The washed and 
lyophilised pellet was resuspended in 100 ul TE 
containing 10 ug RNase A and incubated for 30 min at 
37°C. 60 ul of 20% PEG/2.5 M NaCl was added for 1 hour on 
ice. The DNA was pelleted, washed, lyophilised and 
resuspended in 18 ul TE. The plasmid DNA was denatured in 
0.2 M NaOH for 5 min at RT, ammonium acetate added to 
0.3M and the DNA precipitated with ethanol. The final 
pellet of denatured plasmid DNA was washed, lyophilised 
and resuspended in 40 ul H2O.
(b) Dideoxy sequencing
4 ul of denatured plasmid DNA was annealed with 10 ng 
of primer oligonucleotide in a final vol of 10 ul 
containing 0.1 M Tris.HCl (pH 8.0) and 0.1 M MgCl2 for 30 
min at 37°C. Meanwhile, 2.5 ul of each of 4 termination 
mixes (^i.e., G,A,T and C) were dispensed into separate 
microtitre wells. These mixes comprised 150 uM dGTP, 
dATP, dTTP, dCTP and 15 uM of the appropriate dideoxy 
(dd)NTP (ie G,A,T or C) in 20 mM MgCl2, 40 mM Tris.HCl 
(pH 7.5) and 50 mM NaCl. The annealed DNAs were radio­
labelled by addition of 1 ul 0.1 M DTT, 2 ul labelling 
mix (2 uM dGTP, dTTP and dCTP), 20 uCi [35S]-dATP and 2 
units T7 DNA polymerase for 5 min at RT (final vol 17 
ul). 3.8 ul aliquots of the labelled annealed DNAs were 
transferred to each of the four termination mixes and
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incubated at 37°C for 15 min. 4 ul of formamide dye mix 
were added to the reactions and the products analysed on 
denaturing polyacrylamide gels (section 2.2.5c).
2.2.7 Radioactive Labelling of DNA
(a) Synthesis and Purification of Oligonucleotides
Oligonucleotides were synthesised on a Biosearch 8600 
DNA synthesiser and the DNA was eluted in 1 ml of 
ammonia.
Following a 5 hour incubation at 55°C, the ammonia 
was removed by lyophilising overnight. The DNA pellet was 
resuspended in 50 ul of H2 O and 25 ul removed and stored 
at -70°C. The remainder was mixed with an equal vol of 
90% formamide, lx TBE. The sample was boiled for 2 - 3  
min and loaded immediately onto a 15% non-denaturing 
polyacrylamide gel (acrylamideibis-acrylamide, 19:1). 5 
ul of formamide dye mix was also loaded into an adjacent 
well to act as a migration marker. The gel was 
electrophoresed in lx TBE at 300 V for about 4 hours or 
until the bromophenol blue had reached about 3/4 of the 
way down the gel. The gel was transferred onto cellophane 
and the DNA observed over a silica gel thin layer 
chromatography plate illuminated with an angled UV short 
wavelength lamp. The DNA was observed as a shadow on the 
fluorescent plate as a result of absorption of UV light. 
The oligonucleotide DNA band was excised and eluted with 
0.5 ml H2O overnight at 37°C. The DNA solution was 
subsequently phenol/chloroform extracted, ethanol 
precipitated, lyophilised and the oligonucleotide 
resuspended in 50 ul H2 O.
The concentration of the oligonucleotide was 
estimated by taking an absorbance value of 1 at 260 nm to 
correspond to 20 ug/ml of oligonucleotide.
(b) End-labelling of Synthetic Oligonucleotides and DNA
Fragments
Complementary synthetic oligonucleotides were 
annealed by mixing 5 ug of each in 50 ul H2 O, boiling for
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2 min and incubating for 30 min at 37°C. 0.2 ug annealed 
DNA was radio-labelled in a 40 ul vol of NT buffer (50 mM 
Tris.HCl (pH 7.5), 10 mM MgCl2 , 1 mM DTT) containing 20 
uCi of [ -32P]dATP, 0.1 mM dGTP, dTTP, dCTP and 2 units 
of the Klenow fragment of DNA polymerase I for 20 min at 
RT. Cold dATP was then added to 0.05 mM and the reactions 
left for a further 10 min and extracted with phenol. DNA 
was separated from unincorporated nucleotides by passage 
through a G-50 sephadex column.
Larger DNA fragments were purified from 5% non­
denaturing polyacrylamide gels and radio-labelled as 
above.
(c) Internal Labelling of Plasmid DMA by Nick
Translation
Plasmid DNA (200 - 300 ng) was radio-labelled by nick 
translation (Rigby et al., 1977) using 10 uCi each of [ 
-32P] dCTP and [ -32Pj dGTP, 2 units of E.coli DNA
polymerase I and 1x10“  ^mg DNase I in a final volume of 
30 ul NT buffer containing 40 nM each of cold dATP and 
dTTP. After a 1 hour incubation at 14°C, the reaction was 
brought to 150 ul with H2 O, extracted with phenol and 
labelled DNA purified on a G-50 sephadex column.
2.2.8 Analysis of Proteins
(a) Expression and Preparation of Protein A/UL9 Fusion
Proteins
A 3 ml E .coli culture was shaken overnight at 37°C. 
100 ml of L-broth plus ampicillin was inoculated with 500 
ul of the overnight culture and incubated at 37°C in an 
orbital shaker until an O.D of 0.5 at 630 nm was reached. 
50 ml of the culture was spun at 2300 rpm for 10 min at 
4°C in a Sorvall bench top centrifuge. The cell pellet 
was washed twice with 2 ml TE and resuspended in 1 ml TE. 
The cells were pelleted in a microfuge at high speed for 
30 secs and resuspended in 400 ul buffer C (20 mM Hepes 
pH 7.9, 25% glycerol, 1.5 mM MgCl2 , 0.2 mM EDTA, 0.5 mM 
PMSF and 0.5 mM DTT) containing 0.6 M KC1. The cell
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suspension was subjected to 3x 1 second bursts with a 
soniprobe. After centrifugation at 15000 rpm for 15 min 
(using SS34 eppendorf adaptors in a Sorvall rotor), the 
supernatant protein extract was removed, flash frozen and 
stored at -70°C.
(b) Estimation of Protein Concentration
Estimates of total protein concentration in bacterial 
extracts were obtained using Bio-Rad protein assay dye 
reagent according to the method of Bradford, (197 6). 1 ul 
of the bacterial cell extract was diluted in 1 ml of H2 O, 
800 ul of which was mixed with 200 ul of the dye reagent 
and left at RT for 10 min. The absorbance of the solution 
was measured at 620 nm and the concentration calculated 
from a standard curve produced using BSA solutions of 
known concentration.
(c) SDS-polyacrylamide Gel Electrophoresis (SDS-PAGE)
Vertical polyacrylamide gels were set up in a Biorad 
mini gel protein kit. Stocks of 30% acrylamide with a 
ratio of acrylamide to bisacrylamide of 28.5:1.5 were 
made up in H2 O. A 9% acrylamide resolving gel mix was 
prepared in 375 mM Tris.HCl (pH 8.9) and 0.1% SDS. 10% 
ammonium persulphate (APS) and TEMED were added to final 
concentrations of 0.1% and the resolving gel poured. 
Butan-2-ol was layered on top of the gel solution to 
ensure uniform polymerisation. After polymerisation the 
butan-2-ol was rinsed off using unpolymerised stacking 
gel solution. A stacking gel consisting of 5% acrylamide 
(28.5:1.5) in 122 mM Tris.HCl (pH 6.7), 0.1% SDS was 
layered on top of the resolving gel immediately after 
addition of APS and TEMED. Wells were formed using a 
teflon comb. Before electrophoresis, protein samples were 
boiled for 5 min in sample buffer (final concentration 50 
mM Tris.HCl (pH 6.7), 2% SDS, 700 mM 2-mercaptoethanol 
10% glycerol and sufficient BPB for visualisation of the 
dye front). Electrophoresis was carried out at RT in 
electrophoresis tank buffer (52 mM Tris, 53 mM glycine 
and 0.1% SDS) at 100 V until the dye front reached the
73
bottom of the gel (approximately 60 min).
(d) Staining of Separated Proteins
(i) Coomassie brilliant blue staining
Following electrophoresis, protein gels were fixed 
and stained in a solution of methanol : acetic acid : 
water (50:7:50) containing 0.2% Coomassie brilliant blue 
R250 for 30 min. Gels were then destained in 10% 
methanol, 7.5% acetic acid for at least 1 hour.
(ii) Silver staining
Silver staining was performed essentially as 
described by McLean et al., (1990) .
Following electrophoresis gels were fixed in 30% 
ethanol, 10% acetic acid for 30 min. Gels were then 
incubated for a further 30 min 30% ethanol, 0.5 M sodium 
acetate, 0.5% glutaraldehyde and 0.2% sodium thiosulphate 
followed by 3x 10 min washes in water. The gels were 
soaked next in 0.1% silver nitrate/0.02% formaldehyde for 
15-30 min and developed in a solution of 2.5% sodium 
bicarbonate and 0.01% formaldehyde for around 5 min until 
bands were visible. Band development was stopped by 
addition of EDTA to 0.05 M for 5 min followed by rinsing 
in deionised water. All solutions for silver staining 
were prepared using high purity filtered HPLC grade 
water.
(e) Elecroblot Transfer of Proteins to Nitrocellulose
SDS polyacrylamide mini gels were used to resolve 
polypeptides prior to electroblot transfer to 
nitrocellulose (Towbin et al., 1979).
The gel was washed briefly in blotting buffer 
then placed on 3 mm Whatman paper soaked in buffer. A 
piece of wetted nitrocellulose, cut to the same size as 
the gel, was carefully placed on top ensuring no air 
bubbles were trapped between the layers. Another piece of 
pre-soaked Whatman paper was added and the sandwich 
placed in the Biorad mini transblot cell. The
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polypeptides were electoblotted either at 0.2 A for 3 
hours or 4 0 mA overnight according to the manufacturers 
instructions.
(f) Detection of Protein A Fusions Using Antibodies
After electroblotting, nitrocellulose membranes were 
rinsed in TBST buffer then blocked in a solution of 3% 
gelatin in TBST buffer overnight at 37°C. The blocking 
solution was removed and replaced with a 1 in 10000 
dilution of goat anti-rabbit IgG alkaline phosphatase 
conjugate in TBST buffer for 30 min at RT (this antibody 
can bind to the protein A domain of fusion proteins via 
its Fc region). The membrane was then washed 3x in TBST 
buffer for at least 5 min to remove unbound antibody. 
After the removal of excess liquid, the membrane was 
added to 10 ml of freshly prepared colour development 
solution (Promega). Once the desired intensity of bands 
was obtained, the membrane was washed thoroughly in 
deionised H2 O for a few min, air dried and stored in 
aluminium foil to prevent colour deterioration.
(g) Radiolabelling of Proteins
For the preparation of radiolabelled polypeptides, 70 
- 80% confluent Sf cell monolayers in 35 mm petri dishes 
were used. After removal of medium, cell monolayers were 
infected with 20 pfu/cell of appropriate recombinant 
baculovirus in supplemented TC100 medium for 1 - 2  hours 
at RT with occasional gentle agitation. 2 ml fresh 
medium were added and incubation continued for 50 hours 
at 28°C. The medium was removed and replaced with 1 ml 
TC100 salt solution (43 mM KC1, 10 mM CaCl2 / 6 mM 
glucose, 12.5 mM MgCl2 / 12.5 mM MgSC>4 , 4.6 mM NaHCC>3 , 8 
mM NaH2P0 4 pH 6.2) containing 25 uCi [3^S]-L-methionine. 
Cells were harvested into ice cold TC100 (without 
antibiotics and foetal calf serum), washed three times 
and resuspended in boiling mix. Radiolabelled 
polypeptides were separated by SDS-PAGE on 8.5% gels 
overnight at 10 mA. Gels were fixed for 10 min, treated 
with EnHance for 60 min, dried and exposed to
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autoradiographic film overnight at -70°.
2.2.9 Gel Retardation Assay
3' end-labelled probe fragments were purified either 
by passage through a G-50 column or by elution from a 6% 
non-denaturing polyacrylamide gel, extraction with phenol 
and chloroform and ethanol precipitation.
1 ng of labelled oris~containing oligonucleotide or 5 
ng of a labelled oris~containing fragment, 2 ug of 
sonicated calf thymus DNA and 6 ul extraction buffer 
containing 10 ug of protein extract were incubated at 
22°C in a final vol of 24 ul of 60 mM Hepes, pH 7.5; 1.5 
mM DTT; 3 mM EDTA (150 mM KC1 is contributed by the 
extraction buffer). After 20 min, 5 ul loading buffer 
(25% glycerol, 10 mM DTT and 0.01% BPB in TBE) were added 
and the samples loaded onto a 5% polyacrylamide gel (55:1 
acrylamide: N,N'-methylene bisacrylamide). Gels were run 
in TBE at 150 V for 2.5 - 3 hours, fixed in 10% acetic 
acid, dried and exposed to autoradiography film overnight 
at - 70°C.
2.2.10 Plasmid Amplification Assay
(a) Transfection of Cells
50% confluent monolayers of Sf cells in 8 mm diameter 
linbro wells were transfected with plasmid pEC8 DNA 
containing a functional HSV-1 orig fragment by 
lipofection.
2 ug plasmid DNA were mixed with 30 ul of liposome 
preparation (1 mg/ml DOPE, 1 mg/ml DDAB prepared by 
N.Stow as described by Rose et al., 1991) in 160 ul of 
HBS buffer and incubated at RT for 10 min. 2 ml of 
optimem pH 6.0 were added to the liposome/DNA mixture and 
300 ul of the resulting solution added per linbro well 
after first washing the cells with pH 6.0 optimem. The 
plates were incubated at 28°C for 4 hours after which the 
inoculum was removed and the cells washed once with 
supplemented TC100 medium. Each well was then inoculated 
with a virus mix containing 2.5x 10^ pfu of each
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indicated baculovirus recombinant and incubated at RT for 
60 min with occasional gentle agitation. 1 ml of 
supplemented TC100 medium was then added and the cells 
incubated at 28°C for 50 hours.
(b) Preparation of Total Cellular DNA.
Growth medium was removed from the linbro wells 50 
hours post-transfection and replaced by 400 ul of cell 
lysis buffer (0.6% SDS, 10 mM EDTA, 10 mM Tris-HCl pH 
7.5) containing 0.5 mg/ml protease (Sigma Type XIV). 32 
ul of 4 M NaCl, 0.05 M EDTA was added and the lysate 
sequentially extracted with phenol and chloroform. The 
DNA was precipitated with 1 ml of ethanol overnight at - 
20°C, pelleted, lyophilised and resuspended in TE 
(usually 60 ul).
One third of the total cellular DNA was digested with 
3 units each of the restriction enzymes Dpnl and EcoRI 
overnight at 37°C.
(c) Southern Transfer of DNA. to a Nylon Membrane
Digested DNA fragments were separated on a 1% agarose 
gel in Loening's buffer prior to Southern transfer 
(Southern, 1975) . Following electrophoresis, the gel was 
photographed to confirm that digestion had occurred and 
then placed in Gel soak I for 45 min with agitation 
followed by 45 min in Gel soak II. The DNA was then 
blotted overnight onto a nylon membrane by capillary 
action using a wick of 3 mm Whatman paper in 6x SSC 
solution below the gel and a weighted stack of absorbent 
paper towelling on top of the membrane. The nylon filter 
was air dried and the DNA fixed to the filter by UV 
irradiation using a Stratalinker (Stratagene) prior to 
hybridisation.
(d) DMA/DNA hybridisation
The membrane was incubated in a plastic bag in 20 ml 
of pre-hybridisation buffer for at least 2 hours at 65°C 
with constant agitation. About l-2x 10*? cpm of nick 
translated probe DNA in 1 ml H2 O was denatured by
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addition of 0.2 ml 1 M NaOH for 10 min. The mixture was 
then neutralised by addition of 0.2 ml 1 M HC1 and added 
to 10 ml of hybridisation buffer. The prehybridisation 
solution was removed and the probe added to the bag 
containing the nylon filter. Hybridisation was carried 
out at 65°C overnight with constant agitation. The filter 
was then washed 4x in lx SSC/0.25% SDS for 20 min each at 
65°C. After air drying, the filter was exposed to 
autoradiography film overnight at -20°C with an image 
intensifying screen.
It should be noted that all figures in the following Results 
section are representative of repeat experiments.
78
CHAPTER 3; RESULTS
3.1 MUTAGENESIS OF THE UL9 DNA BINDING DOMAIN
3.1.1 Introduction
The experiments presented in this section are 
concerned with the mutagenesis of the DNA binding domain 
of the UL9 protein and utilise an expression system and 
binding assays based upon those previously described by 
Weir et al., (1989).
The parental plasmid employed in these studies is pBl 
which Weir et al., (1989) previously shown encodes 
functional origin binding activity.
Plasmid pBl (Figure 11) consists of an HSV-1 DNA 
fragment (nucleotides 21655 - 20666, McGeoch et al.,
1988) encoding the C-terminal 317 amino acids of the wt 
UL9 protein inserted, in-frame, into the BamHI site of a 
derivative of the fusion protein expression vector pRIT2T 
(Weir et al., 1989). pRIT2T allows the expression of 
fusion proteins (driven by the bacteriophage lambda Pr 
promoter) which contain sequences from the Staphylococcus 
aureus A protein at their amino terminus. The origin 
binding product encoded by pBl consists of the N-terminal 
2 60 amino acids of the Staphylococcus aureus protein A 
followed by amino acids 535 - 851 of UL9.
As in the previous work (Weir et al., 1989), I have 
assessed the ability of the fusion proteins to bind 
specifically to radiolabelled oligonucleotides containing 
orig sequences using a gel retardation assay. This 
technique, developed by Fried and Crothers (1981), 
involves incubating protein extracts with DNA fragments 
or oligonucleotides containing putative protein binding 
sites. Following incubation, the products are analysed 
by electrophoresis through non-denaturing polyacrylamide 
gels during which protein/DNA complexes are separated 
from unbound DNA on the basis of their lower 
electrophoretic mobility. The detection of sequence- 
specific binding activity is possible, even in crude 
extracts, if an excess of unlabelled carrier DNA is added
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Figure 11. Structure of plasmid pBl
The protein A-UL9 fusion is expressed under the 
control of the phage lambda promoter PR and consists of 
the N-terminal 260 amino acids of the Staphylococcus 
aureus A protein linked to amino acids 535 - 851 of UL9. 
The BamHI and Sail sites are marked.
Ori indicates the presence of an origin of replication.
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(e.g. calf thymus DNA), to the binding reactions, to 
compete for the binding of non-sequence specific DNA 
binding proteins (Garner and Revin., 1981).
Before the mutagenesis of pBl was commenced I 
performed some preliminary experiments in which two host 
strains of E.coli were compared for expression of origin 
binding activity (Section 3.1.2) and also developed a 
Western blot assay for the presence of pBl fusion protein 
in E .coli extracts (Section 3.1.3) .
3.1.2 Expression of pBl Fusion Protein In E.coli Strains
DH5 and K12 A HI A trp
In the experiments reported by Weir et al., (1989) 
expression of the pBl fusion protein was specifically 
induced by temperature upshift of an E .coli host (strain 
K12 AHI Atrp) containing a ;ts bacteriophage lambda 
repressor. Initial experiments were performed to 
determine whether constitutive expression of the pBl 
fusion protein occurred in the E .coli strain DH5 which is 
routinely used in our laboratory for cloning purposes and 
does not contain the lambda repressor. Gel retardation 
assays were used to compare origin binding activity in 
pBl-transformed DH5 cells grown at 37°C with pBl- 
transformed K12AHIAtrp cells grown at 37°C or grown at 
28°C and induced at 42°C. Cells were grown to an OD 0.5, 
harvested and extracts prepared by sonication. Extracts 
were incubated with labelled oligonucleotide I containing 
orig binding site I for 20 min at 22°C and binding 
analysed on 5% polyacrylamide gels. Figure 12 shows the 
presence of retarded complexes in all samples containing 
pBl-transformed cells (lanes 2 - 4)• Since DH5 cells 
efficiently expressed origin binding activity and were 
more convenient to use because temperature upshift was 
not required they were employed as host cells in the 
experiments described throughout this study.
3.1.3 Development of a Western Blot Assay for pBl Fusion
Proteins
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Figure 12. Gel Retardation Analysis of pBl Extracts
Protein extracts were incubated with 32p_iake]_ie(;} 
oligonucleotide I containing the HSV-1 orig site I for 
20 min at 22°C and the products separated by 
electrophoresis through a 5% polyacrylamide gel.
Extracts were from E.coli strain K12 AHIA trp cells 
(lanes 1 - 3 )  or strain DH5 cells (lane 4): lane 1, 
untransformed cells; lane 2, cells transformed with 
plasmid pBl and grown at 28°C with a temperature upshift 
to 42°C; lane 3, cells transformed with pBl and grown at 
37°C; lane 4, cells transformed with plasmid pBl and 
grown at 37°C.
"RC” represents the position of the major retarded 
complex and ”FP", free unbound probe.
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In order to assess the binding ability of mutant and 
wt pBl fusion proteins, it was necessary to have a method 
for confirming the presence of fusion proteins with 
E .coli extracts. Several methods based upon the Western 
blot were attempted. Extracts were resolved on 9% 
polyacrylamide gels and electroblotted on to 
nitrocellulose membranes prior to detection using 
antibodies.
Initially the method for detecting fusion proteins 
involved incubating the blot first with an antibody 
raised in rabbits against a peptide corresponding to the 
C-terminal 10 amino acids of the UL9 protein, a kind gift 
from M. Challberg. Bound antibody was then visualised by 
incubating the blot with a goat anti-rabbit IgG/horse 
radish peroxidase antibody conjugate followed by washing 
and addition of colour development substrates. This 
procedure however resulted in non-specific staining of a 
large number of protein bands (even in untransformed DH5 
cell extracts) which greatly complicated the detection of 
UL9 fusion proteins (data not shown). Also, because the 
mutational analysis of the UL9 DNA binding domain was to 
include constructing C-terminal deletion mutations which 
would remove the antibody's epitope a different detection 
method had to be employed which did not rely on the 
presence of specific UL9 sequences within the fusion 
protein.
A different detection method was therefore developed. 
This involved incubating the Western blot directly with 
the IgG/horse radish peroxidase conjugate followed by 
washing and addition of colour development substrates. 
Fusion proteins were specifically detected using this 
procedure due to the interaction of the protein A domain 
of the protein with the Fc region of the antibody 
conjugate (Figure 13). Very low backgrounds were 
obtained.
Two antibody detection kits supplied by Promega 
(Western blot HRP system and Western blot AP system) were 
compared (data not shown) and the sensitivity of the 
IgG/AP system was found to be greater. As a result, this
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detection method was used to confirm the presence of 
protein A fusions in subsequent experiments.
An example of a Western blot assay carried out using 
this detection method is illustrated in Figure 14. 
Extracts were from bacteria transformed with either 
plasmid pBl encoding the intact fusion protein (A-9CT), 
(lane 1), or plasmid pRIT2T encoding the protein A moiety 
alone (lane 2). Single protein bands corresponding to 
polypeptides of the expected sizes (approximately 63 kDa 
and 30 kD respectively) were detected. Although not shown 
in this figure, no corresponding bands were detected in 
extracts prepared from untransformed DH5 cells (e.g. see 
Figure 22) .
3.1.4 Mutagenesis of Plasmid pBl
The aim of the following experiments was to carry 
out a mutational study of the UL9 DNA binding domain in 
an attempt to characterise further the regions involved 
in the interaction with its target sequence. This 
involved generating series of mutants with either 
C-terminal deletions or small in-frame insertions within 
the UL9 DNA binding domain.
(a) Construction and Characterisation of pBl Deletion
Mutants
Plasmid pBl was linearised at the unique Sail site 
downstream of the UL9 translation stop signal and 
digested with the exonuclease Bal-31. Bal-31 
digestion for different times resulted in the production 
of a family of fragments with deletions extending varying 
lengths into the UL9 coding sequence. The extent of 
deletion was analysed by agarose gel electrophoresis 
after digestion with BamHI (Figure 15).
BamHI digestion of Sal I cleaved pBl yields two 
fragments of approximately 4250 bp and 989 bp in size and 
the degree of Bal-31 digestion was monitored by the 
reduction in size of the smaller fragment. By comparison 
with HinfI cleaved pAT153 DNA molecular weight marker 
fragments, Bal-31 digestion for 4 min was estimated to
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Figure 14. Western Blot Assay of pBl and pRIT2T
Extracts
1 ug samples of protein extract were resolved on a 9% 
denaturing polyacrylamide gel with protein molecular 
size markers and blotted onto nitrocellulose. The blot 
was probed with alkaline phosphatase-conjugated goat 
anti-rabbit IgG which was visualised by the addition of 
colour development substrates supplied in the Promega 
Western blot AP detection kit. Extracts were from E .coli 
DH5 bacteria transformed with the following plasmids: 
Lane 1, pBl; lane 2, pRIT2T which contains sequences 
encoding the N-terminal 260 amino acids of the 
Staphylococcus aureus protein A only.
KD
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Figure 15. Exonuclease Bal-31 Digestion of pBl
Sail linearised pBl was treated with the exonuclease 
Bal-31 for various times at 31°C. After phenol 
extraction, the DNA samples were digested with BamHI and 
analysed on a 1% agarose gel alongside Hinfl digested 
pAT153 molecular weight marker fragments (lanes 1 and 
8), the sizes of which (bp) are indicated at the side. 
Bal-31 digestions were carried out for the following 
times: lane 2, 0 min; lane 3, 1 min; lane 4, 2 min; lane 
5, 4 min; lane 6, 7 min; lane 7, 10 min.
bp
-1631
-5 1 6
-3 9 6
-2 9 8
- 220/221
-1 5 4 /1 4 5
decrease the length of the smaller fragment by about 200 
bp.
Linear DNA molecules from the 4 and 7 min incubation 
periods were treated with calf intestinal phosphatase (to 
prevent direct recircularisation of plasmid) prior to 
ligation to 14 bp phosphorylated Xbal oligonucleotides 
(5'-CTAGTCTAGACTAG-3') containing stop codons in all 
three frames. Multiple linkers were excised by re­
cleaving with Xba I. The products were then recicularised 
and transformed into competent E.coli DH5 bacteria. 
Colonies were selected for ampicillin resistance. Small 
scale plasmid preparations from resulting colonies were 
analysed. The extent of Bal-31 digestion in each plasmid 
was estimated by comparing the size of the smaller 
BamHI/Xbal fragment with the smaller BamHI fragment 
of plasmid pBl. Several plasmids with estimated 
deletions ranging from 50 bp - 200 bp were selected and 
the exact deletion end points determined by 
dideoxynucleotide DNA sequence analysis using two 17mer 
oligonucleotide primers (nucleotides 20956 - 20940 and 
20828 - 20812). Six plasmids referred to as pD17, pD27, 
pD32, pD34, pD50 and pD62, (where the number represents 
the number of codons of UL9 deleted as determined from 
DNA sequence analysis) were subsequently chosen for 
further study. All but one of these mutants (pD62) 
were found to contain single linker insertions.
The products of BamHI plus Xbal double digests of all 
six plasmids resolved on a 1% agarose gel are shown in 
Figure 16. A gradual increase in the electrophoretic 
mobility of the smaller BamHI/Xbal fragment indicates an 
increasing extent of deletion.
An example of a DNA sequence determination is 
presented in Figure 17, in which a portion of the UL9 
sequence of mutant pD62 is shown. The sequence of plasmid 
pD62 clearly diverges from the known wt sequence at 
nucleotide 20895 and the presence of the linker sequence 
which contains a novel Xbal restriction site and three 
termination codons marks the limit of Bal-31 digestion.
The mutations within the six deleted plasmids and the
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Figure 16. Restriction Enzyme Analysis of Deletion
Mutant DNA Preparations
Mini preparations of deletion mutant plasmid DNA were 
double restricted with BamHI and Xbal and analysed on a 
0.8% agarose gel alongside HinfI restricted pAT153 
molecular weight marker fragments (lane 1), the sizes of 
which (bp) are indicated at the side. BamHI/Xbal 
digestions were performed on the following plasmid 
preparations: lane 2, pBl; lane 3, pD12; lane 4, pD17; 
lane 5, pD27; lane 6, pD32; lane 7, pD34; lane 8, pD50; 
lane 9, pD62.
1631-
Figure 17. Mapping of Bal-31 Deletion End-points
Dideoxynucleotide DNA sequence analysis was carried 
out on deletion mutant plasmid preparations and the 
reaction samples analysed on a 6% denaturing 
urea/polyacrylamide gel. The DNA sequence, read upwards 
from nucleotide 20920 for plasmid pD62 is indicated 
below along with the sequence of the wt UL9 gene 
(McGeoch et al., 1988). The Bal-31 end-point at position 
208 96 where the sequence diverges from that of the wt is 
marked with a * and the location of the 14bp Xbal 
oligonucleotide linker indicated between the two arrows.
Xbal Linker 
(pD62) < >
5'-CCCACAGGCAGCTGTACGCCCTGCTCTAGTCTAGACTAG-3'
*
5'-CCCACAGGCAGCTGTACGCCCTGCTTATGGCCCACAAGC-3'
(wt)
20920
alterations to the encoded products are summarised in 
Table 1.
Initially 10 mutants with deletions corresponding to 
between 12 and 62 amino acids from the C-terminus were 
analysed by DNA sequencing. Protein extracts were 
prepared and examined in Western blot assays. Three of 
the mutants (with deletions of 22, 40 and 46 amino acids 
from the C-terminus) failed to yield a UL9 fusion protein 
while another (D25) yielded only low levels of protein. 
The reason for this is unclear, but may result from the 
introduced mutations creating an insoluble or unstable 
protein product or a product whose resulting secondary 
structure is unrecognisable to the antibody conjugate. In 
addition, a defect in the host cell may be responsible. 
Subsequent re-transformation of plasmid pD25 resulted in 
a level of fusion protein expression similar to the 
others suggesting a host cell defect in this case. One 
other deletion mutant (with a 12 amino acid deletion) 
expressed a protein which suffered degradation upon 
storage. This mutant and the three non-expressing mutants 
(D22, D40 and D46), were therefore omitted from further 
study.
(b) Construction and Characterisation of In-frame
Insertion mutants
A series of pBl mutants encoding products with 4 
amino acid insertions were prepared by partially 
digesting plasmid pBl with two multi-cut restriction 
enzymes, Haelll (cleaves at GG/CC sequences) and MvnI 
(cleaves at CG/CG sequences) under conditions which 
produced a maximum of singly cut linear molecules with 
blunt ends. Partially digested pBl samples were analysed 
on 1% agarose gels and those exhibiting the highest 
proportion of linear molecules chosen for use. Linear 
molecules were excised from a preparative gel and 
purified by electroelution and DEAE-sephacel column 
chromatography. Following treatment with calf intestinal 
phosphatase, linear molecules were ligated to 
phosphorylated, blunt-ended 12 bp EcoRI linker
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Table 1. Plasmids Used in these Studies: Deletion Mutants
PLASMID LINKER1 POSITION2 CHANGE3
pBl - - -
pDl6 T 20758/20757 834 LPTE— >LP*
pD27 T 20791/20790 823 ADII— >AD*
pD32 T 20807/20806 818 SANPNA— >SASLD*
pD34 T 20810/20809 817 SSANPN— >STSLD*
pD50 T 20859/20858 800 RFKLR— >RFLV*
pD62 T 20896/20895 788 LLMA— >LL*
1 T denotes termination linker (CTAGTCTAGACTAG).
2 Position of linker within HSV-1 DNA sequence (McGeoch et 
al., 1988).
3 Alteration to UL9 amino acid sequence. The number refers 
to the position of the adjacent amino acid. * represents 
the C-terminus.
oligonucleotides. The linkers inserted at MvnI and Haelll 
sites had the sequences 5'-CCGGAATTCCGG-3' and 5'- 
CCCGAATTCGGG-3' respectively. Linker multimers were 
reduced to single copies by EcoRI digestion followed by 
ligation to circularise the plasmid molecules. The 
products were then transformed into E .coli cells and 
colonies selected for ampicillin resistance. Plasmids 
containing linker insertions within the UL9 coding region 
were identified by screening small-scale plasmid 
preparations from selected bacterial colonies by 
digestion with EcoRI plus BamHI.
The sites of linker insertions were first mapped 
using an EcoRI/PstI double digestion then verified by 
dideoxynucleotide sequencing of the entire UL9 C-terminal 
fragment. Within the C-terminal one third of the UL9 gene 
there are 15 MvnI and 13 Haelll restriction sites 
spanning the region (Figure 18). Unfortunately, enzyme 
analysis of mini DNA preparations of bacterial colonies 
transformed with mutagenised pBl revealed that linker 
insertions were only present in 12 of the available 28 
sites. Indeed, the two enzymes appeared to cleave 
preferentially at three of these sites in particular. 
Dideoxy sequencing of the entire UL9 specific region of 
mutants with insertions in these 12 sites revealed that 
each one contained a single linker insertion although one 
mutant (with a linker insertion at amino acid 594) also 
contained an internal deletion. The latter was omitted 
from further study.
Figure 19 shows part of the DNA sequence of.one 
insertion mutant (pl838) and compares it with the known 
wt sequence. The linker insertion occurs at position 
20750 and a novel EcoRI restriction site is present.
Ten plasmids, pI581, pI591, pl630, pl652, pl668, 
pl691, pI708, pI719, pI799 and pl838, containing 
insertions spanning the UL9 C-terminal sequence were 
selected for further analysis (the number represents the 
amino acid position within the UL9 polypeptide 
corresponding to the site of insertion). The products of 
EcoRI plus PstI double digests of the 10 mutant plasmids
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Figure 18. Location of Haelll and MvnI Restriction 
Sites Within the C-terminal One Third of 
the UL9 Gene
A diagramatical representation of the UL9 gene is 
shown. The C-terminal one third of the gene has been 
enlarged below and the approximate position of the 
Haelll and MvnI restriction sites within this region are 
indicated. The numbering of the scale refers to 
positions within the HSV-1 UL9 gene (McGeoch et_al., 
1988). Those marked with a diamond represent sites where 
EcoRI linker oligonucleotides were inserted.

Figure 19. Mapping of EcoRI Linker Oligonucleotide
Insertion Sites
Dideoxynucleotide DNA sequence reactions were carried 
out on insertion mutant plasmid preparations and the 
reaction samples resolved on a 6% denaturing, 
urea/polyacrylamide gel. The DNA sequence read upwards 
from nucleotide 20766 for mutant pl838 is indicated 
below. The site of the linker insertion at position 
20750 is marked with a * and the 12bp EcoRI linker 
itself is indicated between the arrows.
EcoRI linker 
(pl838) < >
5'-GGAGCTCCCCACCGAGGCCCGAATTCGGGCCTGGCCCATGATGCA-3'
★
5' -GGAGCTCCCCACCGAGG CCTGGCCCATGATGCA-3'
(wt)
2 0 7 6 6
resolved on a 1% agarose gel are shown in Figure 20.
The resulting alterations to the protein coding 
sequence are described in Table 2.
Initially eleven insertion mutants were tested for 
expression of UL9 fusion proteins in Western blot assays. 
Two of these (with linker insertions at amino acids 799 
and 807) failed to express detectable UL9 fusion protein. 
Re-transformation of mutant 1799 but not 1807 into DH5 
cells resulted in fusion protein expression. It is 
possible that the 1807 mutation results in production of 
an unstable protein. Interestingly this insertion lies 
close to or within the region where mutants with 
deletions terminating there also failed to express a UL9 
fusion protein. Indeed, Martinez et al., (1992) reported 
that a mutant containing a 2 amino acid insertion within 
this region (at amino acid 798) failed to express a 
stable UL9 protein.
3.1.5 Analysis of pBl Deletion Mutants
The ability of the pBl deletion mutant proteins (A- 
9CT mutant proteins) to bind to the HSV-1 origin of 
replication was examined in gel retardation assays.
Extracts were prepared from untransformed E .coli DH5 
cells and transformants carrying the wt plasmid pBl or 
plasmids pD16, pD27, pD32, pD34, pD50 and pD62 which 
express C-terminally truncated forms of the protein A-UL9 
fusion. The presence of fusion proteins was confirmed by 
Western blots and gel retardation assays were performed 
to examine sequence-specific DNA binding activity. 32p_ 
labelled oligonucleotides containing either the sequences 
of orig binding site I or II (Figure 21), or a 32p_ 
labelled 100 bp fragment from plasmid pEC8 (Weir et al., 
1989) containing the complete orig (i.e both binding 
sites) were used as probe fragments. The labelled DNA 
fragments were incubated with the extracts at 22°C and 
resulting complexes resolved on 5% polyacrylamide gels.
(a) Western Blot Analysis
To determine whether a pBl-related product was
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Figure 20. Restriction Enzyme Analysis of Insertion
Mutant DMA Preparations
Mini plasmid preparations of insertion mutant DNA 
were double resticted with EcoRI and PstI and analysed 
on a 0.8% agarose gel alongside HinfI restricted pAT153 
molecular weight marker fragments (lanes 1 and 13), the 
sizes of which (bp) are indicated at the side. Enzyme 
restrictions were performed on the following plasmid 
preparations: Lane 2, pBl; lane 3, pI581; lane 4, pI591; 
lane 5, pI630; lane 6 , pl652; lane 7, pI6 6 8 ; lane 8 , 
pI691; lane 9, pI708; lane 10, pI719; lane 11, pI799; 
lane 12, pI838.
bp
-1631
-5 1 6
-3 9 6
- 2 9 8
- 220/221 
“ 145/154
Table 2. Plasmids Used in these Studies: Insertion Mutants
PLASMID LINKER1 SITE2 POSITION3 CHANGE4
pBl
pI581 *1 MvnI 21519/21518 581 TR­->TPEFRR
pI591 12 Haelll 21491/21490 591 AC-->ARIRAC
pi 630 *2 Haelll 21375/21374 630 AL-->ARIRAL
pi 652 II MvnI 21308/21307 652 AR-->AGIPAR
pi 6 6 8 *2 Haelll 21259/21258 6 6 8 GP-->GPNSGP
pi 691 12 Haelll 21190/21189 691 GH-->GPNSGH
pI708 II MvnI 21139/21138 708 RV-->RRNSGV
pI719 II MvnI 21106/21105 719 RG-->RRNSGG
pI7 99 II MvnI 20865/20864 799 AR-->APEFRR
pI838 *2 Haelll 20750/20749 838 AW-->ARIRAW
1 Ii and I2 denote insertion linkers CCGGAATTCCGG or 
CCCGAATTCGGG respectively.
2 Enzyme cleavage sites at which I]_ and I2 linkers were 
inserted.
3 Position of linker within the HSV-1 DNA sequence (McGeoch 
e t a l ., 1988).
4 Alteration to UL9 amino acid sequence. The number refers 
to the position of the adjacent amino acid.
Figure 21. Recognition Sequences for the HSV-1 UL9 
Protein within HSV-1 Orig
(a) DNA sequence of the ori0 region.
(b) DNA sequence of oligonucleotides containing 
binding sites I and II.
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Minor degradation products of the pD50 product can be seen in 
lane 7.
present in each of the extracts a Western blot was 
performed and probed directly with an IgG-alkaline 
phosphatase conjugate.
UL9 fusion protein was present in all six extracts 
from transformed DH5 cells, and a gradual increase in 
electrophoretic mobility was apparent correlating with 
the increasing extent of deletion (Figure 22).
(b) Gel Retardation Analysis; Interaction with Binding
Site I
The results of a gel retardation assay examining the 
ability of the A-9CT deletion mutants to bind to a 32p_ 
labelled probe containing only binding site I of orig 
are presented in Figure 23. As shown previously (Weir et 
al., 1989), extract from cells containing pBl forms a 
major retarded complex (RC), (lane 2) which is absent 
from untransformed cells (lane 1) or cells transformed 
with the vector pRIT2T (data not shown). Retarded 
complexes were also obtained with extracts from 
cells harbouring plasmids pD16, pD27, pD32, and pD34 but 
not pD50 or pD62 (lanes 3 - 8) .
(c) Gel Retardation Analysis: Interaction with Binding 
Site II and the Complete Orig Fragment
The ability of the mutant proteins to interact with 
orig binding site II and with the pEC8 orig fragment 
(containing both binding sites) at 22°C was also tested 
(Figures 24 and 25, respectively). Comparison of Figures 
23, showing the interaction with site I, and Figure 24 
reveals that the mutant proteins showed similar behaviour 
towards the two probe fragments, i.e. only those mutant 
proteins showing a positive interaction with site I bound 
efficiently to site II. Gel retardation experiments using 
a probe containing both binding sites (Figure 25) , also 
showed a similar behaviour of the various extracts. 
However, with the proteins exhibiting positive binding 
the bands appear more smeared and no free probe remains. 
The reason for the lack of free probe is not obvious. It 
could reflect higher affinity binding possibly as a
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Figure 22. Western Blot Analysis of pBl Deletion
Mutant Extracts
lug samples of protein extract were resolved on a 9% 
denaturing polyacrylamide gel alongside protein 
molecular size markers and blotted onto nitrocellulose. 
The blot was probed with alkaline phosphatase-conjugated 
anti-rabbit IgG which was visualised by the addition of 
colour development substrates supplied in the Promega 
western blot AP detection kit. Extracts were from 
bacteria transformed with the following plasmids : Lane 
1, untransformed DH5 cells; lane 2, pBl; lane 3, pDl6 ; 
lane 4, pD27; lane 5, pD32; lane 6 , pD34; lane 7, pD50; 
lane 8 , pD62. The positions of the protein molecular 
size markers are indicated on the left.
kDa
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Figure 23. Gel Retardation Analysis of pBl Deletion
Mutants: Interaction with Binding Site I
Bacterial protein extracts were incubated with 32p 
end-labelled oligonucleotide I (see Figure 21.) 
containing the HSV-1 orig binding site I for 20 min at 
22°C and the products separated by electrophoresis 
through a 5% polyacrylamide gel as described in 
materials and methods. Extracts were from E .coli DH5 
bacteria transformed with the following plasmids: Lane 
1, untransformed DH5 cells; lane 2, pBl; lane 3, pDlk; 
lane 4, pD27; lane 5, pD32; lane 6 , pD34; lane 7, pD50 
lane 8 , pD62.
"RC" indicates the major retarded complex and "FP" 
free unbound probe.

Figure 2 4. Gel Retardation Analysis of Deletion
Mutants; Interaction with Binding Site II
Binding was analysed as described in Figure Legend 
23, except oligonucleotide I was replaced by 
oligonucleotide II containing orig binding site II 
(Figure 21). Extracts were from E.coli DH5 bacteria 
transformed with the following plasmids: Lane 1, 
untransformed DH5 cells; lane 2, pBl; lane 3, pD17, lane 
4, pD27; lane 5, pD32; lane 6 , pD33; lane 7, pD50; lane 
8 , pD62.
"RC" indicates the major retarded complex and "FP", 
free unbound probe.

Figure 25. Gel Retardation Analysis of Deletion
Mutants: Interaction with Complete Prig
Binding was analysed as described in Figure Legend 
23. except that oligonucleotide I was replaced with a 
100 bp fragment from plasmid pEC8 containing the whole 
orig sequence. Extracts were from bacteria transformed 
with the following plasmids: lane 1, untransformed DH5 
cells; lane 2, pBl; lane 3, pD17; lane 4, pD27; lane 5, 
pD32; lane 6 , pD33; lane 7, pD50; lane 8 , pD62.
"RC" indicates the major retarded complex and "FP", 
free unbound probe.
In repeat experiments the slightly faster migrating retarded 
complex was seen with the pD27 extract.

result of cooperativity between proteins bound to both 
sites. The smeared appearance of bands is probably due to 
a mixed population of complexes comprising DNA fragments 
with protein bound to both sites (lower electrophoretic 
mobility complex) or to only one site (higher mobility 
complex).
The results from the gel retardation analysis 
demonstrate that removal of 34 amino acids from the C- 
terminus of the UL9 protein does not impair its ability 
to interact with sequences from the HSV-1 orig region. 
Since the product specified by plasmid pD50 is non­
functional, residues essential for this interaction must 
lie between amino acids 801 and 818 of UL9.
3.1.6 Analysis of pBl Insertion Mutants.
The abilities of the A-9CT insertion mutants to 
interact with HSV-1 origin sequences were also examined 
using gel retardation assays.
Extracts were prepared from untransformed E.coli DH5 
cells and transformants carrying the wt plasmid pBl or 
plasmids pI581, pI591, pI630, pl652, pl6 6 8 , pI691, pI708, 
pI719, pI799 and pl838 which express fusion proteins 
containing insertions of four amino acids within the UL9- 
specific portion. Extracts were tested for the expression 
of pBl-related UL9 fusion proteins using Western blot 
assays.
(a) Western Blot Analysis
A Western blot was carried out to determine whether 
the extracts from cells containing the 10 insertion 
mutant plasmids contained stable pBl-related fusion 
proteins (Figure 26a and b). Fusion proteins with 
electrophoretic mobilities indistinguishable from the pBl 
product (lane 2 in both Figures) were observed in 
extracts from the bacterial cells transformed with each 
of the insertion mutants.
(b) Gel Retardation Analysis: Interaction with Site I
at 22°C and 37°C
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Figure 26. Western Blot Analysis of pBl Insertion
Mutant Extracts
lug samples of protein extracts were resolved on a 
9% denaturing polyacrylamide gel and blotted onto 
nitrocellulose. Proteins were detected using the Promega 
IgG/alkaline phosphatase detection kit. Extracts were 
from bacteria transformed with the following plasmids : 
Figure a. Lane 1, untransformed DH5 cells, lane 2, pBl, 
lane 3, pI581; lane 4, pI591; lane 5, pl630; lane 6 , 
pi651; lane 7, pi6 6 8 .
Figure b. lane 1, untransformed DH5 cells; lane 2, pBl; 
lane 3, pI691; lane 4, pI708; lane 5, pI719; lane 6 , 
pI799; lane 7, pI838.
Protein molecular size markers are indicated on the 
left.
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The ability of the mutated proteins to bind to a 32p_ 
labelled probe containing the HSV-1 orig binding site I 
sequence was examined and the results of the binding 
assays performed at 22°C are presented in Figure 27a. 
Although each of the extracts from cells transformed with 
a mutant plasmid contained a fusion protein which 
exhibited an electrophoretic mobility indistinguishable 
from the pBl product, only the pl691, pI708, pI719 and 
pl838 products were unaffected in their binding ability 
(Figure a; lanes 8, 9/ 10, 12). The products of pl7 99 and 
pi630 showed slightly, and more severely impaired binding 
(lanes 11 and 5, respectively) whereas no binding was 
detected with the remaining pI581, pI591, pl652 and pl6 6 8  
encoded proteins (lanes 3, 4, 6, 7) .
When similar assays were performed at 37°C using the 
32p-iabelled oligonucleotide containing site I, the 
ability of the pl630 product to form a protein/DNA 
complex at the higher temperature was abolished while the 
relative binding activities of the other proteins 
remained unchanged (Figure 27b).
(c) Gel Retardation Analysis: Interaction with Site II 
and the Complete Prig at 22°C and 37°C
The ability of the mutant proteins to interact with 
orig binding site II at 22°C and 37°C was also examined 
(Figure 28a and b). Comparison of Figures 27a and 28a in 
which binding was at 22°C reveals that the mutant 
proteins showed similar behaviour towards the two probe 
fragments with the exception that the pl630 and pI799 
products formed much lower amounts of retarded complex 
with binding site II than site I (lanes 5 and 11). 
Repetition of the experiment at 37°C demonstrated that 
the pI630 protein was unable to form a complex with 
binding site II at the higher temperature while the 
relative binding activities of the other proteins were 
not affected (Figure 28b). Thus, the pl630 expressed 
protein exhibits temperature sensitivity in its binding 
to both sites I and II.
The ability of the mutant proteins to bind to
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Figure 27. Gel Retardation Analysis of Insertion
Mutants: Interaction with binding site I at
22°C and 37<>C
Bacterial protein extracts were incubated with 32p 
end-labelled oligonucleotide I (Figure 21) containing 
the HSV-1 orig binding site I for 20 min at either 22°C 
(Figure a.) or 37°C (Figure b.). The products were 
separated by electrophoresis through a 5% polyacrylamide 
gel as described in materials and methods. Extracts were 
from E .coli DH5 bacteria transformed with the following 
plasmids: Lane 1, untransformed DH5 cells; lane 2, pBl; 
lane 3, pI581; lane 4, pI591; lane 5, pl630; lane 6 , 
pl652; lane 7, pI6 6 8 ; lane 8 , pl691; lane 9, pI708; lane 
10, pI719; lane 11, pI799; lane 12, pl838.
"RC" indicates the major retarded complex and "FP", 
free unbound probe.
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Figure 28. Gel Retardation Analysis of Insertion
Mutants: Interaction with site II at 22°C
and 37°C
Binding was analysed as described in Figure legend 
27, except that oligonucleotide I was replaced with 
oligonucleotide II. Extracts for binding analysis 
performed at 22°C (Figure a.) and 37°C (Figure b.) were 
from E .coli DH5 cells transformed with the following 
plasmids: lane 1, untransformed DH5 cells; lane 2, pBl; 
lane 3, pI581; lane 4, pI591; lane 5, pl630; lane 6 , 
pl652; lane 7, pl6 6 8 ; lane 8 , pl691; lane 9, pI708; lane 
10, pI719; lane 11, pI799; lane 12, pI838.
"RC" indicates the major retarded complex and "FP", 
free unbound probe.
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It would also appear that pl691 (lane 8 ) and pI719 (lane 10) 
mutant extracts exhibit a temperature sensitive effect with 
binding to the complete orig fragment as an increase in 
temperature resulted in a change in the amount of the two 
electrophoretically distinct complexes being formed.
fragment III which contains a functional orig with both 
binding sites was tested at 22°C and 37°C (Figure 29a and 
b) .
At 22°C (Figure a), the behaviour of the extracts was 
similar to that observed with binding to site II and in 
general all the proteins exhibiting positive binding were 
slightly impaired compared with wt. Binding of mutant 
1630 to the complete orig fragment produced a single 
retarded complex of higher electrophoretic mobility than 
that observed by the wt A-9CT protein. Binding of the 
remaining mutants also produced this higher mobility 
complex as a minor band, in addition to a major complex 
of equal mobility to that produced by wt A-9CT protein. 
The position of the major complex of mutant 17 99 appears 
to be intermediate between the major and minor complexes 
of the other mutants. It is most likely that the higher 
mobility complex represents binding to a single site and 
the lower mobility complex binding to both sites.
Binding to the complete orig fragment at 37°C (Figure 
b) , confirmed that the weak binding of mutant 1630 was ts^  
as it was unable to form a complex at the higher 
temperature.
These results indicate that 4 amino acids can be 
inserted at 4 separate sites within the DNA binding 
domain without affecting interactions with the UL9 
recognition sequence (mutants pl691, pI708, pI719 and 
pl838) . However, insertions at 4 different sites 
abolished detectable interactions (mutants pl581, pI591, 
pl652, pl6 6 8 ) and at two further positions (mutants pl630 
and pI7 99), generated products which exhibited reduced 
binding, particularly to the lower affinity site II 
sequence.
3.1.7 The Effect of Competitor DMA on Fusion Protein
Binding Activity
Competition experiments were carried out to compare 
the relative binding affinity of the A-9CT and 1719 
proteins to orig site I.
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Figure 29. Gel Retardation Analysis of Insertion
Mutants: Interaction with complete orig at
22°C and 37°C
Binding was analysed as described in Figure legend 
27# except that oligonucleotide I was replaced with a 
100 bp fragment containing both orig binding sites I and 
II. Extracts for binding analysis performed at 22° 
(Figure a.) and 37°C (Figure b.) were from E .coli DH5 
cells transformed with the following plasmids: lane 1, 
untransformed cells; lane 2, pBl; lane 3, pI581; lane 4, 
pI591; lane 5, pl630; lane 6, pl652; lane 7, pI668; lane 
8, pl691; lane 9, pI708; lane 10, pI719; lane 11, pI799; 
lane 12, pl838.
"RC" indicates the major retarded complex and "FP", 
free unbound probe.
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Protein extracts from E .coli DH5 cells transformed 
with either plasmid pBl or pI719 were incubated with 32p_ 
labelled oligonucleotide I either in the presence or 
absence of unlabelled oligonucleotide I DNA (500 fold 
excess), for 30 min to allow binding to reach 
equilibrium. A 500-fold excess of unlabelled 
oligonucleotide I was then added to the reaction lacking 
competitor DNA. Samples were taken at various time 
intervals (from 0 - 1 0  min) after addition of unlabelled 
probe and immediately loaded and subjected to 
electrophoresis through a 5% polyacrylamide gel.
The samples containing A-9CT extract are shown in 
Figure 30. When competitor DNA was added together with 
the labelled probe (lane 1), the signal intensity of the 
retarded complex was very weak. The sample taken just 
before addition of competitor DNA (lane 2) demonstrated a 
retarded complex of high intensity, similar to those 
observed in other gel retardation assays. The samples 
taken at each of the times (from 1 min) after addition of 
competitor DNA, however demonstrated that the signal 
intensity of the retarded complex fell rapidly to the 
level observed when the unlabelled probe was included at 
the start of the reaction. Similar results were observed 
when the effect of competitor DNA on the binding activity 
of 1719 extracts was analysed (data not shown).
These results indicate that the A-9CT protein must 
have a rather low affinity for orig site I (since the 
half-life of the complex is less than one minute). For 
this reason it was not possible to determine whether the 
1719 had a reduced affinity compared with A-9CT.
3.2 CONSTRUCTION AND ANALYSIS OF BACIXLOVIRUS
RECOMBINANTS EXPRESSING MUTANT UL.9 PROTEINS
3.2.1 Introduction
Although the experiments in which mutated fusion 
proteins were expressed in E .coli enabled the effects of 
the mutations on origin binding to be studied it was not 
possible to determine the effects of these mutations on
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Figure 30. The Effect of Competitor DNA on Fusion 
Protein Binding Activity
Protein extract prepared from E,coli DH5 cells 
transformed with plasmid pBl was incubated with 32p_ 
labelled oligonucleotide I containing the HSV-1 orig 
binding site I in the presence (lane 1) or absence of 
500-fold excess of unlabelled oligonucleotide I. After 
30 min at 22°C, 500-fold unlabelled oligonucleotide I 
DNA was added to the binding reaction lacking competitor 
DNA. Samples were taken at one minute intervals after 
the addition of unlabelled probe and analysed 
immediately on a 5% polyacrylamide gel. An 
autoradiograph of the dried gel is shown.
RC
HSV-1 origin dependent DNA synthesis. A selection of the 
mutations described in the previous sections were 
therefore introduced into the full length UL9 ORF to 
allow the investigation of whether the alterations 
had any effect on the replicative function of the intact 
protein. The resulting full length UL9 proteins were then 
expressed under the control of the strong late polyhedrin 
promoter of the baculovirus Autographa californica 
nuclear polyhedrosis virus (AcNPV). This enabled the 
replicative ability of the mutated proteins to be 
assessed in a transient replication assay in Sf insect 
cells in which recombinant baculoviruses are used to 
supply all the HSV-1 DNA replication proteins.
3.2.2 Cloning of DNA Fragments into a Baculovirus
Transfer Vector
Due to the large size of baculovirus genomes, 
recombinant viruses are produced by first cloning the 
gene to be expressed into a bacterial plasmid transfer 
vector. Foreign genes are cloned into the transfer vector 
downstream of a strong viral promoter and flanked by 
baculovirus sequences. When the modified transfer vector 
and infectious baculovirus DNA are introduced into insect 
cells homologous recombination, involving the flanking 
sequences in the transfer vector, allows insertion of the 
foreign gene into an infectious recombinant virus.
(a) Construction of Transfer Vector pY9N2/3
In order to introduce deletion and insertion 
mutations into an intact UL9 gene an intermediate plasmid 
(pY9N2/3) was first constructed which included the the N- 
terminal two thirds of the UL9 gene inserted into the 
baculovirus transfer vector pAcYMl (Matsuura et al.,
1987). This was achieved by using a previously described 
plasmid pBL91, in which the intact UL9 gene is located 
downstream of the AcNPV polyhedrin promoter. The small 
BstEII to BamHI fragment of plasmid pBL91 encoding the 
amino-terminal two thirds of the HSV-1 gene (nucleotides 
23542 - 21655), was ligated to the large BstEII to BamHI
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fragment of the baculovirus transfer vector pAcYMl which 
provides the remainder of the vector sequences (Matsuura 
et al., 1987), (Figure 31). DH5 cells were transformed to 
ampicillin resistance, colonies selected and mini DNA 
preparations analysed. Plasmid pY9N2/3, with the desired 
structure, was selected for further use. The plasmid 
pY9N2/3 contains a unique BamHI restriction site into 
which the previously described mutated fragments encoding 
the C-terminal portion of UL9 could be inserted, in the 
correct orientation, to generate a complete UL9 gene.
(b) Insertion of Fragments into pY9H2/3
BamHI fragments corresponding to the 3' portion of 
the UL9 gene from seven of the insertion mutants, pI581, 
pI591, pl630, pI651, pI668, pI719 and pI799, were cloned 
into the unique BamHI site of plasmid pY9N2/3 (Figure 
31) .
The seven pBl derivatives were digested with BamHI 
and the smaller of the two resulting DNA fragments 
purified by agarose gel electrophoresis followed by DEAE 
sephacel column chromatography. The purified fragments 
were then ligated to pY9N2/3 DNA which had been 
linearised with BamHI and treated with calf intestinal 
phosphatase.
E .coli DH5 cells were transformed with the ligation 
products and ampicillin resistant colonies selected. Mini 
plasmid preparations were analysed for the presence and 
correct orientation of the inserted fragment. An example 
of this analysis is shown in Figure 32 in which the BamHI 
fragment from plasmid pI719 was inserted into pY9N2/3. 
Digestion of plasmid DNA with Smal should produce 
fragments of 9860 bp, 1412 bp, 584 bp, 75 bp and 45 bp in 
size if the inserted fragment is present in the correct 
orientation (Figure 32, lane 9/ Figure 33a). The presence 
of fragments of 10185 bp, 1000 bp, 584 bp, 75 bp and 45 
bp is however indicative of the reverse orientation 
(Figure 32, lanes 5, 7, 11/ Figure 33b). Digestion of a 
plasmid with no insert present produces fragments of 
10987 bp, 584 bp, 75 bp and 45 bp only (Figure 32,
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Figure 31. Cloning of DMA Fragments into a Baculovirus
Transfer Vector
The cloning of a DNA fragment from plasmid pI581 into 
a baculovirus transfer vector is outlined opposite. An 
intermediate vector pY9N2/3 was constructed first by 
ligating the large BstEII to BamHI fragment of the 
baculovirus transfer vector pAcYMl (Matsuura et__a_l., 
1987) to the small BstEII to BamHI fragment of plasmid 
pBL91 encoding the amino terminal two thirds of the UL9 
gene (nucleotides 23542 - 21655). Plasmid pY9N2/3 
contains a unique BamHI restriction site into which the 
mutated C-terminal fragments of the UL9 gene (e.g. from 
plasmid pI581) could be inserted, in the correct 
orientation, thus completing the sequence of the full 
length gene.
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Figure 32. Smal Digestion of pY9N2/3 Cloned UL9 
Mutants
This figure shows a Smal digestion of mini plasmid 
preparations of a UL9 mutant in which the BamHI fragment 
from plasmid pI719 was inserted into plasmid pY9N2/3 
which contains the N-terminal two thirds of UL9 gene 
(nucleotides 23542 - 21655). Uncut and Smal digested DNA 
samples of mini preps 1, 2, 3 and 4 (lanes 4 - 11) were 
resolved on a 6% polyacrylamide gel alongside uncut and 
Smal digested pY9N2/3 (lanes 2 and 3 respectively) and 
Hinfl digested pAT153 molecular weight markers (lanes 1 
and 12), the sizes of which are indicated at the side.
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Figure 33. Correct and Incorrect Orientations of the
UL9 C-tenninal Fragment
This figure shows the correct and incorrect 
orientations of the UL9 C-terminal fragment; Smal 
restriction sites as indicated were used to determine 
the direction of the inserted fragment. A correctly 
inserted C-terminal fragment would result in a Smal 
digestion producing fragments of 9860 bp, 1412 bp, 584 
bp, 75 bp and 45 bp (Figure a.). An incorrectly inserted 
fragment would result in a Smal digestion producing 
fragments of 10185 bp, 1097 bp, 584 bp, 75 bp and 45 bp 
(Figure b).
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i
Smal
1 Smal 
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lane 3 ) .
The resulting plasmids pMAI581, pMAI591, pMAl630, 
pMAI668, pMAI719 and pMAI799 contain full length UL9 
genes which contain the insertion mutations derived from 
plasmids pI581, pI591, pl630, pl668, pI718, and pI799 
repectively.
BamHI/Xbal restriction fragments of DNA containing 
UL9 C-terminal deletions from two mutant plasmids pD50 
and pD62 were similarly cloned into the unique BamHI 
restriction site of plasmid pY9N2/3 after the addition of 
synthetic BamHI oligonucleotide linkers to the Xbal 
terminus. Plasmids pD50 and pD62 were cleaved with Xbal 
and BamHI. Blunt ends were produced by a klenow "fill in" 
reaction and BamHI linkers ligated. The products were 
then recleaved with BamHI and the fragment purified by 
sephacel chromatography. These mutant transfer vectors 
were named pMAD50 and pMAD62 respectively.
3.2.3 Isolation of Recombinant: Baculoviruses
Co-transfection of insect cells with modified 
transfer vector and baculovirus DNA linearised at the 
insertion locus results in a great reduction in the level 
of non-recombinant virus obtained (Kitts et al., 1990). 
This is because linear AcNPV DNA is of very low 
infectivity, and as a consequence there is a selection 
for the production of infectious circular genomes by 
recombination with the transfer vector thereby inserting 
the foreign gene into the progeny virus.
The linear baculovirus genomes were produced by 
digestion of the DNA of an AcNPV derivative (AcRP231acZ) 
with Bsu36l. The use of this derivative, in which the 
E .coli lacZ gene, encoding the B-galactosidase protein, 
has been inserted into the wt AcNPV genome at the 
polyedrin locus, provides an efficient method for 
isolating recombinant baculoviruses since the unique 
Bsu36l cleavage site is located within the lacZ gene.
The presence of any parental AcRP231acZ plaques on Sf 
cell monolayers can be detected following the addition of 
a chromogenic substrate (X-gal) that produces a blue
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product when cleaved by B-galactosidase. In contrast, in 
recombinant viruses the lacZ gene has been replaced by 
the gene of interest and easily distinguished white 
plaques are produced.
70% confluent monolayers of Sf cells in 35 mm petri 
dishes were co-transfected, using the calcium phosphate 
precipitation method (Graham and van der Eb, 1973) , with 
Bsu36l linearised AcRP231acZ DNA and modified transfer 
vector DNA containing the mutant UL9 genes. After three 
days at 28°C, the cells and medium were harvested and the 
virus titrated as described in Materials and Methods. 
After 4 days at 28°C, the plaques were stained with 
Neutral Red stain containing X-gal at 28°C and examined 
for the presence of viral plaques the following day.
In each case, approximately 60% of the viral progeny 
of co-transfected cells produced white plaques. Several 
white plaques were picked using sterile pasteur pipettes.
The progeny from white plaque were used to infect Sf 
cells in Linbro wells. 50 hpi the cells were harvested 
and proteins analysed by SDS-PAGE in parallel with mock- 
infected cells and cells infected with AcUL9 which 
expresses the wt UL9 gene (Stow, 1992). UL9 related 
polypeptides were detected by coomassie brilliant blue 
and silver staining (data not shown). Nine recombinant 
viruses (ACMAI581, AcMAI591, AcMAI630, AcMAl652,
AcMAI668, ACMAI719, AcMAI799, AcMAD50 and AcMAD62), 
expressing the mutant UL9 proteins were identified and 
large scale working stocks prepared. These stocks were 
titrated on Sf cell monolayers at 28°C and the titres 
obtained ranged from 3x10® to 9x10® pfu/ml. Western blot 
assays and ®^S-labelling of expressed proteins were 
subseq uently performed to confirm expression of UL9- 
related proteins .
3.2.4 Protein Synthesis By Recombinant Baculoviruses
(a) Western Blot Analysis
Western blot assays were performed using a rabbit 
antibody raised against a peptide corresponding to the C-
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terminal 10 amino acids of the UL9 protein in conjunction 
with the IgG/alkaline phosphatase detection system 
described earlier (see section 3.1.3). As this antibody 
recognises the C-terminal ten amino acids of the UL9 
protein, Western blot analyses could only be carried out 
with the insertion mutants (Figure 34a and b).
Protein extracts were obtained from cells which had 
been either mock infected (lane 1; a and b), or infected 
with the parental AcRP231acZ virus (lane 2; a and b), 
AcUL9 (lane 3; a and b) or one of the seven recombinants 
expressing the UL9 insertion mutants (lanes 4 - 7 in 
Figure a; lanes 4 - 6 in figure b). The presence of a 
novel protein band with the expected apparent molecular 
size of approximately 93 kDa (indicated by an arrow) in 
all extracts except from mock-infected and AcRP231acZ 
infected cells indicated that the recombinant 
baculoviruses expressed the mutated UL9 proteins. The 
amounts of mutant UL9 protein expressed by several of the 
recombinant viruses was slightly lower than the level of 
wt UL9 produced by AcUL9 and, mutant AcMAI668 expressed 
very low levels. These differences probably reflect poor 
infections since 35s- radiolabelling of proteins 
subsequently demonstrated levels of expression almost 
indistinguishable from wt (See Figure 35).
(b) of Proteins
Monolayers of Sf cells in 35 mm petri dishes were 
infected with either wt AcNPV, AcUL9 or one of the nine 
recombinant baculoviruses carrying mutated UL9 genes at a 
multiplicity of 20 pfu/cell. At 40 hpi, infected cells 
were labelled in TC100 salts (Calder and Stow, 1990) 
containing 25 uCi/dish of [35$]-L-methionine for 20 hours 
at 28°C.
The cells were harvested in boiling mix and proteins 
resolved by SDS-PAGE on 8.5% gels prior to 
autoradiography (Figure 35).
The presence of a polypeptide the same size as UL9 
protein produced by AcUL9 (lane 2), (indicated by arrow), 
in all the samples except from the wt baculovirus
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Figure 34. Western Blot Analysis of Baculovirus 
Expressed Insertion Mutants
Infected cells were harvested, the proteins resolved 
on a 9% SDS polyacrylamide gel and blotted onto a 
nitrocellulose membrane as described in the materials and 
methods. Proteins were detected using an anti-UL9 
antibody and the Promega IgG/alkaline phosphatase protein 
detection kit. Extracts were from cells infected with the 
following recombinant baculoviruses: Figure a: lane 1, 
mock-infected cells; lane 2, AcRP231acZ; lane 3, AcUL9; 
lane 4, AcMAI581; lane 5, AcMAI591; lane 6, AcMAl630; 
lane 7, AcMAI651. Figure b: lane 1, mock-infected cells; 
lane 2, AcRP231acZ; lane 3, AcUL9; lane 4, AcMAl668; lane 
5, AcMAI719; lane 6, AcMAI799.
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Figure 35 .  ^ S - l a b e l l i n g  Q f  Foreign Proteins Expressed
in Recombinant Baculoviruses
The figure shows SDS-PAGE analysis of 35s-iabelled 
polypeptides prepared from Sf cells infected with either 
wt AcNPV (lane 1), wt AcUL9 (lane 2) or the following 
individual recombinant viruses AcMAI581, AcMAI591,
AcMAI630, AcMAI652, ACMAI668, AcMAI719, AcMAI799, 
AcMAD50, and AcMAD62, (lanes 3 to 11 respectively). The 
overexpressed UL9 polypeptides are indicated by the 
arrow.
The data for this experiment was kindly provided by 
Dr G. McLean.

infected cells (lane 1) confirmed the expression of 
stable UL9 insertion mutant proteins (lanes 3 - 9 )  and 
also stable deletion mutant proteins (lanes 10 and 11) .
3.2.5 Analysis of Replicative ability of Mutant UL9 
Proteins Expressed By Recombinant Baculoviruses
It was reported by Stow, (1992) that seven 
baculoviruses expressing the seven essential HSV-1 DNA 
replication proteins can, in a mixed infection, support 
HSV-1 origin dependent replication of a co-transfected 
plasmid.
To determine whether the UL9 mutations affected 
origin-dependent replication similar replication 
experiments were performed in which the wt AcUL9 virus 
was substituted with each of the nine viruses expressing 
mutated UL9 polypeptides.
Stocks of seven recombinant baculoviruses, each 
expressing a functional wt copy of one of the seven 
essential replication genes under the control of the 
polyhedrin promoter were provided by Dr N.D. Stow.
Sf cells in Linbro wells were transfected with plasmid 
pEC8, which contains a functional copy of the HSV-1 orig 
replication origin using a liposome-mediated transfection 
procedure. After 4 hours at 28°C, the Sf cells were 
subsequently superinfected with a mixture of viruses 
expressing the seven replication proteins (AcUL5, AcUL8, 
AcUL2 9, AcUL30, AcUL42, AcUL52 plus AcUL9 or one of the 
recombinants expressing a mutated UL9 protein). Total 
cellular DNA was prepared from the cells at 50 hpi and 
examined for the presence of replicated (Dpnl-resistant) 
plasmid sequences by cleaving with EcoRI and Dpnl. The 
resulting fragments were resolved on 1% agarose gels, 
transferred to nylon membranes and hybridised to 32p_ 
labelled pAT153 DNA. The results are shown in Figure 36.
A band corresponding to replicated input plasmid DNA, 
which co-migrated with EcoRI-cleaved pEC8 (lane 1), was 
detected in the samples from cells infected with all 
seven wt viruses (lane 4), the six wt viruses plus 
AcMAI630 (lane 7), and the six wt viruses plus AcMAI719
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Figure 36. Replication of an Oriq-containing Plasmid
Sf cells were transfected with plasmid pEC8 
(containing a functional orig) and either mock-infected 
(lane 2) or super-infected with a mixture containing 5 
pfu of each of the six recombinant baculoviruses AcUL5, 
AcUL8, AcUL29, AcUL30, AcUL42 and AcUL52 (lane 3), all 
six viruses plus AcUL9 (lane 4) or all six viruses plus 
one of the AcUL9 mutants: lane 5, AcMAI581; lane 6 
AcMAI591; lane 7 AcMAI630; lane 8 AcMAI652; lane 9,
AcMAI668; lane 10, AcMAI719; lane 11, AcMAI799; lane 12, 
AcMAD50; lane 13, AcMAD62; lane 14, mock infected. One 
third of the DNA recovered from the infected cells at 50 
hpi was digested with EcoRI and Dpnl and the fragments 
resolved on a 1% agarose gel alongside linearised pEC8 
(lane 1). Replicated plasmid molecules were detected by 
Southern blotting using 32p_ia);5eiie(^  plasmid pAT153 as a 
probe. An autoradiograph of the washed filter is shown. 
The position of Dpnl resistant EcoRI-cleaved molecules 
is indicated by an arrow. The smaller fragments detected 
are Dpnl cleavage products of unreplicated input plasmid 
DNA.
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(lane 10). The degree of DNA replication observed with 
AcMAI630 was slightly higher than with wt AcUL9 while the 
infection including AcMAI719 shows a much reduced level 
of plasmid amplification. Replicated plasmid DNA was not 
detected in any of the remaining samples.
Of the mutations tested in this assay those amino 
acid insertions which abolished DNA binding of the UL9 
fusion proteins also abolish the ability of the full 
length mutant protein to function in origin dependent DNA 
replication. Of the mutations tested which showed 
positive binding of UL9 fusion proteins to orig 
sequences, an insertion at amino acid 799 in the full 
length UL9 protein also failed to produce a protein 
functional in DNA replication. Insertions at two further 
positions (mutants AcMAl630 and AcMAI719) however, 
generated products which were functional in the 
replication assay, and resulted in either greater than or 
less than wt levels of DNA replication respectively.
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CHAPTER 4: DISCUSSION
4.1 FUSION PROTEIN EXPRESSION IN E.COLI
Weir et al., (1989) had previously expressed
fragments of the UL9 polypeptide fused to Staphylococcus 
aureus protein A in E.coli, and demonstrated that the C- 
terminal 317 amino acids specify all the structural 
information required for sequence-specific recognition 
and binding. The E.coli expression system used in these 
experiments provided a very convenient source of DNA 
binding activity. Bacterial extracts were simple to 
prepare and because DNA binding activity remained stable 
at -70°C for a few months, this system appeared to be 
ideal for use in a mutagenic analysis of the UL9 DNA 
binding domain.
In the work of Weir et al., (1989), fusion proteins
were expressed under the control of the bacteriophage 
lambda Pr promoter and synthesis was induced by 
temperature upshift of an E . coli host containing a t_s 
bacteriophage lambda repressor. This method ensured that 
protein expression could be controlled and minimalised 
any toxic effect the foreign protein may have had on its 
host.
In preliminary experiments I examined the expression 
of origin-binding activity by another E .coli host (DH5) 
lacking the lambda repressor, which had been transformed 
with the same fusion protein expressing plasmid, pBl. 
Extracts were prepared and their orig binding activity 
compared with the heat induced activity from the E .coli 
strain K12A HIAtrp carrying the lambda repressor, in a 
gel retardation assay.
Efficient constitutive expression of UL9 fusion 
proteins was demonstrated in DH5 cells. As this method of 
expression was much more convenient to use since a 
temperature shift stage was not needed and did not appear 
to have a detrimental effect on the host, DH5 cells were 
chosen for all subsequent experiments with fusion 
proteins.
Another advantage of expressing the DNA binding
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domain fused to protein A was that it also provided an 
easy tag for identifying the expressed proteins in 
Western blot assays. Initially, because of a lack of good 
antibodies against the HSV-1 UL9 protein, detection of 
the fusion protein proved to be difficult. The only 
suitable antibody available at the time was a rabbit 
antibody which had been raised against a peptide 
corresponding to the C-terminal 10 amino acids of UL9 
protein (Olivo et al., 1988). Unfortunately, the antibody 
was of low affinity and produced a high non-specific 
background in Western blot assays. In addition, it was in 
short supply being a gift from Dr M.Challberg. Also, any 
mutation eliminating the antibody's epitope would render 
it useless in detecting the mutant protein. An 
alternative method was therefore developed which did not 
rely on a primary UL9-specific antibody for detection. In 
this method, fusion proteins were specifically detected 
due to the interaction of their protein A moiety with the 
Fc region of the antibody conjugate. This method provided 
a very specific detection system with no background 
problems and was suitable for all the mutants isolated.
In addition, because the primary antibody incubation step 
was omitted, it also proved to be quicker and more 
convenient.
This method should be generally applicable and be of 
particular use when no specific antibody to the protein 
under study is available.
4.2 MUTATIONAL ANALYSIS OF THE UL9 DMA BINDING DOMAIN
Although Weir et al., (1989) had demonstrated that 
the UL9 DNA binding domain was contained within the C- 
terminal one third of the protein (amino acids 535 - 
851), at the start of this study it was unclear as to 
which residues within this region were important for 
sequence-specific DNA binding. During the course of this 
work Deb and Deb (1991) narrowed the DNA binding domain 
to within a 269 amino acid segment (amino acids 564 - 
832). My aim was to carry out a mutational study of the 
DNA binding domain in order to identify the structurally
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important regions required for UL9/origin interactions.
By analysing a series of mutants with C-terminal 
deletions of varying lengths a C-terminal boundary for 
the DNA binding domain was defined, (See section 4.3).
It was also desired to examine the effect of 
mutations within the DNA binding domain which, in 
principle, could be introduced at pre-selected or random 
locations. Although sequences conserved within UL9 
homologues may have provided a useful target for 
mutagenesis, it was also of interest to determine whether 
poorly conserved regions of the C-terminal domain were 
essential for its function. For this reason a series of 
linker insertion mutations were introduced essentially at 
random throughout the region.
4.3 THE UL9 DNA BINDING DOMAIN
DNA sequence motifs identical to those recognised by 
HSV-1 UL9 have been identified within the known or 
presumed replication origins of other members of the 
alphaherpesvirus subfamily (Stow and Davison, 1986; 
Baumann et al., 1989; Nicolson et al., 1990). These too 
share a similar location either adjacent to or within an 
A + T-rich palindromic region. DNA sequence analysis thus 
far has revealed the presence of UL9 gene homologues 
within the genomes of varicella zoster virus (VZV) and 
equine herpesvirus type 1 (EHV-1), (genes 51 and 53 
respectively). Like UL9, the VZV gene 51 product has been 
shown to bind specifically to DNA sequences within its 
own origin. Indeed, Stow et al., (1990) demonstrated that 
the C-terminal 322 amino acids of the VZV counterpart was 
able to bind specifically to the conserved UL9 
recognition sequence.
A comparison of the aligned amino acid sequences of 
all three origin binding proteins revealed that 86 of the 
317 residues within the UL9 DNA binding domain were 
conserved in both the VZV and EHV-1 homologues. The 
positions of these residues are indicated on the amino 
acid sequence of the UL9 DNA binding domain shown in 
Figure 37, which also summarises the results from
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Figure 37. Summary of Results
Amino acids 535 - 851 of UL9 are shown with the 
positions at which identical residues are present in the 
VZV gene 51 and EHV-1 gene 53 products indicated by 
asterisks. The positions of insertion and deletion 
mutants described in this thesis are shown above the 
sequence with their binding ability indicated in 
parentheses. The positions and phenotypes of mutants 
described by Deb and Deb (1991) (“f / h. andj ) and 
Martinez et al./ (1992) ( I. and Cf.) are similarly 
indicated . The N-terminal boundary of
the DNA binding domain as identified by Deb and Deb 
(1991) lies within either region c or d (the intervening 
amino acids are not essential) and their C-terminal 
boundary within region e. The boxed sequences a and b 
indicate the pseudo-leucine zipper and helix-turn-helix- 
motifs proposed by Deb and Deb (1991).
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mutagenesis experiments from two other laboratories (Deb 
and Deb, 1991; Martinez et al., 1992).
Deb and Deb, (1991) reported that the N-terminal 
boundary of the DNA binding domain is most probably 
located between residues 565 and 596 (although the 
presence of essential amino acids between positions 535 
and 541 was not excluded by their experiments). The 
presence of inactivating mutations within this N-terminal 
boundary region (mutants 1581 and 1591 described in this 
thesis) indeed supports their conclusion.
Deb and Deb (1991) previously referred to the sequence 
spanning amino acids 570 - 591 as a pseudo-leucine zipper 
(LMRNLNSLMGRTRF_IYLALLEA) in which the underlined residues 
form the proposed heptad repeat). This region is clearly 
important for sequence-specific DNA binding since the 
insertions in mutants 1581 and 1591 inactivates binding. 
Two observations however suggest it is unlikely to act as 
a traditional leucine zipper. First, the heptad repeat 
residues are not well conserved in the alligned VZV and 
EHV-1 sequences (VFKALACPIEQPRLVNTAILGA and 
LLVELNSPIVREQFVNVAVLGA, respectively), and second, amino 
acids involved in UL9 dimerisation are located outside 
the DNA binding domain (Elias et al., 1992).
The results from the gel retardation assays 
demonstrate that a deletion of up to 33 amino acids from 
the UL9 C-terminus can be tolerated without affecting the 
protein's ability to bind specifically to orig. Deletions 
of 50 amino acids and greater however completely 
abolished this binding activity. My study therefore 
places the C-terminal boundary of the DNA binding domain 
between residues 802 and 818 (defined by mutants D50 and 
D34) indicating that this region must contain essential
e.
sequences required for sequnce-specific DNA recognition. 
This finding is in agreement with and further refines the 
mapping of the C-terminal boundary between amino acids 
833 and 805 (Deb and Deb, 1991). Interestingly, the 
sequences close to the C-terminus (amino acids 839 - 851) 
represent one of the more conserved regions within the C- 
terminal one third of the protein (Figure 37). The
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presence of conserved residues suggests that the C- 
terminus of UL9 may be involved in a function other than 
origin binding.
Gel retardation analysis of the insertion mutants 
demonstrated that four amino acid insertions introduced 
at amino acid positions 691, 708, 719 and 838 did not 
affect sequence-specific binding of UL9 to orig. 
Insertions at amino acid positions 581, 591, 652 and 668 
however abolished this interaction. Two further 
insertions at positions 630 and 799, generated proteins 
which exhibited reduced orig binding activities.
Binding experiments carried out at an increased 
temperature (37°C) revealed that the weak binding of 
mutant 1630 was t£. In addition, binding of the 1630 
protein to the complete orig fragment produced a single 
retarded complex with a higher mobility than that 
observed for the wt product specified by pBl. Binding of 
the other mutants to the complete oris also resulted in 
the production of this higher mobility complex as a minor 
band together with a major complex of the same mobility 
as that produced with the wt UL9 fusion protein. The most 
likely explanation is that the lower mobility major 
complex represents DNA molecules with protein bound to 
both sites I and II while the higher mobilty complex 
represents molecules with protein bound to only a 
single site.
Mutant 17 99 also exhibited reduced binding to orig 
sequences, particularly to the lower affinity site II. 
Indeed, binding to the complete oris fragment produced a 
major retarded complex whose electrophoretic mobility was 
intermediate between the major and minor complexes 
produced with the other mutants (Figure 29a and b, lane 
11). The explanation for this is unclear. It is possible 
that the mutant protein has an altered conformation which 
may effect the mobility of the complex in polyacrylamide 
gels. This explanation however seems unlikely since a 
corresponding increase in electrophoretic mobility was 
not observed for the complex with the site I 
oligonucleotide (Figure 27a and b, lane 11). An
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alternative explanation is that the 17 99 protein exhibits 
slightly weaker binding than the other mutants and tends 
to dissociate from and reassociate with the probe during 
electrophoresis. This may also explain the streaking 
effect observed with 1799 protein in the presence of site 
I oligonucleotide.
Three of the insertion mutants which were unaffected 
in their interactions with sites I and II (1691, 1708 and 
1719) are grouped near the centre of the DNA binding 
domain and identify a region of the protein which appears 
relatively tolerant of change. Two of these insertions 
(1708 and 1719) lie within a helix-turn-helix motif 
(amino acids 698 - 733) predicted by Deb and Deb (1991) 
using the method of Chou and Fasman (1978). An 
independent mutant with a two amino acid insertion within 
this region was unimpaired in its replicative function 
(Martinez et al., 1992). It therefore seems very unlikely 
that the sequences comprising the predicted helix-turn- 
helix motif are involved in DNA binding.
In order to investigate whether the mutations which 
had abolished ability to bind orig had altered the 
structure of the proteins, the secondary structure of the 
DNA binding domains of wt UL9 and the 10 UL9 insertion 
mutants were predicted using the method of Chou and 
Fasman, (1978). In general the insertion of 4 amino acids 
did not appear to have much effect on the predicted 
secondary structure of the mutants compared with wt. 
Indeed the mutant which exhibited the most significant 
change to its predicted structure, was 1719 whose binding 
ability was not significantly altered by the mutation.
The picture which emerges from these studies of the 
UL9 C-terminal DNA binding domain is that sequence- 
specific binding does not appear to be associated with a 
single discrete stretch of amino acids. Rather, residues 
toward either end, separated by at least 200 amino acids 
appear to contribute. It is not known whether the 
inactivating mutations affect parts of the protein which 
interact directly with the DNA target or whether they 
operate indirectly through changes in protein
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conformation. Since the UL9 protein and its VZV and EHV-1 
counterparts recognise identical seuences, it is tempting 
to speculate that the most conserved parts of the DNA 
binding domain would participate in sequence-specific 
recognition. Unfortunately, mutations within two 
particularly conserved segments (amino acids 746 - 762 
and 111 - 190) have not yet been examined. It is 
nevertheless interesting to note that one mutant, 1799, 
with an insertion close to one of these regions appears 
more greatly impaired in its binding to site II than to 
site I suggesting that this region may in fact be 
important for sequence recognition.
4.3.1 Conserved Structures Found in Protein DNA
Binding Domains
Analysis of predicted amino acid sequences and X-ray 
crystallography studies of many sequence-specific DNA 
binding proteins have identified three types of conserved 
structural motifs which proteins use for recognition of 
DNA or in dimerisation; i) Helix-turn-helix motif, ii) 
Leucine zipper motif, iii) Zinc finger motif (Anderson et 
a l., 1981; Landshulz et a l., 1988). Much of this work has 
arisen from the extensive study of DNA binding proteins 
such as gene activator and repressor proteins.
(a) Helix-turn-helix motif
The helix-turn helix motif is characterised by two 
successive alpha helices juxtaposed at an angle of 
approximately 90° by a turn of 4 amino acids (Steitz et 
al., 1982). Some bacterial gene regulatory proteins use 
this motif for dimerisation on the target sequence where 
one alpha helix from each monomer is arranged in such a 
way to fit into successive major grooves of DNA. These 
are then held in position due to hydrophobic 
interactions. Helix-turn-helix motifs are also found in 
many eukaryotic homeo domains.
When statistical procedures based on known helix- 
turn-helix DNA-binding motifs (Brennan and Mathews, 1989) 
were used on the predicted amino acid sequence of UL9, no
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part of the DNA binding domain scored very highly (Weir, 
1990, Ph.D. thesis). Thus, if UL9 utilises this type of 
motif to bind DNA it is likely to be substantially 
different from other helix-turn-helix structures.
Moreover as discussed above, the properties of insertion 
mutants with alterations in the helix-turn-helix region 
postulated by Deb and deb, (1991), suggest that this 
region (what ever its actual structure) is not important 
for DNA binding.
(b) Leucine Zipper Motif
The leucine zipper was first described by Landschultz 
et a l ., 1988, as a motif involved in sequence-specific 
DNA binding and dimerisation. This motif contains 4 - 5  
leucine residues separated from each other by six amino 
acid residues [ie. (L X X X X X X)4 _5 ] within a sequence 
which can form a stable alpha helix. Adjacent to this 
region lies a stretch of basic amino acid residues. It 
has been proposed that during dimerisation, the leucine 
side chains of one alpha helix interdigitate with those 
of a matching helix from a second polypeptide to form a 
stable non-covalent interaction. This leads to a 
particular positioning of the basic regions of the two 
polypeptides in a manner suitable for sequence-specific 
recognition of DNA (Landschultz et a l ., 1988).
Within the UL9 amino acid sequence, a motif
containing four leucine repeat elements is located 
between residues 150 - 170. This region however does not 
lie adjacent to a basic segment and the leucine residues 
do not appear to reside within a predicted stable alpha 
helix. These points and the fact that it also lies 
outwith the DNA binding domain suggest that it does not 
play a significant role in DNA binding. However this 
motif may be important in UL9 dimerisation since the 
whole protein but not the isolated C-terminal DNA binding 
domain exists as a dimer in solution. It has also been 
suggested that the leucine zipper may allow the formation 
of heterodimers so long as each subunit contains such a
motif (Landschultz et al., 1988). Thus, this motif may
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enable interaction of UL9 with other replication 
proteins.
As described above, a second leucine repeat is 
located within the DNA binding domain of UL9 from 
positions 570 - 593, but again this region does not 
appear to be a traditional leucine zipper motif as there 
are no adjoining basic residues and 8 residues lie 
between the second and third leucine.
(c) Zinc Finger Motif
Many eukaryotic gene regulatory proteins contain zinc 
finger motifs, (Berg, 1986) which comprise a repeating 
motif of cysteine and histidine residues. Studies have 
shown that the cysteine/histidine motif complexes with a 
zinc ion. The resulting tetrahedral coordination of this 
complex is known to impart a stable conformation which in 
some instances is associated with DNA sequence-specific 
binding of the protein (Diakun et al., 1986). No such 
motif occurs within the UL9 sequence.
It is clear from studies made thus far that the UL9 
protein does not contain any obvious counterpart of 
structural motifs identified in other sequence-specific 
DNA binding proteins and that a more detailed 
understanding of sequence specific recognition is needed. 
Hopefully this will be achieved using techniques such as 
specific mutagenesis of single amino acids within the DNA 
binding domain to pin point essential residues involved 
in these interactions. In addition, chemical cross 
linking of the protein to DNA followed by protease 
digestion could identify the peptides protected by 
binding and ultimately single amino acids involved. 
Purification of the protein would also enable the 
interactions to be examined by X-ray crystallography.
4.4 THE EFFECT OF MUTATIONS ON UL9 FUNCTION DURING HSV-1 
ORIGIN DEPENDENT DNA SYNTHESIS
Although it was convenient to study the effect of 
mutations on the ability of UL9 to bind to HSV-1 origin
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sequences by expressing the DNA binding domain as part of 
a fusion protein, it was not possible to directly relate 
these results to the overall function of UL9 during HSV-1 
origin dependent DNA synthesis. Several C-terminal 
mutations were therefore introduced into the whole UL9 
gene and the mutated proteins expressed by recombinant 
baculoviruses in order to investigate whether the 
alterations had any effect on the replicative function of 
the intact protein.
This system is routinely used in the lab and was 
chosen because it would allow high level expression of 
mutant UL9 proteins which would facilitate future 
biochemical studies and also the screening of mutant 
proteins for ability to participate in a transient origin 
dependent DNA replication assay (Stow, 1992).
Mutations were introduced into the full length gene 
by inserting the appropriate C-terminal fragments into a 
specially constructed baculovirus transfer vector 
containing the polyhedrin promoter and the N-terminal two 
thirds of the UL9 gene flanked by baculovirus DNA 
sequences.
The proportion of recombinants generated within 
insect cells co-transfected with transfer vector and 
infectious circular AcNPV genomes is usually very low 
which makes the identification of recombinant 
baculoviruses against a high background of parental virus 
very difficult. In view of this problem I used a method 
developed by Kitts et al., (1990) for increasing the
percentage of recombinants among the progeny virus. This 
method is based on the fact that viral DNA linearised 
within the non-essential polyhedrin locus is of extremely 
low infectivity. Recombination events between the 
linearised genome and circular transfer vector to 
generate circular infectious AcNPV molecules are 
therefore strongly selected (Figure 38). Such events 
concommitantly insert the gene of interest into the AcNPV 
genome and as a result the proportion of recombinants in 
the progeny is greatly increased.
As a parental virus I used an engineered derivative
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Figure 38. Rescue of Linear Viral DMA by Recombination
with a Transfer Vector
Upper panel: linear DNA cannot replicate because the 
replication apparatus of AcNPV is designed to work on 
the native viral DNA which is circular.
Lower panel: the circularity of the viral DNA can be 
restored by recombination with a transfer vector 
carrying DNA homologous to the viral sequences on either 
side of the break. A double crossover generates a 
recombinant viral DNA molecule which, being circular, is 
competent for replication (reproduced from Kitts et a l ., 
1990).
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of AcNPV, AcRP231acZ (Possee and Howard, 1987), which 
contains the E.coli lacZ gene encoding B-galactosidase, 
inserted into the viral DNA at the polyhedrin locus. The 
virus contains a unique Bsu36l within the lacZ gene.
Since recombination between linear parental DNA and 
transfer vector deletes the lacZ gene, recombinants can 
be recognised by their failure to express a functional 
B-galactosidase product. Using a chromogenic substrate, 
recombinant viruses can be easily identified since, in 
contrast to the parental virus, they form white plaques. 
White plaques may also arise as a result of 
recircularisation of parental DNA by processes that 
disrupt DNA sequences around the double strand break and 
result in the generation of a mutated lacZ gene.
It was therefore necessary to confirm the expression 
of UL9 polypeptides by recombinant viruses using SDS- 
PAGE, Western blot assays and radiolabelling of proteins. 
As discussed earlier, the only antibody available for 
Western blot assays was of low affinity, and non- 
specifically detected a large range of proteins. It 
nevertheless allowed expression of the seven UL9 
polypeptides containing insertions mutations to be 
unambiguously demonstrated. The two recombinant viruses 
carrying deletion mutations could not be tested on 
Western blot assays using the UL9 antibody because the 
antibody epitope had been deleted. However, by 
radiolabelling the proteins expressed by the recombinant 
baculoviruses, expression of all the mutant UL9 proteins, 
including the C-terminal truncations, was demonstrated.
Using an in vitro replication assay developed by Stow, 
(1992) I confirmed that multiple infection of Sf insect 
cells with seven recombinant baculoviruses expressing the 
seven essential HSV-1 DNA replication proteins 
facilitated replication of a co-transfected HSV-1 oris- 
containing plasmid. Using the same assay and by 
substituting the wt UL9 recombinant baculovirus with each 
of the mutant UL9 viruses it was possible to investigate 
the effect of the alterations on UL9 function in origin- 
dependent DNA replication.
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Each of the mutations which had previously been shown 
to abolish DNA binding activity also prevented 
replication of the HSV-1 oris~containing plasmid 
suggesting that the interaction of UL9 with the origin is 
essential for the process of DNA replication. Of the 
mutant proteins which retained their DNA binding activity 
(AcMAI799, AcMAl630, AcMAI719), one failed to promote 
replication of the origin-containing plasmid (AcMAI799) 
while the others showed slightly higher than wt 
(AcMAl630) or diminished levels of activity (AcMAI719).
The mutation in AcMAI7 99, although not abolishing UL9 
DNA binding activity, may have altered the structure of 
part of the protein which is not required for binding but 
has some other essential function in DNA replication.
This might be an interaction with either other HSV-1 DNA 
replication proteins or perhaps cellular proteins which 
may play a role in replication. Interestingly this mutant 
also exhibits a reduced binding activity towards orig 
binding site II. It is possible that due to its reduced 
binding, appropriate protein/protein interactions between 
UL9 molecules bound to binding sites I and II may not be 
able to occur.
The diminished levels of replication observed with 
mutant AcMAI719 whose cognate fusion protein exhibited 
binding activity indistinguishable from wt may also be 
the result of the insertion altering an important site of 
interaction with other essential proteins or perhaps even 
interactions between UL9 molecules.
Mutant AcMAl630 exhibited a somewhat surprising 
result: although its ability to interact with the origin 
was impaired by the introduced insertion mutation, 
replication of the orig-containing plasmid was greater in 
its presence than in the presence of the wt UL9 protein. 
The reason for this unexpected result is unclear. One 
possibility may be that the insertion alters the protein 
structure in such a way that although its affinity for 
the origin is decreased, its affinity for one of the 
other components of the replicative machinery or a 
cellular protein important for DNA replication is
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enhanced. It is also possible that UL9 may act in a 
negative regulatory manner during HSV-1 DNA replication. 
The mutation at amino acid 630 may affect this role by 
decreasing the ability of UL9 to down regulate 
replication resulting in levels of replication greater 
than wt.
Clearly the production of these mutations has 
provided the basis for a number of future experiments. It 
is firstly important to repeat the origin binding assays 
using the intact mutant UL9 polypeptides to determine 
whether they exhibit identical origin binding properties 
to those observed with the Protein A/UL9 fusion proteins. 
Because the mutant UL9 proteins can be expressed in large 
quantities using the baculovirus system, they can be 
tested for various biochemical activities including 
nuclear localisation and helicase activities. By 
performing helicase assays, one could investigate whether 
the sequence-specific DNA binding function of UL9 is 
necessary for helicase activity of the protein.
The in vitro replication assay described earlier 
could also be used to investigate whether different 
defective mutants are able to complement one another.
This is of particular interest since the possibility of 
intragenic complementation is suggested by observations 
that UL9 exists as a dimer in solution. Finally, it will 
be interesting to perform similar experiments to 
determine whether UL9 homologues encoded by other alpha 
herpesviruses can substitute for the UL9 protein in HSV-1 
origin-dependent DNA replication.
4.4.1 Comparison of Two Assays Osed To Study In vitro 
HSV origin Dependent DMA Synthesis
The ability of mutant UL9 proteins to support 
replication has been analysed by other groups using a 
transient replication complementation assay (Zhu and 
Weller, 1992a). This assay is also based on the 
observation that a HSV origin-containing plasmid can be 
amplified in a transient transfection experiment if all 
the necessary trans-acting functions are provided either
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by superinfection with HSV or by co-transfection with 
plasmids encoding the set of essential replication 
proteins.
Weller and collegues used a viral null mutant in 
which the lacZ gene had been inserted within the UL9 
coding sequence. This virus is completely defective in 
viral growth and DNA synthesis, and is propagated on a 
complementing cell line which expresses wt UL9 protein.
Their assay involves the introduction of two plasmids 
into cells by transfection, one of which contains the 
HSV-1 origin, oris, while the other expresses the mutant 
UL9 product under the control of the UL39 promoter (Zhu 
and Weller, 1992a). These cells are subsequently super­
infected with the UL9 null mutant virus which provides 
the other six replication genes and viral factors which 
trans-induce the UL39 promoter. Only if the mutation 
within the transfected UL9 gene does not disrupt 
replicative function will amplification of the oris- 
containing plasmid and complementation of the mutant 
virus occur.
Both this approach and the baculovirus system 
therefore provide a general method of assaying the effect 
of introduced amino acid changes on the ability of the 
replication proteins to function in viral DNA 
replication. There are however various advantages and 
disadvantages to both systems.
The assay described by Zhu and Weller (1992a), is 
convenient because mutations generated by site-directed 
mutagenesis of a UL9 containing plasmid can be assayed 
immediately without the time consuming generation of 
recombinant viruses. This system may also more closely 
resemble what happens in vivo as the other six essential 
replication genes are expressed from their own promoters 
within the HSV-1 genome.
A possible disadvantage of the baculovirus system is 
that the overexpressed replication proteins may not be 
present in the optimum amounts or ratios for efficient 
DNA replication. However, a major advantage to expressing 
mutant polypeptides using recombinant baculoviruses is
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that in addition to assaying for the ability of the 
protein to function in viral replication, amounts of 
protein suitable for biochemical examination can be 
obtained.
4.4.2 Functions of UL9 other than DMA. Binding
The sequence of the UL9 gene has been determined and 
the amino acid sequence of the encoded protein predicted 
(McGeoch et al., 1988a;b;). Figure 39 shows the predicted 
amino acid sequence of the HSV-1 UL9 protein (amino acids 
1 - 851) and indicates the locations of several 
interesting features which have been noted during the 
analysis of the sequence.
(a) Dimerisation
UL9 contains a putative leucine zipper motif towards 
its N-terminus (between amino acids 150 and 170). As 
mentioned earlier these motifs are common to several DNA 
binding proteins and are believed to signal regions of 
protein/protein interactions. Results with mutations 
producing alterations to the leucine residues of the 
leucine zipper motif within the N-terminus of UL9 suggest 
that these leucines are essential for UL9 function 
(Martinez et al., 1992). Whether the leucine zipper motif 
represents a site for dimerisation or for the interaction 
of UL9 with other members of the replicative machinery 
however remains to be elucidated. Indeed Elias et al., 
(1992) reported that the structural elements required for 
the cooperative binding of the HSV UL9 protein to orig 
reside in the N-terminal part of the protein.
(b) UL9 as a helicase
The UL9 protein has been shown to exhibit a 3' - 5' 
intrinsic DNA helicase activity (Fierer and Challberg, 
1992; Bruckner et al., 1992)). The finding that UL9 
exhibited a helicase activity suggested that the protein 
may act to initiate DNA synthesis after binding to the 
origin by catalysing the unwinding of the two parental 
strands. Studies have revealed that UL9 is capable of
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Figure 39. Primary Structure of the UL9 Polypeptide
The predicted amino acid sequence (residues 1 - 851) 
of the HSV-1 UL9 protein is shown in the single letter 
amino acid code. The six conserved helicase motifs 
predicted by Gorbalenya et al., 1989 (motifs I - VI) are 
highlighted within boxes. Motif I and II contain the NTP 
binding sites predicted by Gorbalenya and Koonin,
(1989). Leucine residues within potential leucine zipper 
motifs have been indicated by asterisks (*) above the 
sequence. The C-terminal DNA binding domain (amino acids 
535 - 851) has been outlined but a more detailed picture 
can bee seen in Figure 37.
1 MP FVG6 AES GDPLGAGRPIGDDECEQYTS SVSLARMLY GGDLAEWVPRVH
51 PKTTIERQQHGPVTFPNASAPTARCVTj/VRAPMGSGKTTALt RWLREAIH
Motif I
  (*)
101 SPDTSVLWSCRRSFTQTLATRFAESGLVDFVTYFSSTNYIMNDRPFHRL
(*) (*) (*)
151 IVQVES LHRVGPNLfiMNYDVLVLDEVMSTL^QLY S PTMQQLGRVDALMLR
Motif II
201 LLRICPR3 IAMDATANAQLVI 
Motif III
FLCGLRGEKNVHVWGEYAMPGFSARRCL
251 FLPRLGTELLQAALRPPGPPSGPSPDASPEARGATFFGELEARLGGG1|NI
351 VTVGLSFE 
Motif V
301 Cl FSSTVSFAEp: VARFCRQFTDRVLLLHSLTPLGDVTTWGQYRVVIYTTV 
Motif IV
PLHFDGMFAYVKPMNY
Motif VI
ELLIYM
401 DGSGARSEPVFTPMLLNHWSSCGQWPAQFSQVTNLLCRRFKGRCDASAC
451 DTSLGRGSRIYNKFRYKHYFERCTLACLSDSLNILHMLLTLNCIRVRFWG
I  ......... »
501 HDDTLTPKDFCLFLRGVHFDALRAQRDLRELRCRDPEASLPAQAAETEE V
(*) (*) (*) (*)
551 GLFVEKYLRSDVAPAEIVALMRNLNSLMGRTRFIYLALLEACLRVPMATR
601 SSAIFRRIYDHYATGVIPTINVTGELELVALPPTLNVTPVWELLCLCSTM
651 AARLHWDSAAGGSGRTFGPDDVLDLLTPHYDRYMQLVFELGHCNVTDGLL
701 LSEEAVKRVADALSGCPPRGSVSETDHAVALFKIIWGELFGVQMAKSTQT
751 FPGAGRVKNLTKQTIVGLLDAHHIDHSACRTHRQLYALLMAHKREFAGAR
801 FKLRVP AWGRCLRTH S S S ANPNAD11LEAALSELPTE AWPMMQGAVNF ST
851 L
unwinding long segments of duplex DNA in the presence of 
the HSV-encoded ss-DNA binding protein (Fierer and 
Challberg, 1992). Unfortunately, origin-specific 
unwinding by UL9 has yet to be demonstrated. It is 
possible that the optimum experimental conditions to 
detect origin unwinding have not been found or that other 
factors such as a cellular component may be needed.
Nevertheless, strong evidence exists that the 
helicase activity is essential for viral DNA replication 
since insertion mutations within the six conserved 
helicase domains present within the N-terminal one third 
of the protein rendered the protein inactive for DNA 
replication.
(c) Nuclear Localisation
Nuclear localisation studies have shown that the UL9 
protein is capable of entering the cell nucleus without 
the aid of other components of the replicative machinery 
(Calder et al., 1992). The sites to which UL9 localises 
resemble the pre-replicative sites to which the mDBP 
localises when DNA synthesis is blocked. Whether these 
sites are functionally equivalent however remains to be 
determined. In view of these observations it appears 
likely that the UL9 polypeptide contains a nuclear 
localisation signal although no obvious candidate has yet 
been identified.
(d) Interaction with other HSV-1 Replication Proteins
None of the other replication proteins have yet been 
shown to interact with UL9, but by analogy with other DNA 
replication initiator proteins it is likely that such 
interactions do occur.
(e) Interaction with cellular proteins
Studies of the interactions between UL9 and orig have 
demonstrated the existence of a cellular factor(s) which 
is capable of binding to the HSV-1 orig (Dabrowski and 
Schaffer, 1991). This factor(s) was also shown to enhance 
complex formation between the UL9 protein and site I DNA,
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suggesting that the cellular factor (s) may facilitate 
initiation of HSV-1 DNA synthesis by enhancing the 
UL9/origin interaction (Dabrowski and Schaffer, 1991).
The identification of this factor and a detailed study of 
its interaction with UL9 and the origin would be of 
considerable interest.
Cellular transcription factors have been shown to be 
involved in the initiation of bovine papilloma virus, 
adenovirus and SV40 virus DNA synthesis (Yang et al., 
1991; Guo et al., 1989). It is interesting to note that 
in HSV-1, both oriL and orig lie close to or within viral 
promoter regions and it is possible that cellular 
transcriptional activators binding to these sequences may 
be involved in initiation of DNA synthesis. For example, 
HSV-1 orig is surrounded by multiple Spl-binding sites 
(Jones and Tjian, 1985) generating the possibility of a 
significant interaction between OBP and Spl at the 
origin.
Further biochemical characterisation and isolation of 
additional mutations across the UL9 gene are required for 
a more complete understanding of the domain structure of 
this multifunctional protein.
4.5 THE ROLE OF UL.9 IN THE INITIATION OF HSV-1 DNA
SYNTHESIS
The events following the interaction of UL9 with HSV- 
1 origin sequences which lead to initiation of viral DNA 
synthesis are not yet well understood.
In vitro studies have demonstrated that UL9 exhibits 
several interesting properties which include the ability 
to form dimers in solution, a DNA-dependent nucleoside 
5'-triphosphatase activity, cooperative origin specific 
DNA-binding activity and a DNA helicase activity.
A prelude to the initiation of daughter strand 
synthesis is the unwinding of the two parental strands.
By analogy with other prokaryotic and eukaryotic 
initiator proteins, it has been suggested that the 
binding of UL9 to orig or ori^ is just the first step in
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Figure 40. A Model for the Initiation of HSV DNA
Replication
A model for the initiation of HSV-1 DNA replication 
is outlined opposite. As shown, a putative local 
unwinding event at the origin mediated by the binding of 
UL9 could be followed by the entry of the 
helicase/primase complex (UL5/UL8/UL52). This complex 
could function to enlarge the unwound region, prime 
nascent strands at the origin, and then continue 
unwinding the duplex along the lagging strand template 
as semidiscontinuous DNA synthesis proceeds (reproduced 
from Olivo and Challberg, 1989)
It should be noted that this model could not be used for the 
initiation of VZV as its OBP binding sites are all located 
on one side of the origin palindrome.
5 --------------- Site 1 A/T Site II
—  1
UL9
w)
J M f a l iS l  A/T A A l CT*
ATP f
UL5, UL8, UL52
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